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Introduction: The use of guidelines in prescribing has become part of clinical practice 
in many countries around the world. Guidelines are considered to provide information 
based on scientific evidence from high quality research and hence are expected to lead 
to appropriate prescribing. Prescribing based on evidence is expected to improve 
morbidities and mortalities. Pharmacists in different parts of the world are acquiring a 
clinical professional identity especially in hospital settings where they have moved to 
bed-side roles to become an effective member of the patient–care team. They are thus 
expected to play an important role in assisting appropriate prescribing and have a 
positive impact on patient care. The influence of guidelines on prescribing and the 
practice of clinical pharmacy have not been studied in Sudan. 
Aim: The aim of the study was to investigate the use of guidelines (if any) for 
prescribing by doctors in the main cardiac hospitals in Sudan, and to explore the 
influence of availability (or non-availability) of guidelines on the new role of clinical 
pharmacy in hospitals in Sudan. 
Method: The study used a mixed method approach to examine the study questions. 
Interviews were conducted with the cardiology consultants in two of the main cardiac 
hospitals in Sudan. This was followed by a survey among all the doctors in the 
hospitals. Later on a focus group discussion was carried out with clinical pharmacists in 
the two hospitals followed by an online survey sent to the available email addresses of 
clinical pharmacists in Sudan.  
Results: Twelve prescribers were interviewed and 47 prescribers (60%) replied to the 
questionnaire that followed. The majority of the doctors relied on foreign guidelines to 
prescribe for their patients. The doctors acknowledged the limitation of using foreign 
guidelines in Sudan. Few prescribers were not in favour of following any guidelines as 
they perceived that the practice in Sudan does not allow implementation of guidelines. 
The prescribers were positive about the new role of clinical pharmacists in patient care 
but they seem not to be in contact with these clinical pharmacists. On the other hand, 
four pharmacists participated in one focus group and 51(34%) completed the on-line 
survey. Clinical pharmacists faced a number of obstacles that hindered their progress in 
practice and the unavailability of guidelines was considered to be one of these obstacles. 
Other obstacles were related to the pharmacists themselves, to the lack of senior clinical 
pharmacists for leadership, to the environment they were working in and to the training 
they received in clinical pharmacy. 
Conclusion: The making of guidelines is usually a tedious and costly process.  Medical 
practice in places with limited resources has to rely on guidelines made in foreign 
countries if they want to get the benefits of these guidelines to their patients. The 
prescribers in Sudan had to find a way to adapt foreign guidelines to their patients and 
to the healthcare system they are working within. With regard to the clinical 
pharmacists in Sudan, they are faced with a number of obstacles that they will have to 
overcome in order to advance in their new role. The new clinical pharmacists will have 
to be the leaders to pave the way for clinical pharmacy in Sudan. However, they will 
require support from pharmacy educational institutions, other healthcare professionals 
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The use of clinical guidelines has been adopted in many healthcare 
settings in different parts around the world (Shaneyfelt and Centor, 2009, 
Hewitt-Taylor, 2006). Prescribing guidelines are considered to assist in 
translating the evidence available from clinical trials into clinical practice 
and thus can lead to appropriate prescribing (Feder et al., 1999, Hewitt-
Taylor, 2006, Woolf et al., 1999). Treatment options presented in clinical 
guidelines are derived from scientific evidence and hence it is said to 
improve morbidities and mortalities. However, in addition to the expected 
benefits from guidelines, there are also challenges to the use of 
guidelines, that if not addressed, can lead to guidelines being rejected 
(Berg, 1997, Keeley, 2003, Shaneyfelt and Centor, 2009, Woolf et al., 
1999). One of the main challenges to the use of guidelines is that they 
should be made to suit the patients and the healthcare system in which 
they are supposed to be applied (Keeley, 2003, Lindback et al., 2014, 
WHO, 2007b). This can be a problem in developing countries like Sudan 
where this study was conducted, which may have limited resources to 
construct their own guidelines but at the same time may find international 
guidelines difficult to apply in their healthcare settings.  
 
Another valuable source of information that can increase 
appropriateness in prescribing is the pharmacist (Calvert, 1999). 
Specifically in hospitals, and with the introduction of the clinical pharmacy 
service in hospitals in many countries around the world, these pharmacists 
are expected to have a role in assisting prescribing.  A number of studies 
examined the positive contribution of clinical pharmacists in patient care in 
hospitals (Alison Dale, 2003, Anderson et al., 2010, Bond et al., 2001, 
Boyko et al., 1997, Horning et al., 2007, Howard et al., 2003, Leape et al., 
1999, Miller et al., 2011).  Pharmacists were also found to have a positive 
effect in ensuring that therapy is prescribed as per guidelines (Horning et 
al., 2007). Although the clinical role of pharmacists is well established in 
some countries, it is considered to be a new area of practice in some parts 





Considering the above, that is the use of clinical guidelines in 
prescribing and the potential role of clinical pharmacists in assisting 
prescribing, this research has thus examined the use of clinical guidelines 
in prescribing in Sudan and the new practice of clinical pharmacy in 
hospitals in Sudan with special regard to the influence of availability of 
clinical guidelines on the practice. Prescribing in cardiology was 
purposively  selected for this study due to the increase in prevalence of 
cardiovascular disease in Sudan (Federal Ministry of Health, 2007),  and 
also because it was argued to be one of the clinical disciplines with the 
most guidelines ( Meulen, 2005). 
 
1.1 Aim of the research 
 
The aim of this study was to identify if guidelines are used and can be 
followed in prescribing in cardiology in Sudan, and to identify the influence 
of availability or non-availability of guidelines on the role of clinical hospital 
pharmacists in Sudan together with other challenges facing these 
pharmacists. 
 
1.2 Structure of the thesis 
 
The study was conducted in a sequential manner to encompass all 
areas of inquiry required.  Different methods at different stages were used 
to collect the data for this study. Data collected at different stages helped 
to inform the next phase of the study.  These different stages are 
presented in separate chapters in this thesis. Following this introduction 
chapter, the thesis outline can be described as follows: 
Chapter 2 presents the literature review that underpins this study; 
Chapter 3 outlines the aim, objectives and the main research questions 
of this study  
Chapter 4 presents a framework of the methodology followed to meet 





Chapter 5 discusses the first phase of data collection which was the 
interviews conducted with senior prescribers in cardiology in two of the 
main cardiology hospitals in Sudan. The interviews studied influences on  
prescribing, particularly the use of guidelines, and the prescribers’ 
experience with the new role of clinical pharmacists in their hospitals; 
Chapter 6 presents the survey conducted among cardiology 
prescribers in the two hospitals to examine their views with regard to the 
use of guidelines and their perceptions of the new clinical role of the 
pharmacists; 
Chapter 7 describes the focus group discussion (FGD) that was 
conducted with the clinical pharmacists working in the cardiology 
hospitals. The FGD examined the views of the clinical pharmacists with 
regard to their new role, their contribution to patient care and the 
challenges they were facing in their practice; 
Chapter 8 presents the online survey that was conducted among the 
clinical pharmacists of Sudan to explore their perceptions with regard to  
the role of clinical pharmacists, the obstacles facing clinical pharmacy and  
their views about the use of guidelines in clinical practice in Sudan; 
Chapter 9 provides a final discussion of the key findings of this study, 
the areas of strength of the study, a reflection from the researcher and a 
suggested way forward from the study. 
 
1.3 The Researcher 
 
The idea of this research came from a previous work experience as a 
hospital pharmacist in the United Kingdom covering cardiology wards. 
Although there are different sources of information available nowadays, 
the use of clinical guidelines is considered to be a valuable source of 
information that assists healthcare professionals in the management of 
different medical conditions, and has become a familiar practice in 






by government or specialised bodies very much influenced doctors’  
prescribing and pharmacists’ interventions in hospitals.  As a pharmacist 
from Khartoum in Sudan, this led me to question whether guidelines are 
followed in prescribing for patients in cardiac hospitals in Khartoum  and 
what  influence do guidelines availability has on the  contribution of the 














The aim of this chapter is to provide an overview of the key issues 
underpinning the development of this research project which was 
undertaken in Sudan.  The first section will discuss some of the factors 
influencing prescribing in clinical practice, focusing on the use of clinical 
guidelines in prescribing as for the purpose of this study. The next part of 
the chapter will consider cardiovascular disease as an example of a 
clinical discipline with a large number of guidelines, with special reference 
to Sudan. The final part of this chapter will be about clinical pharmacy 
practice, the use of clinical guidelines by clinical pharmacists, also with 
special regard to the new role of clinical pharmacy in Sudan. The chapter 
is by no means intended to be an exhaustive discussion of all the literature 
behind clinical guidelines and clinical pharmacy but it is meant to provide a 
background for the issues investigated in this research based in Sudan. 
 
 2.2 Literature search criteria 
 
A literature search was conducted at the beginning of the research and 
repeated at various stages during the project. As different aspects were 
examined in this project, the literature search was carried out using 
different search terms to cover the issues to be investigated. In addition, 
as new areas of interest emerged during data collection and were further 
investigated, new search terms were introduced during different stages of 
the literature search as described in Table 2. 
 
The search involved a number of databases mainly Pubmed, Embase 
and Web of Knowledge. In addition journals such as Pharmacy World & 
Science and International Journal of Pharmacy Practice were searched. 
Most of the relevant studies obtained were found using Pubmed. Hence, 
towards the end of the study, the ‘repeat’ literature search was conducted 
using mainly Pubmed. The studies from the literature were selected based 




identified from the title of the study or the abstract. No restriction was put 
on the year of publication, but only studies available in English language 
were selected. 
 
Table 2 Literature search 
 
HISTORY OF LITERATURE 
SEARCH 
SEARCH  TERMS 
 
NUMBER OF RELEVANT 
ARTICLES IDENTIFIED 
 October 2010 
 Web of science, Web of 
Knowledge`, University library 
theses`, IJPP`, UK Pubmed-
central`, Google scholar`, PJ`, 
BMJ. Hospital Pharmacist`, 
Clinical Pharmacy`, the Annals 
of Pharmacotherapy`, NeLM`, 
pharmacy practice.org 
 
Evidence based medicine 
Prescribing and cardiovascular disease 
Cardiovascular disease and Guidelines 
Clinical pharmacy /pharmacist 
Clinical pharmacy and cardiovascular 
disease 
Pharmacists and prescribing 
Hospital pharmacists and interventions 
Clinical pharmacy in Sudan 
Factors influencing clinical decisions 
 
 
 70 relevant articles  
February 2011  
Pubmed, Embase, Web of 
knowledge, NeLM 
Prescribing and Guidelines 
Prescribing and cardiology 
Prescribing decisions 
Factors affecting prescribing 
Sudan and cardiovascular diseases 
Khartoum and cardiovascular disease 








Sudan and cardiovascular diseases  
Sudan and Practice Guidelines  
Hospital and cardiology 
Cardiology and prescribing guidelines  
Hospital pharmacy and Sudan   
Hospital pharmacy and cardiology  
Pharmacy practice and Sudan  
 
2 new relevant articles 
 September 2012 
Pubmed, Embase, Web of 
knowledge 
Prescribing and Guidelines in Sudan 
Prescribing decisions 
Factors affecting prescribing  
Prescribing and cardiology 
Sudan and cardiovascular disease 




No new relevant articles  
April 2013 
Pubmed 
Obstacles in clinical pharmacy practice  
Barriers to clinical pharmacy practice  
Pharmacists and guidelines 
Pharmacists implementing guidelines  
Pharmacists adherence to guidelines  
 
7 new relevant articles 
July 2013 
Pubmed 
Pharmacists adherence to guidelines  
Obstacles and hospital pharmacy  
Factors affecting prescribing  
 
 
5 new relevant  articles 
August 2014 
Pubmed,  
Guidelines and Pharmacists, Pharmacy 
role and guidelines, Pharmacy benefit  
and guidelines 
Guidelines and limited resources  
Pharmacy and professionalism 
Professionalism and guidelines  
 
 







Guidelines and Professionalism 
Clinical pharmacy development 
Appropriate prescribing/Evidence based 
medicine 
Guidelines and clinical experience 
 





2.3 Prescribing of medicinal therapy 
  
 Prescribing has been practised for a long time in history and the 
symbol ‘Rx’ generally used to denote a prescription, is said to have been 
around for centuries. Prescribing of medicinal therapy is the most 
commonly used form of treatment intervention (Lundborg, 1999). The use 
of medicinal therapy has grown dramatically as the range of medication 
used for different diseases has widened. To make sure that patients are 
getting the maximum benefit from their medicinal therapy, prescribers as 
well as other healthcare professionals need to ensure that prescribing is 
conducted appropriately and safely. Healthcare institutions and regulatory 
bodies also play a role in ensuring the appropriateness and safety of 
prescribing.   The World Health Organization (WHO) provided a guide on 
good prescribing with the aim to ensure that the most appropriate choice 
of drug for an individual patient, in the right form and for the right duration 
of time is to be made (World Health Organization, 1994) . The aim from 
the guide was for future prescribers not just to be able to select the right 
drug but also to use existing clinical guidelines to achieve rational and 
appropriate prescribing. Examining the use of clinical guidelines in 
prescribing is one of the aims of this study. 
 
2.4 Appropriate prescribing 
 
The cognitive approach to prescribing is considered to be based on two 
criteria:-  ‘problem solving’, which is the early reasoning process involved 
in diagnosis and ‘decision making’ which is the final opinion and 
judgement part of the clinical decision (Elstein and Schwartz, 2002).  
Prescribing, and in particular appropriate prescribing, is advocated as a 
mixture of science and art (Buetow et al., 1997) . Whereas evidence and 
safety of a certain treatment are the main factors in prescribing, other 
factors like intuition, limited resources and patient related factors have to 
be considered. Thus achieving appropriate prescribing combine both 




One of the definitions given for appropriate prescribing is  when ‘the 
benefits anticipated from the treatment prescribed far outweighs any risks’ 
(Brook, 1994).  Another definition of appropriate prescribing is ‘the 
outcome of a process of decision making that maximizes net individual 
health gains within society available resources’ (Buetow et al., 1997). This 
later definition which relates the individual health gain with the society 
resources in prescribing is an important element for this study which is 
examining some of the challenges of prescribing in Sudan considering the 
limited resources.  
 
Furthermore, a distinction has been made between rational prescribing 
and appropriate prescribing (Aronson, 2004). Whereas rational prescribing 
is considered to end up with the decision to prescribe and the choice 
made, appropriate prescribing is considered as the whole process 
resulting in desirable outcomes (Aronson, 2004, Buetow et al., 1997). 
These outcomes can possibly make a rational prescribing decision 
inappropriate and in some occasions an appropriate prescribing decision 
irrational (Aronson, 2004, Yu et al., 1991). However, this does not 
minimize the importance of rational decision making as it is more likely that 
rational prescribing will lead to appropriate prescribing (Aronson, 2004). 
Several methods have been suggested to measure the appropriateness of 
prescribing focusing on factors related to the drug itself such as, efficacy, 
drug-drug interactions, duration of therapy and even cost effectiveness 
(Aronson, 2004, Hanlon et al., 1992). What is important for this study 
which is looking into the use of clinical guidelines in practice in Sudan, is 
that appropriate prescribing has been considered as an element in 
transferring scientific evidence into clinical practice (Brook et al., 1986, 
Buetow et al., 1997).   
 
 The variation in prescribers’ views about the concept of appropriate 
prescribing was studied by Higgins and Tully (2005).  The study involved 
interviewing 17 doctors from different specialities and with different years 





in a teaching hospital in UK.  For junior doctors, appropriate prescribing 
meant the match between the right drug and the patient presentation.  
This match according to some doctors was made easier by the availability 
of protocols and guidelines that can be followed. For consultants, 
appropriate prescribing was perceived to be a more complex approach 
which could include factors related to the health care system as a whole 
such as considering cost-effective treatment.  
 
The study found that the concept of prescribing changes gradually as 
prescribers become more experienced moving towards a more holistic 
approach for prescribing. However, the above finding does not make 
senior prescribers  better in achieving appropriate prescribing than juniors 
as this was found not always to be true (Stolley et al., 1972). The study is 
very limited in that it took place in one hospital, and as variation in 
prescribing is known to occur between different practices, these concepts 
of appropriate prescribing can vary between doctors of the same grade in 
different hospitals. To confirm the above findings more studies are 
required whereby appropriate prescribing is examined for the same 
prescribers at different stages in their career. 
 
2.5 Factors influencing prescribing 
 
The presumption that different prescribers can make different decisions 
when presented with the same medical condition is attributed to the fact 
that there are medical and non-medical factors that influence prescribing 
(Denig et al., 1993, Hemminki, 1975, Segal and Hepler, 1982). The effect 
of these factors on prescribing can differ between different prescribers, 
health care organizations and between different countries. In addition, 
different physician characteristics such as age, training and experience 
are believed to have an effect on the quality of prescribing (Stolley et al., 






(1975) attributed some of the main influences on prescribing on the 
physician characteristics, the education of the physician, the patient 
characteristics, the pharmaceutical industry, the working circumstances in 
any healthcare system and the influence of other colleagues.  Some of 
these factors were considered to be easier to change, such as the effect of 
the pharmaceutical industry, while others were more difficult to modify 
such as the characteristics of the doctor and the patient.  
 
In more recent published studies from different parts of the world, other 
classifications were given for factors affecting prescribing (Joyce et al., 
2011, Oshikoya et al., 2011, Theodorou et al., 2009, Ljungberg et al., 
2007, Greenfield et al., 2005, Nutescu et al., 2005). Factors influencing 
prescribing were generally classified in these studies as either directly 
drug-related or indirectly drug related. That is, the non-drug factors such 
as doctors’ characteristics were not considered in these studies.   Most of 
the prescribers in these studies claimed that a number of factors affected 
their prescribing including, recommendation by clinical guidelines, the cost 
of treatment, the hospital drug formulary and the advertisement provided 
by the pharmaceutical industry. However, the level of importance of any 
particular factor on drug choice was different between prescribers in 
different settings and countries where the studies were conducted. For 
example, in a study in Nigeria by Oshikoya et al (2011), the majority of the 
prescribers involved in the study identified using the pharmaceutical 
company representative as a source of drug information for prescribing. 
This is different from prescribers in other countries in Europe and USA 
where the information provided by pharmaceutical companies was 
considered to be of less influence (Schumock et al., 2004, Theodorou et 
al., 2009). 
 
Considering the focus of this study, most doctors as well as other 
healthcare professionals in a number of studies, explained that one of the 
factors directly affecting their drug choice was prescribing guidelines 
(Ljungberg et al., 2007, Blackburn et al., 2004, Nutescu et al., 2005). 




strictly followed in all situations. For example, in the study by Nutescu et 
al. (2005) in the United States, participant doctors in community hospitals 
considered that when prescribing within the same therapeutic class, they 
depended on their experience and not guidelines for the choice of the 
suitable member within the same class. 
 
Not only prescribers’ views but also the views of clinical pharmacists 
were sought in some studies that described the influences on drug choice 
(Nutescu et al., 2005, Schumock et al., 2004). In a survey based study by 
Schumock et al (2004) in the United States about influences on drug 
choice, both physicians and clinical pharmacists who participated in the 
study considered direct related drug factors such as effectiveness of the 
drug, as having higher influence than non-direct factors, for example, the 
effect of the pharmaceutical industry.  However, physicians and clinical 
pharmacists differed in their response with regard to the influence of 
experience in prescribing. While physicians considered personal 
experience to be an important influence, clinical pharmacists thought of it 
as being of less importance compared to direct drug related factors. 
Although the study has its limitations including the limitations of self- 
reports, the main element of interest in this study is that it considered 
pharmacists as members of the healthcare team with key roles in 
recommending medications and thus their views on prescribing are of 
importance. In recognition of this, the second part of this research is aimed 
to explore the role played by clinical pharmacists in assisting prescribing. 
 
The different factors that can lead to variation in prescribing as 
discussed earlier may lead to patients with similar conditions not receiving 
similar pharmaceutical therapies required for their conditions. It  has been 
proposed that the use of clinical guidelines could limit the unjustified 
variation in prescribing and ensure that patients are getting the drugs that 
according to evidence from research, can improve their medical conditions 






research; the effect of guidelines in particular as a tool in guiding the  
choice of pharmacological interventions and as a factor affecting 
prescribing is going to be examined in the following part of this review. 
 
2.6 Clinical guidelines and their influence on prescribing 
 
Healthcare professionals are facing several issues that may challenge 
appropriate prescribing (Feder et al., 1999). These include, rising 
healthcare costs and the increasing volume and complexity of information 
coming across from scientific research. Moreover, as large numbers of 
drugs are becoming available with more clinical conditions requiring the 
use of a number of drugs; the safety of use of these drugs has 
necessitated the availability of guidance on their use (Andrejak et al., 
2008).  
 
Clinicians as well as health policy makers needed to develop tools for 
making prescribing and patient care more effective especially with regard 
to pharmacological intervention (Feder et al., 1999, Hewitt-Taylor, 2006, 
Woolf et al., 1999). The development of guidelines for clinical practice is 
perceived as a way of maintaining consistency in prescribing and 
narrowing the gap between what research data supports and what is 
prescribed. In addition to assist in prescribing, practice guidelines have 
also been used by some healthcare organizations to measure the quality 
of clinical care provided (Keeley, 2003, Berg, 1997). 
 
The standard definition in the literature for clinical guidelines is the 
definition by the Institute of Medicine in the Unites States which states that 
guidelines are ‘systematically developed statements to assist practitioners 
and patients decisions about appropriate healthcare for specific clinical 
circumstances’ (Field and Lohr, 1990). From this statement it is 
emphasized  that the main criteria for writing guidelines are ‘systematic 
development’, the joint decision between practitioners and patients and 




According to Meulen (2005) guidelines were rarely mentioned in the 
literature before the 1970s. The development of guidelines has gone 
through stages starting from the earlier less detailed ‘protocols’ of the 
seventies to the more evidence dependent guidelines of the nineties 
where more consideration was also given to quality of care, cost 
implications and the evidence from research (Meulen, 2005). Nowadays, 
the production and use of clinical guidelines is known to have become a 
familiar practice in different parts of Europe, North America and Australia 
(Shaneyfelt and Centor, 2009, Hewitt-Taylor, 2006).   
 
In clinical practice there are care protocols as well as guidelines.  In 
some cases the two words are used interchangeably.  Both were argued 
to be  sets of instructions to be followed by prescribers leading to what 
was referred to as ‘a cookbook medicine’ (Berg, 1997). Although both are 
required to be evidence based, a distinction  does exist between the two 
(Hewitt-Taylor, 2006).   Protocols are considered as a more obligatory set 
of comprehensive instructions to be followed than guidelines. In addition, 
the ‘systemic’ detailed approach in reviewing and presenting the evidence 
in guidelines is also considered to distinguish guidelines from protocols 
(Keeley, 2003, Meulen, 2005).  In this study guidelines will be explored as 
different from protocols, considering them as a set of recommendations 
that serve as guidance for treatment rather than fixed rules, as may be the 
case with protocols. 
 
2.6.1 Developing clinical guidelines 
 
Guidelines are developed after a detailed, systematic and focused 
process of reviewing the scientific evidence available (Hewitt-Taylor, 2006, 
Shekelle et al., 1999). Before developing guidelines there are stages 
involved before a decision is made to construct them. These include first, 
identifying and agreeing on the need to develop a specific guideline, and 
then ensuring that having a guideline is the best way to approach the 
problem identified.  The steps that lead to construction of ‘good guidelines’ 




identifying critical outcomes required and ensuring that benefits from the 
studied intervention much outweigh any harm (Atkins et al., 2004).  
 
Guidelines are usually constructed by multidisciplinary teams in which 
there is representation of different disciplines and different skills (Hewitt-
Taylor, 2006, Shekelle et al., 1999). Not only healthcare professionals are 
included in these teams but the views of other individuals such as health-
policy makers and financial experts are sought as cost is usually an 
important criterion in assessing the benefits of the treatment. Furthermore, 
involving patient representatives in guidelines committees is argued to be 
of importance in producing guidelines that can be implemented in practice.  
 
2.6.2 Guidelines and evidence-based medicine 
 
The use of clinical guidelines in medicine has been advocated based on 
the assumption that the information provided by these guidelines is 
derived from strong scientific evidence and hence will lead to  evidence 
based practice  or what is generally known as ‘evidence based medicine’ 
(EBM) (Keeley, 2003). By implementing guidelines in practice the 
perception is that evidence based treatment will be translated into practice 
(Hewitt-Taylor, 2006).  
 
The term EBM was said to have made its first appearance in the 
literature in 1991 (Guyatt, 1991, Guyatt and John Cairns, 1992). Others 
argued that EBM is just a new view for an already old existing practice 
(Bystander, 2010). The great scientist Avicenna (or Ibn Sina) who died in 
1037 was said to have written the first book in medicine known as ‘Al-
Qanun fi al –Tibb’ (The law in medicine) which dealt with evidence based 
medicine and randomised controlled trials (RCTs).  
 
Sacket et al (1996) defined EBM as ‘the conscientious, explicit, and 
judicious use of current best evidence in making decisions about the care 





step in prescribing, after problem solving, by  interpreting information from 
clinical trials to assist in the decision-making criterion (Elstein and 
Schwartz, 2002).  The aim behind EBM as advocated is not to diminish 
clinicians’ decision making, but to be used in conjunction with the 
prescribers’ judgement and experience to make the most appropriate 
decision for the patient (Guyatt, 1991, Montori and Guyatt, 2008).   
 
Different levels of evidence based on the different types of clinical trials 
design and the susceptibility to bias have been identified and are used in 
making different levels of recommendations in clinical guidelines (Shekelle 
et al., 1999). Randomised controlled trials (RCTs) and specifically meta-
analysis of RCTs, which are based on systemic reviews of RCTs,  have 
become the highest level of evidence to be considered when making 
guidelines especially with regard to effectiveness of treatment (Keeley, 
2003, Sackett et al., 1996, Shekelle et al., 1999). Results obtained from 
RCTs will have a higher degree of recommendation in clinical guidelines 
than those obtained from non-randomised or uncontrolled trials. However, 
it has been argued that there are clinical care situations in which  evidence 
based medicine from randomized controlled trials is considered not 
suitable in providing the desired effective patient care (Keeley, 2003). An 
example of these situations is the clinical care needed for patients in 
palliative care. One of the reasons described for the limitation of EBM in 
these situations is that qualitative research which might benefit this type of 
patients is not usually considered as a high level of evidence compared to 
RCTs to generate EBM. This can limit the effectiveness of clinical 
guidelines if only quantitative data are considered (Berg, 1997, Keeley, 
2003).  
 
For EBM to provide benefits, a number of perspectives need to be 
considered (Greenhalgh, 2010, Montori and Guyatt, 2008). These include 
the quality of evidence, the patient perspective and the nature of the 
particular healthcare system. The non-patient factors that may influence 





restricting element in providing evidence based-medicine (Hajjaj et al., 
2010). 
 
2.6.3 Benefits and challenges of guidelines 
 
Although guidelines are adopted in healthcare settings in many parts 
around the world, there have been different arguments in favour or against 
the use of clinical guidelines (Berg, 1997, Woolf et al., 1999). In addition to 
the expected benefits, there are perceived challenges from clinical 
guidelines to the patients, the healthcare professionals and the healthcare 
system (Berg, 1997, Keeley, 2003, Shaneyfelt and Centor, 2009, Woolf et 
al, 1999). 
 
The main reason for the use of guidelines in clinical settings is to 
improve the quality of healthcare (Woolf et al., 1999). Potential benefits for 
patients are expected from the use of clinical guidelines. Having 
information based on strong scientific evidence about effective treatment 
available to healthcare professionals, should improve patient health.  This 
evidence–based information provided by the guidelines does not only 
assist prescribers in providing optimum treatment but can also assist 
patients making informed decisions about their treatment.  
 
The main harm which can come from using guidelines is if they are 
developed from a misleading  evidence from research (Woolf et al., 1999). 
Although guidelines committees are expected to critically appraise the 
evidence, this may not always avoid misinterpreting the evidence. This is 
perceived by the researcher to be true as there were situations in clinical 
practice where recommendations for the use of certain medications were 
changed. This was due to either further reviewing of the existing evidence 
or new evidence becoming available. This also makes it of importance that 
guidelines are continuously reviewed and updated based on the current 





trials may not always be representative of the population that need to be 
treated, for example, patients with comorbidities may not be included in 
trials, and thus following  evidence derived from these trials may not only 
lack benefit but may well induce harm (Vinod, 2015). 
 
 It has also been considered that by referring to the available guidelines, 
prescribers will be more skilful in dealing effectively and appropriately  
specially with complex clinical situations (Berg, 1997). The other argument 
has been that the opposite may happen and prescribers, in the presence 
of guidelines, may develop less decision making skills (Berg, 1997, Berg, 
2000). As the main aim of clinical guidelines is to benefit the patient, and 
as long as prescribing based on guidelines is improving patient care, it can 
be argued that the skilling or ‘deskilling’ of the prescribers debate should 
not be a reason to deprive the patients from the benefits of guidelines.  
Other educational measures can be adopted in doctors’ training to ensure 
that the skills, assumingly affected by the presence of guidelines, are 
maintained. 
 
The availability of guidelines has also been perceived to strengthen 
inter-professional communication and understanding (Berg, 1997, Currie, 
2000). However, some argued that this may not always be the case (Atwal 
and Caldwell, 2002). Different healthcare professionals may have different 
views in how to assess, implement and achieve the desired goal for 
patient care (Atwal and Caldwell, 2002, McDonald et al., 2005). For 
example, it has been argued that nurses have a more rule-adhering 
attitude towards implementing guidelines than doctors and this may be a 
challenge when decisions are to be made that involve both doctors and 
nurses (McDonald et al, 2005). 
 
The provision of uniformity of treatment is one of the most advocated 
reason for guidelines use (Woolf et al., 1999).  This means that patients 






get treatment. However, one can argue that to fulfil this it may also be 
necessary to ensure uniformity of facilities in the health services in the first 
place. This can expected to be a challenge in healthcare systems which 
are already struggling for example, in Sudan where this research was 
conducted. 
 
It has also been argued that if guidelines are to lead to appropriate 
prescribing, they should be made with direct patient related needs 
prioritized over other non-patient related factors (Woolf et al., 1999). 
Paradoxically, the same authors have argued that guidelines may harm 
the healthcare organizations if treatment costs to the healthcare system, 
although a non-patient related factor, were not considered.  It is expected 
that in making treatment recommendations cost-effectiveness is a core 
criteria to be taken into consideration. This balance between cost 
effectiveness and  treatment effectiveness is considered by some as 
difficult to achieve (Berg, 1997).  
 
In trying to resolve the above issue of the balance between the cost of 
treatment and its effectiveness, some guideline committees, for example 
NICE in UK, has been making  decisions with regard to costly treatment by 
using the international measure of QALY (Quality Adjusted Life Years 
Measurement) (NICE, 2010a). In its simple meaning, QALY measures how 
many more years would a certain treatment give a certain patient and 
what quality of life is expected and compare this to the cost implication of 
the drug.  Considering the above and acknowledging that the increasing 
cost of medical care is a challenge for many healthcare organizations, it 
seems that it will lie on the guidelines-making committees to maintain the 
balance between the patients’ needs and the healthcare system needs, 
prioritizing the former as expected in making treatment recommendations. 
However, it will be difficult for healthcare professionals using the 







Furthermore, a potential limitation for guidelines use is expected to 
occur if they are not flexible (Field and Lohr, 1990, Hewitt-Taylor, 2006, 
Keeley, 2003). Guidelines could be rejected if they put individualized 
patient care at risk. It is known from practice that even the best available 
guidelines or evidence could not be applicable to every patient 
(Greenhalgh, 2010, Sackett et al., 1996).  Prescribers are thus expected to 
exercise autonomy in making decisions and weigh the perceived benefits 
from guidelines against the individual patients’ needs. Prescribers are 
meant to consider the guidelines with the patient’s best interest in the 
particular clinical circumstances to make their clinical decisions (Keeley, 
2003). On the other hand, complete autonomy in clinical decisions  can 
have its disadvantages as it could lead to irrational, incompetent and 
biased decisions (Armstrong, 2002, Gylling, 2004) .   
 
2.6.4 Implementing guidelines 
 
As mentioned earlier, recommendations provided by guidelines are 
considered as a way of assisting prescribers in providing treatment based 
on scientific evidence. Once these guidelines are written they need to be 
implemented into practice (Feder et al., 1999, Keeley, 2003).  There are 
certain elements that are related to the guidelines itself and to the 
healthcare institution that need to be considered in order that these 
guidelines can successfully be translated into practice.  
 
Some of the criteria that enhance guidelines implementation  need to be 
considered at the early stages of guidelines development (Richter-
Sundberg et al., 2015). For example, it is important that guidelines are 
produced in a way that is understandable and acceptable by the 
healthcare professionals required to use them. This may sometimes 







about its applicability to maximize the implementation of the guidelines  
(Scott et al., 2004). Furthermore, once the guidelines are ready for 
application and although it may sound obvious, prescribers need to be 
aware of their existence and capable of getting easy access to these 
guidelines.   
 
 In addition, to enhance application of guidelines, they need to be  
written with the recipients of the service in mind (Keeley, 2003).  For 
example, to apply guidelines in clinical practice in developing countries 
there is a need to have guidelines that are suitable for such healthcare  
settings (Lindback et al., 2014, WHO, 2005a). Some international societies  
considered making what was referred to as global guidelines based on a 
level-wise approach to treatment that put in mind healthcare settings with 
limited resources (Fried and Krabshuis, 2008). However, the caveat with 
this approach as argued is that it may not provide optimal treatment and 
hence, affects the strength of the guidelines and even the idea behind 
EBM.   
 
The World Health Organization (2007) explained in their guidelines for 
prevention of cardiovascular disease that guidelines should be developed 
to suit economic, social, and cultural in addition to medical circumstances. 
However, it is known to be a very difficult and costly process to develop 
new guidelines  for each different group of recipients (Feder et al., 1999).  
One can thus assume that many healthcare professionals in different 
countries, especially those of limited resources and who want to follow 
guidelines for treating their patients, are likely to depend on foreign 
readymade guidelines. These foreign guidelines are not just about 
recommendations for drugs’ use, but they involve other care aspects 
which may only be implemented when certain criteria are available in the 
particular healthcare system. In addition there are factors related to the 
culture of the society and the socio-economic state of the patients that can 
affect the implementation of these guidelines.  This can be expected to be 





countries who have to use foreign guidelines not made to fit their  
healthcare systems. This study is thus examining this issue by looking into 
the use of international guidelines by prescribers in Sudan. 
 
2.7 Guidelines and professional status 
 
There are different interpretations and definitions for what constitutes a 
professional behaviour (Hammer, 2000, Schafheutle et al., 2013). There 
may also be a cultural element in what a professional behaviour is 
expected to be. Professionalism is usually considered as a set of attitudes,  
behaviour and skills which when conducted by members of a certain 
occupation, elevate the status of such occupation and enhance trust and 
respect towards members of such occupation (Hammer, 2000, 
Schafheutle et al., 2013).   
 
Guidelines have been considered by many as a means of enhancing 
the professional status of healthcare workers by providing  the scientific-
base, efficiency and the uniformity of treatment required to achieve 
healthcare of high quality (Berg, 1997, Hewitt-Taylor, 2006, Keeley, 2003, 
Woolf et al., 1999). Although clinical guidelines are usually written to be 
used by clinicians, other healthcare professionals are considered to 
benefit from the availability of guidelines ( Woolf et al., 1999). Healthcare 
professionals, who form part of the team taking care of the patient, may 
provide a better contribution as part of a team when evidence-based 
guidelines are available.  In addition, the new emerging advanced roles for 
other healthcare professionals such as nurses and pharmacists in 
healthcare   may necessitate the change in perception about guidelines 
being mainly used by doctors.  
 
    On the other hand guidelines can be argued as harming 
professionalism by providing a set of instructions to be followed when 
treating patients and thus limiting  personal judgement about how and 
what to do when dealing with different patients (Armstrong, 2002, Berg, 




promoted by guidelines use, is considered by some as a core to maintain 
professionalism while others consider it as a means of deskilling 
professionals.  Although the importance of the prescribers’ professional 
judgement cannot be denied, the risk from complete autonomy cannot be 
ruled out (Armstrong, 2002). Thus prescribers need to incorporate that 
external factor which is the evidence from research with their clinical 
judgement for a particular patient to make their final decision about 
treatment.  In addition, it seems that those who have seen the benefit to 
their profession from using guidelines are demanding more from clinical 
guidelines. For example, to enhance the aspects of professionalism in the  
medical profession, it has been suggested that guidelines need to focus 
more on ethical issues encountered  in clinical setting in order to improve 
how health prescribers deal professionally with such issues (Mertz and 
Strech, 2014).  
 
Berg et al (2000) studied whether or not guidelines harm the 
professional autonomy of healthcare professionals by interviewing Dutch 
insurance physicians who were dealing with disability claims (Berg, 2000) . 
The authors were interested in discussing the effect of ‘objectivity’ in using 
guidelines with regard to evidence from science in contrast to depending 
on ‘subjective’ practice in enhancing or endangering professionalism.  
Seven insurance physicians, in addition to eight co-ordinating physicians 
and seven managers were interviewed. Physicians as well as managers 
seemed to be positive about the use of guidelines in their practice. 
Guidelines were not considered to take away skills as long as they were 
not rigid; on the contrary they seem to help in making decisions and give 
power for professionals to stand by their decisions.  
 
 Although the above study found from some prescribers’ views that 
guidelines can be used to enhance professional status rather than 
suppressing it, it may not have waived the argument against the use of 
guidelines as it is a very limited study. In addition, the participants in the 





guidelines may have provided the physicians with a means of protection in 
addition to power to make their decisions about insurance claims. 
 
In summary of the above, guidelines and specifically prescribing 
guidelines can be considered as serving the medical profession by 
presenting the best available options for treatment obtained from what is 
perceived as high quality clinical trials. In doing so the quality of patient 
care is likely to improve as prescribers will have the means and confidence 
to recommend treatments that have the potential to improve health 
outcomes.  To achieve this, will depend on two factors; the quality of the 
guidelines presented which hugely relies on the people making the  
guidelines and secondly the best interpretation and rational use of these 
guidelines by healthcare professionals. If any of these two criteria are 
compromised the expected benefit from guidelines use will not be fulfilled. 
 
Prescribing in cardiology as a clinical area is going to be used as an 
example to examine the use of guidelines in prescribing in Sudan. The 
main reasons for this choice is the increase in prevalence of 
cardiovascular disease in developing countries including Sudan where this 
research was conducted, and that cardiovascular disease is a discipline 
with an increasing number of guidelines that are constantly changing. 
There is also the element of the researcher’s previous experience in 
working in cardiology wards.  The above main reasons together with other 
aspects of cardiovascular disease will be examined in the following 
section. 
 
2.8 Cardiovascular disease 
 
  Cardiovascular disease (CVD) includes a range of diseases affecting 
the heart and the blood vessels. These include coronary heart disease, 
rheumatic heart disease, congenital heart disease and cerebrovascular  
disease which affects the brain as well.  Cardiovascular diseases are the 




stroke are considered as the main cardiovascular and cerebrovascular 
diseases and are seen by the World Health Organisation (WHO) as truly 
global epidemics (WHO, 2011).   
 
In contrast to developing countries which will be discussed in the next 
section, death from CVD continues to fall across many countries in Europe 
((ESC), 2012, Allender et al., 2008) . In the United Kingdom, although  
CVD is still one of the main causes of premature death, there is a steady 
decline in the incidence and fatality of the diseases across the last two 
decades ((BHF), 2012).  The decrease in mortality and incidence of CVD 
is believed to be attributed, at least in part of it, to the increase in the use  
of medication for prevention and treatment of the disease as well as 
lifestyle changes with regard to diet, smoking and physical activity ((BHF), 
2012, Smolina et al., 2012) . 
 
2.8.1 Cardiovascular disease in developing countries 
 
According to the WHO (2007), eighty percent of deaths from 
cardiovascular diseases occur in low and middle-income countries and 
occur equally in men and women. In sub-Saharan Africa, CVD is rapidly 
increasing and has a major socio-economic impact on societies (Abanilla 
et al., 2011, Suliman, 2011a). One of the major tasks listed by the WHO 
and its member states was to scale up cost-effective, integrated 
approaches for prevention of CVD. Based on the available health statistics 
from the developing world, the Institute of Medicine (IOM) projects that 
there will be a shift in the incidence of non-communicable diseases 
compared to infectious diseases, which is  considered as the bigger health 
burden, in developing countries (Fuster, 2010). 
 
The IOM supports the implementation of different strategies to reduce 
the risk of CVD in developing countries (Fuster, 2010). One of these 





countries that can provide cost-effective approaches for CVD 
management. ‘Resource-sensitive’  programmes  are considered to be 
required in low-income countries to reduce the prevalence of 
cardiovascular disease (Rabkin and Nishtar, 2011). 
   
The increase in cardiovascular disease in the developing countries may 
be attributed to factors such as urbanisation and life style changes (WHO, 
2011). It can also be argued that developing countries are not strongly  
getting the message about the danger from pre-disposing factors for heart 
diseases such as smoking and obesity. This increase in the prevalence of 
CVD in developing countries may be overlooked by governments because 
of many factors such as competing health issues especially infectious 
diseases, limited resources, lack of management and effective health 
policies (Fuster, 2010). 
 
2.8.2 Use of guidelines in prescribing in CVD 
 
Treatment of cardiovascular diseases is an area which is considered to 
be very much influenced by prescribing guidelines (Meulen, 2005). 
Advances in the management of heart disease are occurring as new drugs 
and cardiac techniques are discovered and hence updates in cardiology 
guidelines are expected to occur. Grilli et al (1994) did an earlier review 
into the published literature of compliance with clinical practice guidelines 
between the years 1980-1991. They claimed from their review that 
cardiology and oncology were the specialities in clinical practice which had 
a high compliance with practice guidelines. The reason for that was 
unknown but the researchers seemed to be inclined to relate part of the 
reason for this to the quality of the guidelines available in these two 
disciplines. Although this is an older review and things may have changed 
during the last two decades, it gives an insight into the strong influence of 
guidelines in prescribing in cardiology. 
 




Cardiology (ESC), the American College of Cardiology (ACC), and the 
National Institute of Clinical Excellence (NICE) in UK are examples of 
health societies and organizations that have written guidelines 
recommending the use of certain medications to reduce morbidity and  
mortality from heart disease (Hamm et al., 2011, NICE, 2010b, Smith et 
al., 2006, WHO, 2007b). Most of these recommendations were said to be 
based on high levels of evidence from clinical research; that is evidence 
from randomised controlled trials (RCTs) and systemic reviews of RCTs.  
Although there are different types of drugs recommended by these 
guidelines based on the type of disease, the main classes of drugs that 
are usually recommended are antiplatelets, angiotensin converting 
enzyme inhibitors, angiotensin enzyme antagonists, cholesterol lowering 
drugs, B-receptor blockers, blood thinning agents and drugs regulating 
heart rhythm. A combination of these drugs is usually required, according 
to the guidelines, to be prescribed for heart disease patients.  
 
Developing countries may benefit from the proven effective clinical 
interventions usually promoted by guidelines that are used in high-income 
countries to manage CVD (Joshi et al., 2008). However, the patients in the 
developing world are the ones who are likely to have limited access to 
these interventions and thus they may be missing the lifesaving 
medications promoted by these guidelines. 
 
2.9 Sudan, cardiovascular disease and the use of guidelines 
 
2.9.1 The Republic of Sudan  
 
Sudan is a multi-ethnic-multicultural country with hundreds of ethnic 
tribal religions and languages located in the northern-eastern part of Africa 
(Ministry of Cabinet Affairs, 2008). The country occupies the middle part 
between Africa and the Middle East. It is currently the second largest 
country in Africa with a total area of about 1.882 million square kilometres 




the World Bank as a developing country with income status of low to 
middle ((WB)), 2015).The majority of the published data about Sudan 
refers to the Sudan before the split of the country into two in July 2011.  In 
addition, as in many less developed countries the epidemiological 
information about diseases in Sudan are scarce (Suliman, 2011a). The 
country is made up of 15 states with Khartoum state being the capital 
which in previous estimates was said to contain 20% of the population 
(Ministry of Cabinet Affairs, 2008). This figure is continuously rising as 
more people are moving to the capital from other states. 
 
2.9.2 Access to healthcare in Sudan 
 
In Sudan both public and private sectors provide healthcare. Since the 
independence in 1956, the Sudanese government has offered free health 
services including free supply of medicine (Ministry of Welfare and Social 
Security, 2010). However, the government was faced with a variety of 
political and economic problems that made the increasing cost of health 
care a huge burden. This has led to the deterioration of the health service 
provided and the government started to charge for many of the services 
provided in its hospitals. With the support of the WHO the government has 
created a health insurance scheme which launched its first service in 
1995. The government health insurance targets the sector of the 
population who cannot afford to pay treatment costs but it is open to all 
members of the community. According to the information from the National 
Health Insurance Fund, the scheme in 2010 covered 39% of the 
population (Ministry of Welfare and Social Security, 2010). 
 
The government Health Insurance Scheme  (HIS) is funded through a 
variety of resources in addition to those insured by the scheme (Ministry of 
Welfare and Social Security, 2010, Mohamed, 2007). Through this 
scheme the government should ideally cover the cost of treatment for the 
retired, poor people and full time students. The HIS covers different types 




cover 75% of the cost of the medicines on its list of essential drugs. Not all 
drugs are available through the scheme according to individual reports 
from patients who have joined the scheme. There is also restriction on the 
branded drugs and usually cheaper generic drugs are covered by the 
scheme. During the time of data collection in Sudan, there was a 
continuous advertisement in the media encouraging people to enrol in 
HIS.  The government is also calling for the financially advantaged sector 
of the population, to contribute as a charity to HIS, so that the government 
can cover healthcare costs for as many needy patients as possible. 
 
     The private sector has expanded rapidly in Sudan and especially in 
Khartoum in  the last decade (EMRO, 2006, Federal Ministry of Health, 
2010). Private profit-making health services are perceived by the public to 
be of better quality than government services. These services are situated 
mainly in urban areas, mainly the capital, and usually accessed by the 
better-off. Private health insurance schemes are also available in Sudan 
and are known to provide almost comprehensive cover for those enrolled 
in these schemes. There are some private non-profit health care services 
provided by non-government and faith organizations but they are mainly 
based in areas of the country affected by conflict and to a lesser extent in 
the capital Khartoum (Federal Ministry of Health, 2010).  
 
In Sudan, until recently patients could choose for themselves which 
health centre or hospital they wanted to receive medical treatment in. The 
government provide health services through its secondary care sector, 
that is the hospitals, and the primary care sector, that is health centres. 
However, it is the perception of the researcher that to say there is a link 
between the two sectors which can enable exchange of information is very 
much debatable. Transfer of medical information and follow up of 
treatment remain as the responsibility of the patient or patient carers. This 
perceived lack of information transfer between primary and secondary 
care is probably one of the major obstacles in providing a high quality 




2.9.3 Incidence of cardiovascular disease in Sudan 
 
Most of the information obtained about Sudan and its health service 
was obtained from the WHO and some government reports in Sudan. 
Statistics from the WHO (2006) and the Sudanese Federal Ministry of  
Health (FMOH) (2007) showed that heart diseases are the fourth cause of 
mortality in hospitals after malaria, pneumonia and septicaemia in Sudan. 
Heart failure was listed separately from heart disease as the sixth cause of 
mortality in hospitals in Sudan (EMRO, 2006). According to an annual 
health report from the FMOH, Khartoum state, the capital of Sudan, had 
the highest percentage of death recorded from CVD in 2007 compared to 
other states of Sudan but at the same time it has got all  the main tertiary 
centres for heart diseases in the country (Federal Ministry of Health, 
2007). The report did not identify if these deaths are actually from patients 
who are resident in Khartoum or from those coming from outside the 
capital seeking treatment in the cardiac centres of Khartoum.  
 
Data obtained from the Department of Non-Communicable diseases in 
the State Ministry of Health in Khartoum showed a drop in deaths from 
CVD in Khartoum from 2007 to 2009; but it is still the highest cause of  
deaths compared to the other non-communicable diseases in Khartoum 
medical units. The same report also describes that the majority of doctors 
registered as specialised in cardiology in Sudan are known to be based in  
Khartoum.  The figure provided for the number of registered cardiologists 
in this report is known to have increased as more cardiology specialists 
working in Khartoum’s main cardiology hospitals were identified during this 
study.  
 
There were few studies found in the literature which relate to the current 
state of cardiovascular disease in Sudan. In 2011, Suliman, a cardiologist 






in Khartoum, conducted a review on the data available concerning the 
state of heart disease in Sudan. The data was gathered from different    
sources including statistical reports by the FMOH in Sudan, the WHO, and 
from Sudan House Hold Survey (SHHS). Cardiovascular disease was 
reported in the top ten causes of death in hospitals in Sudan between 
1998 and 2008. In 2006, the disease affected 2.5 % of the population in 
Sudan and the prevalence of diseases which can predispose to 
cardiovascular disease such as hypertension and diabetes mellitus was 
20.1% and 12.7 % respectively. Although there is a need for more studies 
to be conducted especially in the community about the prevalence of 
cardiovascular disease, the available information indicates the need to 
initiate awareness of the risk factors and the preventative measures for 
cardiovascular disease in Sudan.  In a different study the author also 
examined the pattern of patients’ admissions into Alshaab Hospital which  
the main government cardiology centre in Sudan (Suliman, 2011b). The 
admissions from ischemic heart disease to Alshaab hospital during a 6-
month period constituted 67% of the admissions to the hospital. These 
included acute coronary syndrome (ACS) and heart failure.  ACS 
constituted the main admission to the coronary care unit while heart failure 
comprised the main admission to the wards.  
 
In another study, a population-based survey into the risk factors of 
ischemic heart disease in Khartoum was carried out by the WHO between 
the years 2005 and 2006 (Eltom, 2006). A total of 1573 people 
participated in the study, age between 25-64 yrs.  The overall response 
rate was 98%. Low physical activity was found to be a factor in 86.6 % of 
the population, overweight and obesity, 53.9 %, hypertension, 23.6%, high 
cholesterol, 19.8%, diabetes, 19.2 % and smoking 12%. Based on these 
findings, it is thus of great importance that interventions for primary and 








2.9.4 Use of guidelines in prescribing in Sudan 
 
There is limited information available from the Federal Ministry of Health 
(FMOH) in Sudan and the Sudan Medical Council that indicates any 
specific policies with regard to the use of guidelines in prescribing.  
However, there is a reference to the use of guidelines in  Sudan National 
Drug policy (2005-2009) to promote rational use of drugs (Federal Ministry 
of Health, 2005) . One of the strategies that has been suggested to ensure 
rational prescribing is for the FMOH to publish standard treatment 
guidelines. 
 
Few studies were available in the literature about the implementation of 
guidelines in Sudan.  These studies examined the implementation of the 
international guidelines in some areas of clinical practice in Sudan which 
implies that prescribers in Sudan are considering the use of guidelines in 
their clinical practice (Abdelwahab et al., 2013, Elamin and Abu-Aisha, 
2011, Elmardi et al., 2009, Salih et al., 2014). With regard to the possibility 
of implementing guidelines in Sudan, the World Gastroenterology 
Organization in an attempt to make global guidelines which can be applied 
in developing countries, has referred to a number of gastroenterologists in 
Sudan who found that some of the investigational and management 
approaches recommended by the international guidelines were difficult to 
be applied in Sudan due to their high cost (Fried and Krabshuis, 2008). 
This also indicates that in Sudan prescribers are trying to follow available 
guidelines but may be facing difficulties in doing so. 
   
As an example, Salih et al (2014) examined the implementation of the 
WHO guidelines in the treatment of community acquired pneumonia in 208 
children admitted with pneumonia to the main children hospital in 
Khartoum in the period from June 2009 - July 2010. The study found that 
only 39 children (18.8%) received antibiotics recommended by the WHO 
guidelines. There was no link between patient variables and non-




hours. There was no difference in response based on fever, respiratory 
rate and food intake between prescribing based on guidelines and 
prescribing not based on guidelines. This is important as resistance to 
antibiotics as a result of non-rational use of antibiotics is a serious problem 
worldwide. However, the study did not examine the reasons behind such 
non-compliance.  Many reasons might be involved in the non-adherence 
to guidelines including the junior doctors’ unawareness of the guidelines, 
or the senior doctors who are usually providing the training were not for 
any reason following the guidelines.   
 
There was no study found that looked into guidelines use in 
cardiovascular disease in particular or investigated the attitudes of 
prescribers towards the use of guidelines in practice in Sudan. 
Considering the prevalence of the disease in Sudan and the number of 
international cardiology guidelines available that are promoting life-saving 
treatment for patients with CVD, this research aims to investigate the 
views of doctors working in two of the main cardiology hospitals in Sudan 
about the use of guidelines in prescribing.  
 
2.10 Clinical pharmacy and the role of pharmacists in patient care 
 
The following part of the review discusses the involvement of hospital 
clinical pharmacists in patient care. 
 
 2.10.1 Involving pharmacists in disease management 
 
Although providing treatment is a role traditionally linked with 
physicians, the increasing number of medicines becoming available, the 
more widespread chronic diseases coupled with more recommendations 
for drug use from clinical guidelines and the availability of powerful 
medications that require monitoring, all mean that the sole responsibility of 






of medicines (Weidenmayer et al., 2006).  The involvement of other  
healthcare professions, with the physicians, is considered to be required in  
order to achieve the desired outcomes from prescribing (Hepler and 
Strand, 1990). 
 
Some healthcare organizations have acknowledged that one strategy 
for influencing prescribing is having clinically trained pharmacists involved 
in patients’ therapeutic management (Calvert, 1999). Pharmacists with 
their expertise have the potential to contribute to achieve safe and 
effective use of pharmacological interventions. For example, it was 
reported that the most common drug related errors happening in acute 
coronary syndrome patients were drug omissions and dose errors 
(Michaels, 2010). A number of studies reported the value of having the 
pharmacist as part of the team providing patient care in ensuring 
optimization of therapy based on recommendations from guidelines for 
heart disease patients (Chinwong et al., 2004, Axtell et al., 2001, Gattis et 
al., 1999).  These findings support the involvement of pharmacists in 
disease management. However, a wider recognition from healthcare 
organizations to the potential of the pharmacists is expected to occur only  
if the pharmacists themselves take the initiative to be directly involved in 
patient care and acknowledge their responsibility in ensuring safe and 
effective prescribing  (Weidenmayer et al., 2006) . 
 
    According to the International Pharmaceutical Federation (FIP) report in 
2006, pharmacists were the third largest healthcare professional group 
globally after doctors and nurses. Their distribution based on health sector 
and geographical region was uneven (Chan and Wuliji, 2006). The 
majority of pharmacists were working in the retail sector followed by 
hospitals. Countries most affected by the shortages of pharmacists were 








2.10.2 Clinical pharmacy 
 
The role of pharmacists has changed dramatically over the past years. 
Since the preparation of drugs was taken over by the pharmaceutical  
industry, pharmacists had to identify a new role that can make use of their 
expertise and remodel their profession (Hepler, 1985, Hepler, 1990, 
Hepler and Strand, 1990). This necessitated the need for pharmacists to 
move from their traditional compounding and drug supply roles towards 
new roles that are more patient than product focused.  
 
The clinical practice of pharmacy in its simplest form was described as 
applying drug related knowledge while considering all areas related to the 
patient medical condition (McLeod, 1976). In this sense, clinical pharmacy 
does not need to be linked with certain settings and thus can be practised 
by pharmacists whether they are working in community or hospitals. 
However, the word ‘clinical’ at least by definition may imply that the 
practice is mainly linked with pharmacists working in clinical settings 
(Francke, 1969). 
 
With regard to clinical pharmacy practice in hospitals, the role of 
pharmacists in the hospitals by the patient bedside has been argued  to be 
the only way to maintain the pharmacy profession (Anderson, 2004). This 
move towards clinical roles in hospitals has enhanced the concept of 
professionalism in pharmacy (Hammer, 2000, Schafheutle et al., 2013). 
The clinical movement has also led pharmacy educators to consider the 
need of stressing the importance of teaching the concept of 
professionalism to the undergraduate pharmacy students (Schafheutle et 
al., 2013). 
 
 It is considered that the main attributes of professionalism  such as 
knowledge, skills, accountability, autonomy and the sense of identified 
‘mission’ of the pharmacist can only be achieved, displayed and 
maintained when pharmacists are working  with other healthcare staff as 




The perception is that if pharmacists use their knowledge only for 
supplying medicines, they may face the risk of deprofessionalization as 
this duty can be performed by the lay person (Hall, 2013).  In addition, the 
professionalism of pharmacy was also argued against based on the fact  
that as long as pharmacists are working based on instructions from 
another professional, that is the doctor, they do not exercise full autonomy 
(Hall, 2013).   
 
2.10.2.1 Development of clinical pharmacy 
 
The use of the term clinical pharmacy is thought to have developed in 
the 1960s in the United States in association with pharmacy practice in 
hospital settings (McLeod, 1976, Hepler and Strand, 1990). However, the 
practice of  joint work between the pharmacist and the doctor to provide 
patient care is believed to have started many centuries ago in Europe 
(McLeod, 1976).  It was also believed that the duty of some of the 
apothecaries in the seventeen and eighteen centuries in parts of Europe 
and US was reported as not only to supply drugs but to advise on 
medication and in some cases join the physicians in their visits to their 
hospital patients. 
 
The development of clinical pharmacy in the United States (US) and the 
United Kingdom (UK) was attributed to the rise in medication errors on the 
wards which led pharmacists to move from their pharmacies to provide 
ward based services (Cousins, 1995, McLeod, 1976) . Mcleod (1976) 
explained that in addition to medication errors, the introduction of the unit 
dosage form of drugs and the drug information centres which developed in 
the 1960s, led to the flourishing of the clinical pharmacy service in US. 
This is in spite the fact that clinical practice by some pharmacists was 







In the UK, an increase in medication errors led to the change in the way 
drugs were prescribed, then transcribed by  nurses and later administered 
to the patients in hospitals in the late 1960s (Cousins, 1995). The 
appearance of pharmacists on the wards to check the prescription and 
administration record led to a considerable reduction in medication errors. 
Cousins and Luscombe (1995) made a distinction between the former 
ward based service of pharmacists and the later clinical pharmacy service 
that appeared in the late seventies in UK hospitals when pharmacists 
joined the doctors’ ward rounds. The development in clinical pharmacy is 
known to have existed within hospitals before the establishment of clinical 
pharmacy education in pharmacy schools. In the United States, Mcleod 
(1976) described that despite earlier attempts from some hospital 
pharmacists in the 1930s and 40s to include clinical training for 
undergraduate pharmacists, the official clinical pharmacy training started 
in the sixties in some pharmacy schools in the US. In the United Kingdom, 
in the late 1970s, postgraduate qualifications in clinical pharmacy were 
developed (Cousins, 1995). 
 
The practice of clinical pharmacy although becoming a routine in North 
America and UK, is in its first stages in many countries in Africa and the 
Middle East. In some countries, for example UK, becoming a clinical 
pharmacist is only the first step in the clinical hospital pharmacy career. 
Clinical pharmacists progress in their clinical career to become specialized 
in particular clinical areas, for example, cardiology, antimicrobial therapy, 
intensive care and different other specialities. However, having specialised 
pharmacists in clinical settings was said to have started very much earlier 
as the clinical pharmacy profession was developing (McLeod, 1976).  
Paediatrics was described as one of the first clinical areas in the US to 
have specialized pharmacists. The reason for that was considered to be 
the general willingness of the paediatricians in hospitals to get the support 






The evolving designed role of the clinical pharmacist has shared many 
similarities for the last four decades.  Brodie in 1970 described the role of 
the clinical pharmacist in improving drug utilization. The pharmacist was 
expected to check prescriptions, medications use, maintain drug profiles of 
patients, make treatment plans with the physicians, provide drug related 
information and to work as part of the healthcare team (Brodie, 1970, 
McLeod, 1976) . The American College of Clinical Pharmacy (ACCP) 
(2014) recently published the standards of practice for clinical 
pharmacists. These included most of the pharmacists’ roles mentioned by 
Brodie (1970) such as reviewing medication record, assessing prescribed 
therapy, working with the healthcare team and providing advice to 
patients. The ACCP has in addition included the importance of maintaining 
professionalism attitudes such as competency, integrity and dealing with 
ethical issues in practice. This implies that the aim behind clinical 
pharmacy practice has been consistent in being a patient focused service 
and for clinical pharmacists to be part of the healthcare team.  This is not 
only important to maintain a consistent service but also for other 
healthcare professionals to understand the role of clinical pharmacists 
(Calvert, 1999). In addition, most of the published literature examining  
aspects of hospital pharmacy practice used most of these above roles as 
expected roles of hospital pharmacists (Awad, 2007, Smith et al., 2002, 
Tahaineh et al., 2009, Zaidan et al., 2011) .  Some of these roles such as  
detecting prescription errors, reviewing patient medication record, 
counselling patient and provide advice to other healthcare professionals 
were considered in this study when examining the role of clinical 
pharmacists in hospitals in Sudan. 
 
2.10.2.2 Clinical pharmacy, a speciality or the change to be 
embraced  
 
 Since the emergence of the term clinical pharmacy in the sixties, 




shared the concept of the ‘patient-oriented’ pharmacy service (Francke, 
1969).  In recent years different pharmacists’ associations have provided 
different definitions for clinical pharmacy practice.  
 
A detailed definition of clinical pharmacy by the American College of 
Clinical Pharmacy has stated that ‘Clinical Pharmacy is a health science 
discipline in which pharmacists provide a patient care that optimizes 
medication therapy and promotes health, wellness, and disease 
prevention. The practice of clinical pharmacy embraces the philosophy of 
pharmaceutical care; it blends a caring orientation with specialized 
therapeutic knowledge, experience, and judgment for the purpose of 
ensuring optimal patient outcomes. As a discipline, clinical pharmacy also 
has an obligation to contribute to the generation of new knowledge that 
advances health and quality of life’ ((ACCP), 2005). 
 
The European society for clinical pharmacy has defined clinical 
pharmacy as ‘ A health speciality which describes the activities and 
services of the clinical pharmacist to promote rational use of medicines 
[…], it includes all services performed by pharmacists in any setting, 
hospitals, community pharmacies, nursing homes or home-based services 
where medicines are prescribed and used’ (European Society of Clinical 
Pharmacy, 2010) . 
 
Furthermore, the term ‘clinical pharmacy’ has been described by the 
International Federation of Pharmacists (FIP) in 2006 as ‘The work of  
pharmacists whose primary job is to interact with the health care system, 
interview and assess patients, make specific therapeutic 
recommendations, monitor patient responses to drug therapy and provide 
medicine information’ (Weidenmayer et al., 2006). As this research is 
examining the role of the clinical pharmacist in hospitals in particular, this 







Other definitions for clinical pharmacy by different pharmacy bodies 
exist which raise the question about if clinical pharmacy is a speciality 
linked to practice in certain settings, is it complementing pharmaceutical  
practice or is it the change that pharmacy practice had to embrace and 
thus any pharmaceutical care should involve clinical pharmacy practice 
(Hepler, 1985, Hepler and Strand, 1990, McLeod, 1976, Smith, 2007, 
Provost, 1972).   
 
The above argument can be very much linked with the undergraduate 
education that pharmacists receive in different parts of the world. If 
schools of pharmacy cannot provide clinically oriented teaching for 
different reasons to the undergraduates, which is the case in many 
pharmacy schools around the world, pharmacists will continue to provide 
their classical drug oriented service. In such situations clinical pharmacy 
will be considered a speciality which requires post graduate training. 
Accordingly, it will be expected that only a fraction of pharmacy graduates 
will get the chance to undertake post graduate studies in clinical 
pharmacy.  In such case scenario, clinical pharmacy practice will be 
practised in certain settings where these specialized pharmacists are 
available which is the case in some countries around the world. For 
example, in Sudan where this study was conducted, clinical pharmacy 
practice is currently a speciality whereby only pharmacists who undertake 
a post graduate degree in clinical pharmacy can practice as clinical 
pharmacists in hospitals. 
 
   The above lack of integration of clinical education into the 
undergraduate pharmacy course caused earlier concern  that having two 
tiers of pharmacists, clinical and non-clinical could endanger pharmacy 
practice (Provost, 1972). It was even suggested that both tiers should not 
be referred to as pharmacists for the sake of the profession and the public, 
as they will be providing different levels of service. The argument which 
can be put forward for the above concern is that there are different areas 





and hence there may be very limited use of the clinical skills, for example 
in industry.  These areas may more benefit from pharmacists who have  
strong classical pharmacy education than those with mainly clinically 
oriented background.  This however, does not negate the need for a 
certain level of clinical education integrated into the undergraduate 
pharmacy course which can be further developed after graduation based 
on the pharmacist preferred area of practice.   
 
Clinical pharmacy services are rapidly developing in many hospitals in 
the Middle East and some African countries due to more pharmacists now 
being trained as clinical pharmacists (Kheir, 2013, Mekonnen et al., 2013). 
The defined practice of clinical pharmacy in hospitals is quite a new area 
for pharmacists in Sudan and is going to be examined in this study. 
 
2.10.2.3 Clinical pharmacy and pharmaceutical care 
 
 The concept of pharmaceutical care is believed to have projected in the 
early nineties (Calvert, 1999). Some authors made a distinction between 
clinical pharmacy practice and provision of pharmaceutical care (Hepler 
and Strand, 1990, Smith, 2007, LeBlanc and Dasta, 2005). The goal of 
clinical pharmacy is thought to be that patients should get ‘clinical drug 
knowledge from the pharmacist that improves patient care’ (Smith 2007), 
while pharmaceutical care is defined as ‘the provision of drug therapy to 
achieve definite outcomes and improve patient’s quality of life’ (Hepler and 
Strand, 1990). It has been argued that it is the ‘outcomes’ linked with the 
definition of pharmaceutical care that have made the distinction between 
the two terms (Hepler and Strand, 1990, Hepler, 2004). However, both 
definitions share the idea of patient care and thus can be considered as 
referring to one concept. The ACCP (2005) definition of clinical pharmacy 







On the other hand, there seems to be claims that suggest wider 
differences between the two concepts that can have a negative impact on 
clinical pharmacy practice (Hepler, 2004). For example, there has been a 
claim that clinical pharmacy is a pharmacy service directed mainly to 
clinicians in contrast to  pharmaceutical care that is directed to patients 
(Smith, 2007).  This claim against clinical pharmacy may be due to an 
underlying resistance to change coming from those, whether pharmacists 
or other healthcare providers, who are used to a specific type of service 
from pharmacists and are not willing to accept the new clinical service for 
personal related or organizational reasons.   
 
The dispute about whether pharmaceutical care and clinical pharmacy 
are different or not relied for part of it on some of the definitions that have  
been provided for the two terms. However, it can be considered that 
although these definitions help to provide a means of identifying the 
different concepts it may not be possible to accept the definitions as 
encompassing all aspects of either clinical pharmacy or pharmaceutical 
care. 
 
Hepler (2004) discussed different scenarios for the link between 
pharmaceutical care and clinical pharmacy but with strong argument that 
both can be considered as describing a shared goal of pharmacy practice 
which is the effective and safe use of drug therapy. The different scenarios 
were used to describe situations where clinical pharmacy practice can be 
applied but without achieving pharmaceutical care and vice versa. There 
were also work scenarios described where both clinical pharmacy and 
pharmaceutical care can be achieved. The main point that has been 
argued by Helper is that pharmaceutical care is a broader concept than 
clinical pharmacy that may go beyond what pharmacists can do, and to 
achieve it, unlike clinical pharmacy, it may include other healthcare 
professionals and involve other factors related to the healthcare system. 
Considering the above, one agrees with such a claim that clinical 





any pharmaceutical care will involve clinical pharmacy practice. However, 
different to Hepler’s suggested scenarios, it can be argued that 
pharmacists working in different settings whether in community or in 
hospital, can provide different levels of what can be referred to as 
pharmaceutical services in all circumstances, but not all services can fit 
the  definitions of ‘clinical pharmacy’ or ‘pharmaceutical care’.  
 
2.10.2.4 Clinical pharmacy and hospital pharmacy 
 
   A different distinction also needs to be made between hospital pharmacy 
practice and clinical pharmacy practice. It is the perception of the 
researcher that many healthcare settings in different countries have got 
their own criteria with regard to the two types of practice. Whereas clinical  
pharmacy is considered as one branch of hospital pharmacy practice for 
some, the idea that all appointed hospital pharmacists should be able to 
practice clinical pharmacy is applicable in some other healthcare settings.  
In spite of the above, it is still difficult sometimes to assess from the 
literature that a distinction was made between hospital and clinical  
pharmacy practice. This is important as this research is particularly looking 
into clinical hospital pharmacy practice. 
 
A review was conducted in 2005 into the published data about   
international hospital pharmacy practice (1996-2004) using Medline and 
other internet sources (LeBlanc and Dasta, 2005). The review considered 
the available published information about international hospital pharmacy 
practice as very scarce.  The authors also found difficulty in identifying 
hospital pharmacy practice from clinical pharmacy practice or 
pharmaceutical care. For the sake of their review, the authors decided to 
go for any ‘patient-oriented services’ provided by the pharmacists in 







In the review, some hospital practices were found to be more advanced 
than others with regard to the involvement of pharmacists in patient-care; 
this was usually happening in developed countries. Similar obstacles were  
shared by pharmacy practice in different countries especially developing 
countries including shortage of pharmacists, limited resources, financial  
restrictions and drug supply. What the review identified from the limited 
data from different countries was that there were similarities as well  
as differences between hospital pharmacy practice not only between 
different countries but within the same country.  One can expect that the  
‘inter-country’ variation in practice is likely to occur in countries where it is 
difficult to standardize healthcare. This can be especially true in countries 
with struggling healthcare infrastructure.  
  
In a similar attempt to examine international hospital pharmacy practice, 
a world-wide survey was conducted in collaboration with the International 
Federation of pharmacists (FIP) in 2009 (Doloresco and Vermeulen, 
2009). The survey examined different aspects of hospital pharmacy 
practice within each of the 192 countries which are members of the United 
Nations.  Eighty-five responses were received providing a response rate of 
44%. Respondents for the survey were chosen by their national pharmacy 
organizations according to their capability of understanding the nature of 
hospital pharmacy practice in the country. One reply from each country 
was accepted.  The survey results have shown differences in the type of 
hospital pharmacy service available in different countries.  The relationship 
between the hospital and the pharmacist was divided into three 
categories; high, medium and low, based on the pharmacist involvement 
in therapy management. The’ low category’ was found to be the highest 
with a mean response of 41%. In this category pharmacists were found 
only to be involved in drug supply. In the ‘high category’ (31%), 
pharmacists were found to be involved in the whole process of medication 
use that is not only product supply. In between the two levels of service 
was the ‘medium category’ (11%) were the pharmacists available were not 
actually part of the hospital staff but come to manage some medication 




The above study showed that there were some similarities in the 
obstacles facing hospital pharmacy practice in many countries including 
lack of enough hospital pharmacists and lack of training.  In addition, lack  
of essential medicines and ease of access to electronic information was 
shared by many nations especially those in the developing countries. 
With regard to influence on prescribing, the study found that in 65 (77%) 
nations pharmacists were involved in making decisions about hospital 
formularies.  
 
There are several limitations to the above study. The majority of the 
respondents (74%) were said to have used their ‘personal impression’ to 
reply to the survey questions and not information evident form practice.  In 
addition, a major limitation for the study is that it depended on a 
particularly allocated respondent or respondents to describe the nature of  
hospital practice in the participating countries and this may have resulted 
in biased information. More studies are required to investigate the actual 
practice of hospital pharmacists, especially in areas where clinical  
pharmacy practice is a new area of practice, and the obstacles facing 
those pharmacists in order to understand how to improve practice. 
 
2.11 Clinical pharmacists’ interventions and use of guidelines 
 
A large number of studies that were conducted in UK and US hospitals 
found that the involvement of clinical hospital pharmacists in patient care  
had a positive impact on the  patients’ health  (for example, (Anderson et 
al., 2010, Miller et al., 2011, Bond et al., 2001, Boyko et al., 1997, Howard 
et al., 2003, Leape et al., 1999, Alison Dale, 2003, Horning et al., 2007)). 
Furthermore, it has also been suggested  that  hospital pharmacists’ 
impact can be greater if they can provide input at the time of prescribing 
which usually takes place on the hospital wards (Anderson et al., 2010). 






present as members of the patient healthcare team. Even in some  
developing countries where clinical pharmacy is a new practice, the 
positive value of clinical pharmacists’ interventions on the wards was 
identified (Mekonnen et al., 2013). 
 
As adherence to clinical guidelines is expected to improve morbidities 
and mortalities, Horning et al (2007) studied the role played by 
pharmacists in ensuring that guidelines medications were prescribed.  The 
study compared the effect of having consultant pharmacists providing 
what was referred to as ‘diseases management services’ which particularly 
aimed to make therapeutic recommendations that increase adherence to 
guidelines versus patients receiving what the authors defined as 
‘traditional drug review service’ which is usually focusing on dosing errors 
and side effects of drugs. The study involved 411 patients in six long term 
care facilities for the elderly. Two of these facilities (107 patients) were 
receiving disease management pharmacy service while the rest (304 
patients) were getting ‘traditional’ pharmacy service.  The researchers 
conducted retrospective drug chart review focusing on seven chronic 
diseases; diabetes, coronary artery disease (CAD), heart failure, 
osteoporosis, stroke, hypertension and hyperlipidaemia by comparing 
drugs prescribed, pharmacists’ recommendations and current practice 
guidelines.   
 
The above study found significant improvement in prescribed guidelines 
medication in patients who received disease management service in four 
of the chronic diseases, CAD, HF, diabetes and osteoporosis. For stroke, 
hypertension and hyperlipidaemia there was no difference in adherence to 
guidelines medication compared to those patients receiving traditional 
drug review service.  Pharmacists providing disease management services 
were found to be more likely to make therapeutic recommendations than 
those providing ‘traditional’ drug review service. However, the findings 
may also suggest that there is a role for both types of pharmacy services 





areas which showed no difference in adherence to guidelines can indicate 
that some guidelines were more followed by doctors than others for  
different reasons that had to do with the particular clinical area or the 
easiness of following particular guidelines.  
 
The study has its limitations considering that some of the authors were 
actually the pharmacists doing the diseases management service and thus 
the bias effect from these pharmacists recording their own work cannot be 
ruled out. In addition, the findings depended on documentation which 
according to the authors was very variable. In spite of these limitations, the 
study as argued by Summers (2007) can be of value not only to 
pharmacists but to healthcare organisations who are seeking ways to 
improve adherence to guidelines. 
 
 It is also worth mentioning that a review into the quality of the published 
data between 1990 and 2009 about positive outcomes from pharmacists’ 
interventions, rated the quality of the data from moderate to poor 
(Melchiors et al., 2012). The reviewers considered the studies obtained 
from different online resources as requiring improvement in 
methodological aspects and study design. This implies that more studies 
need to be conducted in order to strengthen the argument that 
pharmacists’ involvement does make a measured and valued difference in 
patient care.  
 
Another review into the effect of clinical pharmacists on hospitalized 
patients examined 343 publications between 1985 and 2005 but included 
only 36 articles (Kaboli et al., 2006). The exclusion criteria were non-
clinical trials, outpatient and paediatrics clinics, no clinical pharmacist 
intervention and no comparison or control groups. The review, albeit, 
found general improvement in health outcome with no harm to the patients 
due to pharmacists’ interventions, identified the need for more research 
including larger samples and more reporting of  pharmacists’ interventions 





Bearing in mind the above limitations in clinical pharmacy studies, the 
information provided by the studies looking into the effect of pharmacists’ 
interventions on patient care can still be considered of value not only to 
pharmacists but to the whole healthcare system. For example, in UK, the  
role of pharmacists in minimizing drug errors is already being documented 
in official reports (Commission, 2001, Smith, 2004) . In addition some of 
the studies, for example, Horning et al., 2007, provided an indication of the 
positive effect of having pharmacists in ensuring that guidelines therapies 
were prescribed. This implementation of clinical guidelines can thus 
benefit the patients as well as the healthcare system. There is no doubt 
that pharmacists are the healthcare professionals with the maximum 
knowledge in the use of medications.  Pharmacists are  expected to have 
a positive role to play in patient care  as individuals and as part of a  team 
(Calvert, 1999). However, considering some of the argued limitations in 
the studies examining positive outcomes from pharmacists ‘involvement in 
patient care, more research is required to emphasize the positive 
contribution of pharmacists to healthcare.  
 
 Although studies were conducted to show how pharmacists can help in 
adherence to guidelines, the influence of having clinical guidelines on the 
practice of clinical pharmacists was rarely studied. Wolf et al (1999) has 
argued that guidelines not only assist prescribers, but other healthcare 
professionals in providing healthcare based on evidence. The influence of 
availability (or unavailability) of guidelines in assisting hospital clinical 
pharmacists performing their clinical role is going to be examined in this 
study. 
 
2.12 Hospital pharmacy practice in Sudan 
 
 The total work force of pharmacists in the public sector in Sudan was 







pharmacists working in the public sector, that is two pharmacists per  
100,000 of population, 341 pharmacists were employed in hospitals which 
constitutes around 49% of the pharmacists in the public sector in Sudan. 
Thus the average pharmacy workforce in hospitals in the public sector in 
Sudan is about 12 %. Although these figures  only refer to pharmacists in 
the public sector, they are comparable to the average global pharmacy 
work force in hospitals in 2006 which was reported to be about 15% (Chan 
and Wuliji, 2006).  
 
In 2006 the Federal Ministry of Health in Sudan, which is responsible for 
the development of national policies and strategic plans, acknowledged 
the need for developing pharmaceutical services in hospitals  (Directorate 
of Pharmacy, 2006). With the help of the Directorate of Pharmacy, a new 
policy regarding hospital pharmacy was included in the pharmaceutical 
strategic plan for the period of 2005-2029. This emphasized the need to 
develop hospital pharmacy in Sudan so that it can stand up to the changes 
and challenges in healthcare nationally and internationally.    
 
In addition, a review conducted in Sudan and published by the WHO 
about rational drug use in Sudan, found a decline in rational drug use in 
Sudan due to inappropriate prescribing, guidelines not being followed and 
patient self-medicating (Awad et al., 2007b). Some of the strategies that 
were suggested in the review to improve appropriate medicine use 
included joint work between different health care personnel, education, 
audit and increase involvement of pharmacists with clinical knowledge to 
assist prescribers and help educate patients about medicines use. 
 
Different criteria have been suggested by the Ministry of Health in 
Sudan in the plan to improve hospital pharmacy practice (Directorate of 
Pharmacy, 2006). These included improvement of the overall hospital 
pharmacies environment and service, provision of cost effective 
medication, rational use of drugs, continuous training for pharmacy staff 





pharmacy concept and training pharmacists to become clinical 
pharmacists. Clinical pharmacists as described in the plan are these 
pharmacists who can provide patient focused pharmaceutical service and 
work closely with other members of the healthcare team to ensure safe 
and effective drug therapy.  
 
At the time of publishing the above report by the Ministry of Health, 
there was not any established clinical pharmacy practice in any of Sudan  
hospitals (Directorate of Pharmacy, 2006). However, in Khartoum there 
were five hospitals which were reported as to be in the process of 
adopting clinical pharmacy. At the same time there were sixteen 
pharmacists from government hospitals who were enrolled in the 
postgraduate course of clinical pharmacy provided by the school of 
pharmacy in the University of Khartoum. Accordingly, two different job 
classifications have been identified for hospital pharmacists in Khartoum 
hospitals during this study. These are clinical pharmacists, those with post 
graduate degree in clinical pharmacy, and non-clinical pharmacists. This 
study will focus on the role of hospital clinical pharmacists. 
 
2.12.1 Studies in hospital pharmacy in Sudan 
 
Few studies were found in the literature that examined the role of 
hospital pharmacists in Sudan.  A study was conducted in 2004 about the 
role of hospital–based pharmacists in some of Khartoum teaching 
hospitals (Awad, 2007a). Awad et al (2007) aimed to investigate the 
perception, experience and expectation of hospital medical doctors 
towards the pharmacists’ role.  Out of 300 randomly selected doctors from 
four teaching hospitals in Khartoum, 200 (66.7%) responded to a self-
administered questionnaire. The study reported that the doctors 
responded positively with regard to their expectations of the pharmacist’s 
role. The medical doctors were found to be more accepting of certain 
duties of pharmacists such as detecting prescription errors and least 





prescription medications for patients. Although one of the study aims was 
to examine doctors’ experiences with hospital pharmacists it is not clear if 
that aim was achieved. The study found that half of the doctors had rare 
contact with pharmacists. In addition, it is not clear how the other half 
came in contact with the pharmacists considering that it is unlikely that the 
pharmacists were available in clinics or on the wards.  
 
Furthermore, some of the doctors’ experiences with pharmacists were 
reported to do with pharmacists’ advice about cost effective medications. It 
is not clear if the doctors were considering medical companies’ 
pharmacists or hospital- based pharmacists. Some of the survey questions  
can also be considered more to do with community pharmacists than 
hospital pharmacists, for example, statements about ‘treating minor  
illnesses’ and ‘suggesting non-prescription medications’. Thus the study 
can be considered more as examining perceptions and expectations 
rather than actual experiences of doctors towards hospital pharmacists.  
 
The above study findings suggested that doctors were willing to accept 
pharmacists’ contributions in health care. However, their actual experience 
with pharmacists is difficult to tell. Currently, with clinical pharmacists 
appointed in some of the hospitals in Khartoum; first graduates in 2007, it 
is worth investigating if the doctors have had actual experiences with the 
clinical pharmacists and how their perceptions have varied.  
 
Similar findings to Awad (2007a) were identified in studies conducted 
about doctors’ perceptions and expectations of hospital pharmacists in 
different countries (Fahmy et al., 2013, Khdour et al., 2013, Matowe et al., 
2006, Zaidan et al., 2011, Tahaineh et al., 2009). Physicians were usually 
positive about pharmacists’ involvement with the physician in hospitals. 
The roles which were usually expected from pharmacists were the 
traditional roles of solving drug related dilemmas. The involvement in 
advanced clinical roles was not yet expected from the pharmacist. 
However, as most of the physicians were not exposed to pharmacists in 




pharmacists may change the physicians’ expectations (Nelson et al., 
1978b, Ritchey and Raney, 1981). 
 
In a similar attempt to investigate the effect of hospital pharmacists in 
Sudan, a study was conducted in Alshaab hospital between 2003-2004 
(Abdelhamid et al., 2008). The study aim was to investigate the effect on 
asthma patients when they have their medicines reviewed by a hospital  
pharmacist. A group of sixty asthma patients had their medication 
reviewed and counselling provided by a trained pharmacist.  Patients were 
followed up every two weeks and for six months on follow up 
appointments. The study found that there was an overall reduction in 
asthma symptoms in the patients who received counselling in comparison 
to a non-intervention group who did not receive such a counselling service 
and received their medication as normal from the dispensary. In spite of 
the limitations of the study, which include patients dropping out or not 
appearing on follow up weeks and depending on self-accounts in part of 
the assessment, the study identified one of the roles that can be played by 
hospital pharmacists in Sudan. 
 
2.12.2 Pharmacy education in Sudan 
 
In the early 1990s there was only one school of pharmacy in Sudan 
graduating between 40 and 50 students each year. This is the school of 
pharmacy in the University of Khartoum (U of K), the oldest university in 
Sudan which was previously known as Gordon Memorial College. Only 
students who get 90% or over in their high school certificate exams will be  
accepted into pharmacy in U of K (Mohamed, 2011). However, in the last 
fifteen years more than ten new schools of pharmacy, public and private, 
have opened in Sudan. It is the perception of the researcher that this may  
not only be due to the government policy to increase the number of 
graduates in Sudan, but also due to an increase in interest in pharmacy 
qualification by many of those students starting their college education. 





have been perceived to be better for pharmacy graduates than for those 
graduates from other health related disciplines.  
 
As perceived by the researcher, many of the newly opened schools of 
pharmacies in Sudan have been trying to attract students by advertising a 
clinically oriented curriculum.  However, it is difficult to tell to what extent 
this clinical curriculum was fulfilled. The oldest schools of pharmacy seem 
to be the ones that are behind in making a move from the classical 
teaching of pharmacy to the new era of clinically based pharmacy teaching 
(Mohamed, 2011). Many reasons were attributed to this, including lack of 
resources, funding and lack of trained personnel who can provide such 
clinical teaching. Other factors also included resistance from some of the 
academics in moving forward with clinically–based pharmacy program 
which may endanger other classical disciplines in pharmacy, for example, 
pharmacognosy or physical pharmacy. 
 
The first post graduate course in clinical pharmacy in Sudan was 
established by the Faculty of Pharmacy, University of Khartoum in 2004 
(Mohamed, 2011). It has been a means for providing a step forward in 
pharmacy practice in the country by offering clinical training which the 
majority of the pharmacy graduates of Sudan are considered to lack. The 
course is a two year course and attracted many applicants each year but 
the course has only allowance for 20-30 applicants per year.  The total 
number of clinical pharmacists graduating from this course reached 141 in 
2011. Although there were pharmacists who did post graduate degrees in 
clinical pharmacy outside Sudan years before the start of this course at 
the University of Khartoum, and worked in hospitals, clinical pharmacy 
practice was officially recognized in the hospitals when the concept was 
recognized by the Ministry of Health and the course in Sudan had its first 
graduates available in the hospitals.  
 
In 2012, the Sudanese Society for Clinical Pharmacists (SSCP) was 





professional training for clinical pharmacists.  The SSCP has been  
organizing lectures about different clinical topics as well as inviting 
members to regular meetings to discuss issues of concern with regard to 
clinical pharmacy practice.  
 
2.13 Summary of the literature review 
 
In summary; clinical guidelines are considered as a useful tool in clinical 
practice. However, certain criteria concerning the development and 
implementation of these guidelines, as discussed earlier, need to be 
considered in order that they can serve the purpose of translating best 
scientific evidence into patient care. One of the challenges of guidelines is 
their application in healthcare settings with limited resources especially in 
developing countries. Cardiovascular disease is an example of a discipline 
with a large number of guidelines, and although it was once considered a 
disease of the developed world, its prevalence is on the rise in many 
developing countries including Sudan. Therapeutic treatment promoted by 
these clinical guidelines is said to reduce morbidities and mortalities in 
patients with heart disease and is endorsed by a number of international 
bodies including the World Health Organization.  Related to therapeutic 
treatment, the role of clinical pharmacists in hospitals is gaining more 
attention worldwide as there is a strong belief in the positive effect these 
pharmacists can provide in assisting prescribing.  Although the role has 
been established for a number of decades in US and UK, it is emerging as 
a new area of practice in countries like Sudan. Therefore, this study is 
going to examine prescribing in cardiology and the new role of clinical 
pharmacy in Sudan focusing on the use of guidelines by prescribers and 
the perceived influence of availability of guidelines on the practice of 


















Based on the areas discussed in chapter 2, the aim of this study is to 
use a mixed method approach to examine the use of guidelines in 
prescribing in cardiology and to explore how availability of guidelines is 




To achieve the above aim, the following objectives were identified: 
 
1. To examine the factors considered by doctors when prescribing for 
patients in Khartoum cardiac hospitals, in particular the use of clinical 
guidelines in prescribing 
2. To identify the possibility of using clinical guidelines whether national or 
international  in clinical practice in Sudan 
3. To explore the new clinical role of hospital pharmacists in Sudan 
4. To identify  the challenges facing clinical pharmacy practice in Sudan, in 
particular the influence of availability (or unavailability) of guidelines on 
the practice of clinical pharmacists in hospitals 
 
3.3 Principal research questions 
 
1. What are the factors influencing prescribing in heart disease in Khartoum 
cardiac units and are clinical guidelines one of these factors? 
2.  Can clinical guidelines and in particular international guidelines be 
applied in clinical practice in Sudan? 
3. What are the major challenges facing the new practice of clinical 
pharmacy in Sudan? 
4.  Does the availability (or unavailability) of clinical guidelines influence the 



















































This chapter discusses the methodology behind this study design. The 
chapter provides an overview of the methods used in this study, the issues 
surrounding their use and the data analysis techniques. The chapter’s 
main focus will be on the methods considered or employed in this 
research. The chapter also includes the materials used in this study. 
 
4.2 Background to methodology 
 
The methods that are to be used in social research are usually linked 
with the theoretical assumption behind how the problem of concern is to 
be studied (Bowling, 2009a, Bryman, 2012). Based on this assumption a 
distinction is made between two most common approaches in research, 
quantitative which is based on the theory of positivism and qualitative  
research which is based on interpretivism.  The choice between using 
either approaches or using both of them that is a mixed method approach 
in a certain study depends on the research questions. In this study a 
mixed method approach was used to answer the research questions. The 
study involved the use of a number of qualitative and quantitative methods 
generally used in health research.  
 
4.3 Mixed methods research 
 
The main feature of mixed methods research is the combination of 
quantitative and qualitative data to answer the research questions 
(Tashakkori and Teddlie, 2010). Mixed methods research is said to be 
derived from Campbell and Fiske’s work in psychological features in 1959 
where multi methods were used for their study (Creswell, 2003, Creswell 
and Plano Clark, 2007). Different concepts of mixing data have later 
emerged and more people were inspired to mix methods in their research 
work.  Although mixed methods research was also known as multi-method 




research is different from mixed methods research in that the former in 
contrast to the later, is based on multiple forms of either qualitative or 
quantitative methods. The following advantages of mixed method research 
as discussed by Creswell and Clark (2007), were the reason for choosing 
a mixed method approach in this study.  
 
1- Each qualitative and quantitative method  has got its strength and 
weakness points so by combining the two methods it may be possible to 
reduce the weakness of each method ((Bowling, 1997b, Creswell, 2003). 
However, others have opposed this argument on the basis that each 
method comes from an opposing epistemological approach (Bowling, 
2009b, Bryman, 2012). The advantages and disadvantages of each 
method are going to be explained in section 4.4 and 4.5. 
2- Results from one method can be used to construct or enlighten 
another method (Creswell and Plano Clark, 2007). For example, a 
qualitative method is used to explore a certain phenomenon within a small 
group followed by a quantitative method to test this phenomenon on a 
larger sample of the population.  
3- The design of mixing both qualitative and quantitative data is said 
to provide a better comprehensive understanding of the research 
problems than either data used alone.  
4- Mixed methods research can be used where the research 
problems cannot be explained by using either qualitative or qualitative 
methods separately. 
 
As mixed methods research involves joint use of qualitative and 
quantitative methods, there are different approaches of combining the two 
methods. Creswell (2003) identified six main designs that can be 
considered for use in mixed methods research depending on the study 
objectives: 
1- Sequential explanatory design: in this design initially quantitative 
data is collected and analysed followed by collection and analysis of 
qualitative data.  In this type of strategy usually the quantitative data is 




2- Sequential exploratory design: Similar to sequential design, the 
main difference is that qualitative data are first collected. The researcher 
usually identifies relevant issues with regard to the research question 
which can then be studied quantitatively. 
3- Concurrent Triangulation design: This is a commonly used 
strategy in research whereby different methods are used in a study to  
validate the findings obtained. The methods are used simultaneously in 
one phase in contrast to the previous sequential designs. 
4- Concurrent Nested (Embedded) design: This is similar to the 
triangulation design in that it occurs in one phase but there is usually one 
approach to data collection which has more priority than the other method. 
The different types of approaches are mixed at the design stage, for 
example, design for experimental studies. 
5- Sequential Transformative design:  In this design the priority can 
go to either type of data, qualitative or quantitative, or both if required. 
Unlike the exploratory or explanatory methods, this design is influenced by 
prior  theoretical assumption  which has a bigger influence in directing the 
study 
6- Concurrent Transformative method: This method can follow the 
triangulation or the embedded strategies but as a sequential 
transformative design the research is usually led by a certain theory. 
  
 Considering the above methods, this study followed a sequential 
exploratory design. As little was known about the phenomenon to be 
investigated, the qualitative data was collected first followed by the 
quantitative data which was used to enhance the qualitative data. Bryman 
(2012) identified that this enhancement of data is the most common 
reason for which mixed method research has been used. However, there 
are some challenges encountered with sequential mixed method research 








Table 4.1 Advantages and challenges of sequential mixed method design  
(Creswell and Clark (2007)   
 
ADVANTAGES CHALLENGES 
Separate phases allow ease of  
description of the report 
Issues with ethical approval  
as the  design of the next  
method may  not  be identified  
prior to the initial method 
 
Emphasis on qualitative findings 
 with  quantitative results  
makes the study  more  
approachable for certain readers 
 
Length of time required  
to conduct each phase separately 
The design can be equally applied 
 on single phase or multiphase studies 
Using the same or different  
participants, the latter is usually  
 the case  in  exploratory studies 
 
 
The above challenges were encountered in this study, for example, 
having to go through ethical committees more than once as changes were 
made to the study design. The time factor was also a challenge as each 
phase of data collection was conducted separately. In addition, different 
participants were used in different phases of this study to explore the 
phenomenon studied. 
  
The different qualitative and quantitative methods used in this study are 
going to be introduced and discussed in the following sections. This will 
include the theory behind each methodology, how data were collected 
using these methods and the different methods of analysis. In this study 
the methods used were, semi–structured interviews, focus group 
discussion and surveys. In addition, an exploratory observation was used 









4.4 Qualitative methodology 
  
Qualitative research is used to gain a better understanding of people’s 
experiences and ways of thinking (Creswell, 2009, Smith et al., 2002). The 
idea behind using this type of research is that the phenomenon explored is 
better understood from the interpretation of the participants involved 
(Bryman, 2012).  However, this is also the main criticism for this type of 
research in that it is too subjective in its accounts by depending mainly on 
people’s views. Another challenge for qualitative research is the effect of 
the researcher  on the research conducted (Malterud, 2001). The 
argument is that the researcher perceptions and opinions will have an 
effect on the whole study process. The solution suggested was that for the 
researcher to claim his/her background, preconceptions and to clearly 
distinguish what is claimed based on previous assumptions from that 
emerging from the data. This is also known as reflexivity. In this study the 
researcher background and experience were earlier identified as these 
may had influence on how the study was conducted. In addition any claim 
in this study based on the researcher’s perceptions or previous experience 
was clearly stated. 
 
In this study, the use of qualitative methods served the objectives of the 
study whereby the views and the experiences of the participants were 
required to understand the issues explored.  In addition, it was possible to 
identify and introduce new areas for investigation that become apparent 
from the participants’ views which is an advantage in qualitative research.  
 
4.5 Quantitative methodology 
 
Quantitative research generally uses numbers to study the problem in 
question (Bryman, 2012). The idea behind using quantitative research is 
that the problem investigated is understood objectively usually by 





obtained from this type of research are expected to be generalizable and 
can be applied in other settings. The main criticism for this type of 
research is that relying on numbers and instruments only in providing 
information, disconnect research from actual people.  In many situations 
especially with relation to healthcare, numbers and scientific experiments 
are not the main important criteria in solving the patient problem (Malterud, 
2001).  
 
Qualitative and quantitative research are often better understood when 
they are compared to each other (Bryman, 2012).  Some of these 
differences are shown in Table 4.2. 
 





































4.6 Validity, Reliability and Rigour of research 
 
There are important concepts which are often considered in research. 
These are validity, reliability and rigour. 
 
 Validity 
A valid method of measurement is a one that is measuring what it is 
meant to measure (Bowling, 2009b). The issue of validity differs between 
qualitative and quantitative research.  In quantitative research, for example 
in a survey, the questions need to be valid so that a reliable answer can 
be obtained, whereas in qualitative research where the data are obtained 
from people’s views and experiences, the validity of the research will be to 
obtain a true reflection of people’s perceptions (Smith, 2002a).  
 
There are different ways in which the validity of an instrument can be 
assessed (Bowling, 2009b, Smith, 2002a). Some of these approaches 
which were applied in the questionnaires used in this study are briefly 
defined below: 
Face validity: This is considered as an initial step in identifying any 
problem with a measure. For questionnaires this can be a check of 
questions which are difficult to understand. 
Content validity:  This is a measure of to what extent is the instrument   
examining or covering the areas that need to be researched. 
Construct validity: This is to test if a group of questions are considered 
to be related to the concept that they are expected to measure. 
 
Validity can also be divided into external and internal validity (Bowling, 
2009b, Smith, 2002a, Malterud, 2001). The external validity, sometimes 
also referred to as transferability, is obtained if the research results can be 
applied beyond the research settings that is generalised. This usually 
involves quantitative data. Internal validity on the other hand occurs if the 






the study actually investigated what it is supposed to. With regard to this 
study which was exploratory in nature, the aim was not to generalize any  
results obtained but a degree of transferability of the results obtained can 




Reliability is a test of whether the same results are reproducible if the 
same process is repeated (Bowling, 2009a). Reliability has also to do with 
consistency of measure, that is, the set of measures are actually all 
‘tapping’ into one criterion that they are measuring (See Cronbach’s alpha 
section 4.9.3).  Unlike quantitative data, the reproducibility of responses is 
not the aim of qualitative data. Reliability of analysis in qualitative research 
is achieved through detailed documentation of data from  interviews, focus 
group discussions or observation (Mays and Pope, 1995). 
 
Rigour 
Rigour is a concept related to the validity and reliability of data (Bowling, 
2009b, Smith, 2002a). The concept refers to essential factors in the 
research process which ensures high quality and confidence in the data 
obtained. The systematic and consistent approach to research design, the 
importance of how data are interpreted and the detailed explanation of the 
steps involved in the research are some of these features. To check the 
rigour of the research, several methods such as the use of an independent 
researcher to verify the findings or the use of triangulation in mixed 
methods can be applied. However, rigour considered to be more 
problematic in qualitative research than quantitative research. Whereas 
rigour in quantitative research can be verified based on the measures of 
validity and reliability of the methods used, the concept in qualitative 
research relates to several features of the study process including 
consistency, care for details and also honest approach during the whole 





4.6.1 Threats to reliability and validity 
 
Beside the validity and the reliability issues linked with the 
methodological approach, there are a number of threats to the study that 
can happen through different stages of the research process, some of  
these threats which were either experienced or cannot be ruled out in this 
study are briefly defined below (Bowling, 2009b). 
 
Non-response bias: This is the difference between those who 
responded and those who did not respond, for example, in a survey. 
Social desirability bias: People providing what they perceive to be the 
‘best’ response and not the ‘true’ response. This was minimized in this 
study by trying to present the questions in the interviews or surveys in a 
way so as not to imply that there is a right or wrong answer.  
Response–set bias: This is the tendency of participants to respond in a 
certain way regardless of the question content. In this study this was 
minimized  by changing the direction and wording of the questions without 
causing confusion to prevent the ‘mind-set’ response. In addition, different 
questions were used to examine the same criterion. 
Interviewer bias: The interviewer can consciously or subconsciously 
affect the interviewee response. The interviewer’s skills can play a role in  
minimizing this effect.  
Observation bias (Hawthorne-effect): People respond differently when 
they are observed. This will be further discussed in section 4.8.1. 
Sampling bias: This refers to the part of the population of interest who 
for different reasons were not sampled. 
Reporting bias: Participants are biased in the information they provide, 
that is what to report and what not to. 
 
Different measures were taken in this study to enhance the validity, and 
reliability of the methods used in this study and to limit the threats to 
validity and reliability that can occur. Some of these measures were 





experienced or cannot be ruled are reported as part of the methodological 
limitations of each phase of the study (section 5.6, 6.6, 7.6 and 8.6). A 
summary of these measures and limitations is also provided in the final 
chapter of this study (section 9.3).  
 
4.7 Sampling of participants 
 
In most quantitative research, sampling is preferably carried out in a 
random manner with a large number of participants and sites selected so 
that the results can be generalised to a larger population (Bowling, 1997a, 
Creswell, 1998, Creswell, 2009). In qualitative studies the aim is not to 
generalise the results but to explore the issues investigated, hence, 
randomisation is not necessarily used.  In this study purposive sampling 
was used which involve deliberate selection of participants with specific 
characteristics who can explain the phenomenon investigated (Bowling, 
2009b, Smith, 2002a). Other methods of sampling that are generally used 
in qualitative research include representative sampling and convenience 
sampling. 
 
4.8 Data collection methods 
 
 In the following sections the qualitative and quantitative methods used 




There are different ways in which observation is used in healthcare 
research (Smith, 2002a). For example, it can be used qualitatively to 
explain phenomena, quantitatively to gather numerical data and also as an 
exploratory tool as part of a mixed method research. Exploratory 
observation is used to generate or identify some ideas which can then be 
researched more thoroughly. The value of observation comes from its 




occur. In an observation study, the observer can either be a participant or 
a non-participant observer, the later was the case in this study (Bryman, 
2001, Smith, 2002a).  Observation was used in this study as a preliminary 
exploratory step to gain an insight into the everyday practice within the 
participating hospitals. In many studies, non-participant observation is 
combined with other methods for data collection to provide additional 
information or to complement the data provided.     
 
An important issue in observation studies arises when the participants 
are aware that they are being observed. This is known as overt 
observation study (Smith, 2002a). This may lead to the participants 
changing their normal behaviour as a result of being observed in what is 
referred to as the ‘Hawthorne effect’. The extent of the ‘Hawthorne effect’ 
usually varies with the type of setting and people to be observed, the 
nature of the participants involved, the type of data collected and also how 
the observer is conducting his/her study. One of the methods which is 
suggested to reduce this effect is by spending much time as possible in 
the observation scene to reduce the reactive effects of the observer’s 
presence.  Considering the option of those being observed not to be 
informed about the presence of the observer, that is covert observation, 
can give rise to ethical dilemmas of not having the consent of those being 
observed to be involved in the study.  In this study, the researcher 
intention to observe was stated as permission was asked in advance 
before any observation was carried out in the participating hospitals. The 
researcher spent different days of the week and different times of the day 
during a period of two months to conduct the observation (section 4.12).  
 
4.8.2 Methods used in qualitative research 
 
The qualitative methods used in this study for data collection were 




4.8.2.1 Semi-structured interviews 
 
Interviews are usually used to gain the views of people who have the 
knowledge in the areas to be investigated and are generally conducted 
face to face or through the telephone (Bowling, 2009b, Creswell, 2009, 
Smith, 2002a). The two main types of qualitative interviews are the 
unstructured and the semi-structures interviews. Both types of interviews 
are flexible in accommodating the interviewees’ points of views, whereas 
the former is completely unstructured the latter will usually have some  
pre-set topics, usually in an interview guide, that the researcher will like to 
cover based on the research objectives.  
 
Semi-structured interviews provide a more precise but flexible way of 
generating knowledge based on people’s views and behaviour than 
unstructured interviews (Creswell and Plano Clark, 2007, Mason, 2002, 
Oppenheim, 2003, Smith, 2005). They also ensure coverage of 
predetermined research questions (Drever, 1995, Ritchie and Lewis, 
2003). While in an interview, the researcher has the advantage of being 
able to explain the research questions and clarify any misunderstandings, 
compared to self-administered questionnaires, face to face interviews can 
be time consuming, costly to organize and also carry the risk of  
interviewer bias (Bowling, 2009a)(section 4.6.1). 
 
Sampling in interviews 
The methods used to sample participants for interviews usually follow 
the sampling criteria employed in qualitative research to select participants 
(section 4.7).  For the interviews conducted in this study, purposive 








4.8.2.2 Focus group discussions  
 
Focus group discussions (FGD) were said to have originated in market 
research but academics started to use them in research in the 1980s 
(Krueger and Casey, 2000). A focus group discussion is a form of a group  
interview which is used in qualitative research to allow the participants to 
express their views in a group discussion (Smith, 2002a). The members of 
the group are influenced by each other’s comments and hence respond 
accordingly (Krueger, 1994) The advantage that focus groups provide for 
the research over the individual interviews, is the interaction that takes 
place between the participants in the group which could  enrich the  
discussion. On the other hand, due to the nature of focus groups, 
individual views will be less easy to identify. However, the purpose of 
conducting a focus group is to provide the stimulation and motivation 
generated by the group discussion so that a wider range of ideas can be 
generated. The limitations of this technique  which were experienced in 
this study were (Bryman, 2012): 
 The difficulty of managing the group discussion especially for the 
inexperienced researcher ,  
 The dominant participant,  
 The quiet participant,  
 The huge amount of data generated from transcribing the group 
discussion 
 
Focus groups are run by a moderator also known as  ‘the facilitator’ 
who is responsible for directing and at the same time partially controlling 
the discussion (Krueger, 1994). The moderator can have an assistant, a 
co-facilitator who assists in handling unexpected events such as 
interruptions, problems with tape recording during the discussion and also 
to note the level of participants’ interactions. The moderator involvement in 
the discussion can either be minimal, moderate or maximum where he/she 
has total control of the discussion proceedings (Bryman, 2012, Krueger, 





involvement in the discussion during the FGD as will be described in 
chapter 7.  
 
Sampling in FGD 
In FGD, there should be a great consideration when selecting the 
participants with regard to their personal characteristics and experiences 
(Smith, 2002a). Groups of similar characteristics are assumed to be easier 
to engage with each other and hence, the desired level of interaction can  
be achieved (Krueger, 1994, Smith, 2002a).  A small variation within the 
group can also be of value in providing contrasting views (Krueger, 1994). 
The number of members in each group is preferred to be between five and 
seven. Small group discussions are easier to run and provide a better 
chance to explore ideas but on the other hand may provide a smaller 
number of ideas than those generated from bigger groups. 
 
4.8.3 Methods used in quantitative research 
 





 Surveys are considered to be one of the most widely used methods in 
research in general and specially in pharmacy practice research (Smith, 
2002a). A survey is a process whereby information is obtained from a 
larger population of participants compared to other methods, for example, 
interviews. Using a survey to collect data is considered to be a less costly 
and easier method than other methods of research and hence, a bigger 
population can be included (Smith, 2002a). Some of the advantages and 
disadvantages of the self-administered questionnaire are shown in Table 






The most frequently used tool for conducting a survey is the 
questionnaire (Smith, 2002a). A questionnaire is made up of a set of 
questions usually closed questions but can have some open questions as 
well. Most of the survey studies are descriptive cross-sectional studies.  
This means that the information about characteristics of the population 
and their views about particular topics are obtained by single 
administration of the questionnaire which was the case in this study.   
 
Unlike interviews and focus group discussions, participants are not 
usually asked to sign a consent form before participating in a survey.  
Answering and returning the survey is considered to be like an informal 
consent to participate (Sue and Ritter, 2012). 
 
Table 4.3 Advantage and disadvantages of the self-administered questionnaire 
 (Bryman, 2012, Bowling 2009) 
 
ADVANTAGES  DISADVANTAGES 
Ease of administration 
 
Risk of missing data 
Large samples can be used Pre-set responses 
Less cost Respondent cannot be asked for 
further verification of the answer 
 
No interviewer effect on the participants 
 
 
Cannot be used  with certain types of  
participants (language/literacy) 
No variability in questions (compared to 
Interviews) 
 
No chance of explaining unclear 
questions to the respondents 
Convenience of responding (none or 
few open questions) 
 
 
Respondents may read the  
questionnaire as a whole before 
responding and that may affect the results 
Less time consuming (compared to 
qualitative measures) 
 
Response rate especially with postal 
questionnaire 







Sampling in surveys 
With questionnaires, a random sampling method is generally applied 
which may allow generalization of the result. Examples of sampling 
techniques which may involve a randomisation technique are, cluster 
sampling and stratified sampling (Bowling, 2009b, Sue and Ritter, 2012). 
Other types of sampling techniques can be used when the aim of the 
research is not to generalise the results (section 4.7). 
 
 Construction of the questionnaire    
There are several steps which are required to be considered during the 
process of constructing a questionnaire as explained below (Bowling, 
2009b, Sue and Ritter, 2012): 
 
Planning research 
The first step in planning the construction of a questionnaire is 
identifying the topics of interest. In this study, the topics of interest were 
defined based on the research objectives, literature search and preceding 
interviews or focus groups.  
  
 Questionnaire design 
  In questionnaire design, scales representing different measures have 
been used to identify respondents’ views (Bowling, 2009b, Bryman, 2012, 
Smith, 2002a). The respondents are asked to choose their response from 
a range within the scale which is usually a five-item range scale.  One of 
the most commonly used scales in research is the Likert scale which was 
used in the two questionnaires administered in this study. The scale is 
said to be measuring respondents’ attitudes when they are presented with 
certain statements on a questionnaire by identifying whether they agree or 
disagree to the statement presented.  Attitudes were described by 
Oppenheim (2003) as ‘a state mind readiness whereby there is a tendency 
to respond in a certain manner when confronted with a certain stimuli’. A 
link is argued to exist between the values that people carry, their attitudes 





A Likert scale is considered to be easy to prepare and easy to use by 
the respondents (Foddy, 1993).  A number of criteria are to be considered 
when constructing a Likert scale including; statements should be related to 
the concepts studied and to each other, the concept studied should be in 
the form of statements and not questions and it is advisable to have a 
combination between positive and negative statements to avoid what is 
known as the ‘response-set’  participants (Bryman, 2012, Foddy, 1993).  
 
Piloting 
Before starting the survey, the questionnaire has to be tested on a small 
scale of respondents. This provides a means to discover any issues 
related to the content and construct of the questionnaire and can also be a 
preliminary test to detect the response rate. 
 
Enhancing good response  
A number of factors are involved in survey design that can help in 
increasing the response rate (Smith, 2002a). Some of the methods used 
to attract participants to a survey which were applied in this study were the 
use of coloured  papers for the self-administered questionnaire, writing 
invitation letters which included information about confidentiality and 
sending reminders to the participants within a short period of time, a week 
is usually considered reasonable (Sue and Ritter, 2012).  
 
Administering questionnaires 
Several methods can be used to administer a questionnaire, these 
include self-administered mail questionnaires, telephone interviews, hand-
delivered self-administered questionnaires and in recent years online 
surveys.   In the first survey in this study, questionnaires were self- 
administered to the participants where as in the second survey, an online 
questionnaire was used. The use of online surveys will be more discussed 
in the following section. 






 Online surveys 
Researchers have identified two types of on-line surveys, e-mail 
surveys and web-based surveys (Sue and Ritter, 2012). In e-mail surveys 
participants access the questionnaire by ‘clicking’ a link sent to them via 
their e-mail addresses which was the case in this study. In a web-based 
survey, the participants access a specific website where they are asked to 
complete a questionnaire. Some of the advantages and disadvantages of 
online surveys are shown in Table 4.4 (Sue and Ritter, 2012). 
 





Relatively low  cost 
 
 
Bias to internet users 
Wide geographic area 
 
Technical problems 
 Speed Blocking emails 
 
 
Similar methods for sampling that are used in other types of surveys 
can be applied for online surveys. With online surveys the chance of 
coverage limitation due to internet use can be a cause of non-response 
error. The users of the internet  can vary according to factors such as  
age, education level and whether they are living in urban or rural 
communities (Sue and Ritter, 2012). Although the targeted population in 
this study for the online survey were expected to be internet users based 
on education, the issues of internet coverage and the use of personal 









4.9 Data analysis 
 
The following section describes some of the approaches that can be 
used to analyse qualitative and quantitative data focusing on the 
approaches considered for this study. 
 
4.9.1 Analysis of mixed method research 
 
In a mixed method study, data can be analysed separately (Creswell 
and Plano Clark, 2011). However, to verify the use of the mixed method 
approach, it should be explained in the study how the qualitative and 
quantitative approaches helped each other in answering the research 
questions. The quantitative and qualitative part of the mixed-method 
research need to be linked or connected at an earlier stage or a later 
stage in the research (Creswell and Plano Clark, 2011, Creswell, 2007). 
According to Creswell and Plano Clark (2011), one of the important criteria 
in evaluating mixed method research is the ability to combine the 
quantitative and qualitative data when discussing the results. In this study 
the data from the different methods used will be discussed separately first, 
and then in combination with the subsequent data collected.  
   
4.9.2 Analysing qualitative data  
 
There are several approaches that can be used to analyse and interpret 
qualitative data. These approaches usually employ either a deductive or 
an inductive process of analysis. While a deductive approach to research 
draws on pre-set assumptions or understanding of the phenomenon to be 
investigated, an inductive approach develops hypothesis purely from the 
data obtained (Dew, 2007). However, there are certain common features 
in analysing qualitative data.  Qualitative analysis usually begins with 
‘coding’ of the data (Bowling, 1997a). This means relating sections of the 
text for example from interviews or focus groups, to a single word or 
groups of words, either derived from the text or generated from the 




together to a category or a theme to which they are related. These themes 
can either be derived from the research questions or identified from the 
data. Computer packages such as N-vivo helps with this process, bearing 
in mind that one interview may generate about ten pages of transcription  
and a focus group discussion can sometimes generate more than double 
that number as experienced in this study.  For the purpose of this research 




Thematic analysis is considered as the most common form of analysis 
used in analysing qualitative data (Pope and Mays, 2006, Bryman, 2012). 
In its simplest form, the relevant part of the data, for example from an 
interview or a focus group discussion, is coded and then these codes are 
grouped into themes, either anticipated in advance or emerging from the 
data. These themes can then either be described as such or relationships 
between the themes and how they are connected can be identified. 
Thematic analysis can be used in exploratory studies or mixed-methods 
studies. 
 
Frame work analysis 
This is a more deductive process of data management compared to 
thematic analysis (Bryman, 2012). The idea is that the research has pre-
set information requirements that need to be explored by the research and 
the results are expected to have the potential that lead to undertake a 
certain action (Bryman and Burgess, 1994). It shares the same features of  
inductive approaches of analysis in that data are collected from people’s 
words. However, it is deductive in that data collection is driven by the set 
of objectives. The process was developed by the National Centre for 
Social Research in the United Kingdom with the idea of conducting applied 
qualitative research (Bryman and Burgess, 1994, Pope and Mays, 2006).  
Data analysis in the framework approach is similar to thematic analysis 
involving coding and identification of themes, however, as discussed 




of framework analysis as explained by Pope and Mays (2006) can be 
explained in the following order: 
1- Familiarization with the data collected. 
2- Identifying key themes using the previous set aims and objectives 
in addition to related issues raised or emerged during data collection 
3- Indexing which is applying the themes to the data, that is each 
part of the text is attached to a relevant theme or a number of themes. 
4- The data is then charted according to the different themes. 
Different headings and subheadings can be used derived from the 
research objectives of from the data analysed (Bryman and Burgess, 
1994). 
5- The data is interpreted based on the previous set objectives. 
Association between themes and explanation is provided at this stage. 
 
In this study two qualitative methods were used which were interviews 
and focus group discussion. Framework analysis was used to analyse the 
interviews conducted with prescribers as the study had pre-set objectives 
that needed to be explored and the findings are expected to be applied 
into practice. While methods of analysis used in qualitative research can 
be employed in focus group discussions, due to the interacting nature of 
FGDs the analysis is usually a more complex process than individual 
interviews (Smith, 2002a). According to Krueger (1994), FGDs can be 
analysed in either of three approaches; raw description of data, summary 
of data or summary and interpretation of data. In this final approach the 
data is analysed in a descriptive manner with minimal interpretation while 
more interpretation of the data is provided in the discussion section. To 
provide more interpretation of the data generated, the final approach was 
employed in analysing the FGD in this study. 
 
4.9.3 Analysing quantitative data 
 
To justify the statistics that was chosen to analyse the surveys’ results 









The type of the statistical techniques to be used for analysis of any 
study will depend on the objectives of the study (Smith, 2002a). Surveys 
are usually considered as descriptive in nature, and therefore, descriptive 
statistics are usually used to describe most of the results obtained. In 
order to choose a certain statistical approach in analysis, the type of data 
attached to the variables, for example, the answer category of questions in 
a questionnaire, need to be identified (De Vaus, 2002b, Smith, 2002a, De 
Vaus, 2002a). There are three types of data or ‘level of measurement’ that 
can be obtained; these are interval (continuous), nominal or ordinal data. 
Data from a Likert scale are considered as ranking data and hence treated 
as ordinal. However, it is worth mentioning that some researchers argue 
that the intervals between the items in a Likert scale can be considered as 
equal and hence, it can be treated as interval data (Bowling, 2009b, 
Bryman, 2012). In this study the data obtained from Likert scale was 
treated as ordinal data. 
 
Parametric and non-parametric statistical methods 
Statistical methods of analysis can be classified into parametric and 
non-parametric. Parametric statistical methods are based on the 
assumption that the data obtained from a certain test ‘conform to a normal 
distribution’ in the desired population (Smith, 2002b, Bowling, 2009a). This 
assumption is more likely to be expected with continuous data than ordinal 
data, and thus parametric statistical tests are usually suitable to use with 
this data, for example, t-test and analysis of variance.  Non- parametric 
tests are considered as ‘free’ from the normal distribution assumption  
(Field, 2009). For ordinal and categorical data non-parametric procedures 






analysis (De Vaus, 2002a, Field, 2009). Therefore, for this study the data 
obtained from Likert-scale were considered to be fit for non-parametric 
statistics. 
 
Data can also be explained in terms of degree of significance (Smith, 
2002a).  A ‘p’ value is the calculated probability usually used to denote the 
possibility of the result occurring by chance.  A p value of less than 0.05 
(that is 1 in 20) is generally considered as predicting statistical significance 
of the test. Lower levels (< 0.01) were also used by researchers for 
example, when there is a necessity for more strict results. Alternatively in a 
small sample, there may be a need to adjust the ‘p’ value to more than 
0.05 to avoid missing significant results that may result in an error.  This is 
going to be explained in the following section. 
 
Type 1 and Type 2 error 
The aim of taking the statistical test is to confirm an assumption 
(Pallant, 2005).  The statistical analysis is used to test whether a certain 
intervention rejects or accepts the ‘null hypotheses’.  That is either there is 
or there is no difference when an intervention is applied. This can lead to 
two types of errors in the results. Type 1 error occurs when the hypothesis 
is rejected and a difference is reported, that is an intervention is claimed to 
make a difference, when there is not actually a difference. Type 2 error 
occurs when the hypothesis is accepted but there is actually a difference 
between the groups which was not identified. These types of errors are 
very much affected by the sample size of the study and may require 
adjustment of the ‘p’ value set for the test. An example of an adjustment 
method is what is known as the ‘Bonferroni test’ which is used to adjust 
the p-value to minimize the chance of reporting a statistical significance 
which is not there, that is Type 1 error. Because these two errors are 
oppositely related, it is considered that any effort to minimize one type of 







Association between variables 
In survey studies, the relationship between variables is usually studied 
to try to propose a link between certain characteristics and the responses  
provided (Smith, 2002a). Depending on the variables’ level of 
measurement, that is, whether nominal, ordinal or interval, a specific  
correlation test is used to measure associations between the variables, for  
example, Kendall’s tau is used to measure associations between ordinal 
variables (De Vaus, 2002a, De Vaus, 2002b). 
 
Cronbach’s alpha (α) 
Cronbach’s alpha (α)  can be used to detect if a set of variables, for 
example, statements in a Likert scale, used to study one particular 
criterion are correlated together and are actually measuring that one 
criterion (Smith, 2002a).  It is one of the commonly used statistical tests for 
internal reliability or consistency of items in a scale (Bryman, 2012, De 
Vaus, 2002a). The value of alpha is said to depend on the type of scale 
and its purpose (Pallant, 2005).  A value of 0.7-0.9 is considered to be a 
positive indicator of consistency. However, some researchers have used 
lower figures to indicate acceptable levels of consistency (Bryman, 2012).  
A different point of view with regard to Cronbach’s alpha is that a lower 
value of (α) can also be positively considered as it shows that different 
issues were tested in a scale (Taylor, 2014). Alpha (α) was used in this 





The following part of the review describes the participants chosen for 
this study. The selection of participants in this study was carried out using 
purposive sampling.  That is those individuals who were considered to 
have the knowledge about the issues to be examined were selected to 





4.10.1 Description of the participating hospitals 
 
Hospitals were selected in this study to represent the main cardiac 
hospitals, or units in Sudan. Government hospitals in Sudan were divided 
into federal and state hospitals. Federal hospitals were based in Khartoum 
and patients from different parts of Sudan could be referred to them. 
These hospitals were under the management of the Federal Ministry of 
Health. State hospitals were managed by the State Ministry of Health. 
However, soon after starting this study, this classification has changed and 
federal hospitals in Khartoum are now under the management of 
Khartoum State Ministry of Health. In government hospitals patients do not 
pay for the hospital bed but they do pay for most of the other services 
including medication. However, the costs are considered to be much lower 
compared to private hospitals. Information about the hospitals were 
provided by verbal communication with hospital managers, pharmacists 
and doctors working in the hospital, human resources department and 
from some pamphlets about the hospitals. A visit was made to the 
hospitals prior the start of the study to get some background information 
about the hospitals. 
 
Alshaab Hospital 
Alshaab hospital is the main government (federal) hospital in Sudan 
specialised in cardiology, located in the centre of Khartoum. The hospital 
was opened in 1959 but the establishment of the cardiac section took 
place in 1962.  At the time of data collection, the hospital had three main  
specialities, cardiology, respiratory and neurology but changes have taken 
place in the hospital since the start of this study. There were two medical  
cardiology wards in the hospital for male and female patients with a total of 
48 beds, a coronary care unit (CCU) with six beds and two intermediate 
care units attached to the CCU accommodating 12 beds. There was a 
minor CCU, three-bed unit, attached to accident and emergency (A&E) 
department where patients were kept till a bed becomes available in the 






This is a state hospital located north of Khartoum. The hospital was 
officially opened in 1993. It has three specialities:-, paediatric, renal and  
cardiology. It is very well known for its open-heart surgery centre which 
was established in 1998. The hospital does not have an accident and 
emergency unit but accepts patients referred from other hospitals and 
clinics if there is a need for cardiac care and especially cardiac 
procedures.  There were two wards for cardiology patients in the hospital 
during the time of data collection, but more wards were added to the 
hospital since that time. Currently the hospital has three cardiology wards 
with a total of 30 beds and two CCU with a total of 20 beds. 
 
4.10.2 Participating healthcare professionals 
 
The participants in this study were the prescribers and the clinical 
pharmacists in the two main cardiology hospitals in addition to another 
group of clinical pharmacists in Sudan.  
 
Participating doctors 
In the two hospitals, the number of doctors varies with time according to 
the rotational program of the training doctors. During preliminary visits to  
the hospitals, an estimation was made to the number of prescribers 
available. In Alshaab hospital, there were around 60 doctors, seniors 
(consultants) and juniors (registrars and medical officers) who looked after 
the cardiology patients.  There were 17 consultants in the hospital with 
varying number of doctors in their units. In Ahmed-Gasim hospital, there 
were five cardiology teams identified in the hospital and six consultants. In 
each team there were about four to five junior doctors. An attempt to verify 
the exact number of doctors was carried out before the start of data 
collection. 
 
 Participating pharmacists 
There were three clinical pharmacists working in Alshaab hospital, one 




clinical pharmacists, one for the cardiology unit and the other one for the 
renal unit. The cardiology pharmacist was known to the researcher from  
previous visits to Sudan to be one of the first clinical pharmacists in 
hospitals in Khartoum.  
 
4.11 Ethical considerations  
 
A protocol was written for the research project. Ethical approval was 
sought from the National Health Research Ethics Committee of the  
Federal Ministry of Health in Sudan (Appendix 1). At the beginning of the 
research three cardiology hospitals were selected to be included in the 
study.  These were two government hospitals and one partly-private 
military hospital. The committee requested that individual approval from 
the hospitals should be sought before data collection. The individual 
approval was given by the managers of two hospitals, Alshaab hospital 
and Khartoum–North-Ahmed Gasim Hospital.  
 
4.12 Translation in multi-language research 
 
The first language in Sudan is the Arabic language; however, the 
participants in this study who were pharmacists and doctors in Sudan 
were expected to have a good understanding of the English language 
considering that the majority of universities in Sudan have their pharmacy 
and medicine undergraduate courses in the English language. It was also 
the expectation of the researcher that the participants would be more 
familiar with many of the terms used in the study in the English language 
than the Arabic language as the former is the science language in Sudan.  
 
With regard to the qualitative part of this study, the participants were 
allowed to choose the language of their choice that is either the Arabic or 
the English language, so that it would be easier to conduct the discussion 





For the quantitative part which was the survey, the questionnaires were in 
the English language but were piloted first to ensure the suitability of the 
language used. 
 
In multi-lingual research, there are two approaches for translation, 
either an interpreter is used  to assist in translation of the research to the 
language of publication or the researchers are familiar with the language 
of the participants and do the translation by themselves (Choi et al, 2012). 
The latter was the approach taken in this study. It is important that the 
context is considered during translation to provide meaningful data that 
are understandable to different population (Al-Amer et al., 2014, Im et al., 
2015).  Eposito (2001) explained that the translator in research acts as the 
interpreter of data in that he/she considers the actual words as well as the 
context in which they were said, the culture behind them and the 
individual’s experiences before providing transcription of data. In 
qualitative research specifically, the meaning-based rather than the word –
based interpretation of the language is crucial to ensure the validity of the 
findings (Eposito, 2001, Choi et al, 2012). In this study, when required, 
meaning-based translation of the data was provided.  
 
 Although some have argued that if the researcher is the translator this 
may influence the results by producing biased transcripts, a greater 
danger is considered to occur if the translator cannot understand the 
culture, language and background of the participants (Choi et al, 2012). 
Not only does the translator need to be familiar with the language but also 
in the dialect used by the participants, For example, the Arabic language is 
spoken by many countries around the world but dialect differences exist 
between these countries in what is known as  ‘colloquial Arabic’  (Eposito, 
2001, Al-Amer et al 2016). Understanding the dialect used in Sudan has 
been considered as an important factor in the translation of the 
participants views and hence enhance the overall credibility of the 
research.  In this study the researcher, being from Sudan was the 





is the language of this study.  In addition the researcher used a Sudanese 
pharmacist to do a random validation of some of the translated data.   
 
4.13 Study Design 
 
The research design may be classified as a sequential exploratory  
mixed method design but can also be classified as a multi–mixed method 
research (Creswell and Plano Clark, 2007, Tashakkori and Teddlie, 2010). 
Different data collection tools were used at different stages during this 
study (Fig 3).  In addition, different participants were used in different 
stages of the research which is expected in sequential exploratory studies  
(section 4.3). The data for the study was collected over three years 
between the years 2011-2014. After the literature review, the data 
collection tools were designed using qualitative and quantitative methods 
as is the case with mixed methods research.  
 
The qualitative instruments which were the interviews and the FGD 
were used to get the participants views and perceptions in their own words 
about the areas investigated. The participants were also given the chance 
to identify any related issues to the study that they would like to discuss. 
The discussion in the interviews and the FGD led to emerging ideas from 
the participants that were not considered before and enriched the study 
discussion. The data from the qualitative methods were used to develop 















Fig 4 Study Design 
     
 
   
 
 
    
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
         
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
         
         
         
         
         
          
The quantitative tool used in the research which was the questionnaire, 






related to the research objectives within a larger and a more diverse  
population of participants. This can increase the chance of the results 
obtained being transferred to similar areas of practice. The data were then 
integrated together when the results of the different methods were 
discussed. Integrating the findings from the different methods was meant 
to better explore the research questions. 
 
The different methods of research conducted in this study according to 
the study design are shown below. The exploratory observation phase of 
the study is going to be presented in this section while the following 
phases of the research will be explained separately in the coming chapters 
of this thesis. 
 
1- Observation  
   
Observation was used as an exploratory method to inform the 
subsequent research instruments. It also examined the feasibility of the 
suggested study design.  
 
Different methods of observation were used in the two hospitals to try to 
capture the widest picture of patient management. Time was spent in the 
hospitals between May and August of 2011 and different days and times 
were used for observation. A number of ward rounds were attended in the 
two hospitals to observe how treatment plans were discussed and 
initiated. This was more difficult to follow in Alshaab hospital than Ahmed-
Gasim hospital as the former is a larger teaching hospital with a larger 
number of health care professionals and students attending the ward 
rounds. The researcher was not to participate in the ward activity and was 
shadowing prescribers or the clinical pharmacist as was the case in 
Ahmed-Gasim hospital. In addition to the ethical approval from the Ministry  
of Health, individual approval to conduct the observation was obtained 
from the hospital manager, the nurse in charge on the wards and the team  
leader of any ward round. The pattern of prescribing of cardiovascular 




There was also time spent in accident and emergency admissions and 
outpatient clinics. This provided a good opportunity to identify several 
issues faced by the patients and the doctors with regard to treatment. For 
example, the doctors had to depend on the patient to bring all his/her 
medicines or to have a prescription with all the medicines written as there 
was no hospital or primary care records to identify this information. In 
addition, issues related to patients’ follow up, patients experiencing side 
effects or patient not taking their medicines because of cost or availability 
issues were also observed. Field notes were collected during the 
observation which assisted in conducting a guide for the design of the 
subsequent data collection methods. 
 
2-  Interviews with senior prescribers in Khartoum cardiology 
hospitals  
 
The second phase of the research was to conduct interviews with 
prescribers working in the selected hospitals to explore the use of 
guidelines in clinical practice and the perceived role, if any, of the clinical 
pharmacists in the hospitals. Consultants and cardiologists working in the 
two hospitals were approached for semi-structured interviews (Chapter 5).  
 
3- Survey among prescribers in the two cardiology hospitals 
To get a wider range of views with regard to the issues investigated in 
this study, a survey was conducted with the prescribers working in the two 
hospitals (chapter 6). 
 
4- Focus group discussion with clinical pharmacists in the two 
cardiology hospitals 
 
To identify the role of the hospital pharmacists in Alshaab hospital and  
Ahmed-Gasim hospital, a focus group discussion was carried out with the  





5- Online survey among the clinical pharmacists of Sudan 
 
Considering that there were only few pharmacists with a clinical 
pharmacy qualification in the two hospitals, the decision was made to 
conduct a survey among clinical pharmacists in Sudan (chapter 8).  
A discussion of the results of each phase will be presented separately 
at the end of each chapter.  As the different stages of research were 
connected with each other, some of the results will be more discussed in 
the subsequent chapters that follow after more data were collected. 
Furthermore, a final discussion of the results obtained will be presented at 
the end of this study to provide a comprehensive synthesis of the whole 































   
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 




     
 
 
        
        
        
        
        
        
        
        




















This chapter discusses the second phase of this study after the 
preliminary observation, and the first stage of data collection which is the 
interviews that were conducted with the senior prescribers in cardiology in 
the main two cardiology hospitals in Khartoum. The objectives of the 
interviews were to identify the prescribers’ views with regard to the factors 
affecting their prescribing particularly, the use of guidelines in prescribing 
and the role of clinical pharmacists in their hospitals. The chapter includes 
the method involved, the results obtained, discussion of these results and 
the methodological limitations.  
 
5.2  Method 
 
Semi-structured interviews were conducted with the senior prescribers in 
Alshaab and Ahmed-Gasim hospitals. 
 
     5.2.1 Sampling of participants 
 
Senior prescribers working in the selected hospitals in Khartoum were 
the targeted population for individual semi-structured interviews. These 
senior prescribers were either cardiologists or consultants in their training 
to become cardiologists. These prescribers were believed to be the ones 
with the most influence on how prescribing is carried out in these hospitals 
and hence, they were purposively selected. The themes generated from 
these semi-structured interviews informed the design of the second 
research instrument, the survey with the prescribers, which will be 
discussed in chapter 6. 
 
Arranging interview dates required several attempts due to the 






interviews were conducted in the hospitals where the doctors were  
working and in their place of choice which was either offices or treatment 
rooms. An information sheet describing the purpose of the study and the 
request for the interview was handed to each prescriber (or a secretary) 
before-hand when the prescriber was approached to conduct an interview 
(Appendix 3). 
 
Eleven consultants out of possible 17 in Alshaab hospital initially agreed 
to participate in this study. The list of consultants was provided by the 
human resources department in the hospital. The rest six consultants were 
either not available at any time an attempt was made to approach them or 
apologized for not being able to commit to any interview date. Of the 
eleven consultants recruited, seven were senior consultants, three were 
junior consultants which mean that they were qualified as consultants but 
on rotational training to become cardiologists, and one was not a 
cardiology consultant but a physician working in cardiology for the last ten 
years.  Of the 11 consultants who initially agreed to participate, two did not 
manage to make it on the interview date. A different date was again set 
but with no success.   
 
In Ahmed-Gasim hospital, four senior prescribers out of possible eight, 
initially agreed to participate in the interviews. It was easier to identify the 
names of the consultants from the working staff because it was a smaller 
cardiac unit than AlShaab hospital. For the rest four of the prescribers it 
was either not possible to get hold of them or they apologized for not being 
able to take part in this research. Of the four consultants who initially 
agreed to participate, one did not manage to make it for any of the 
interview dates set.  
 
5.2.2 Developing the interview guide 
 
An interview topic guide was developed based on the objectives of this 





of guidelines and from the observation conducted at the start of the 
research (Appendix 2). The observation has provided the opportunity to 
get an overview of how drugs are prescribed and how treatment plans are 
discussed between doctors and between the doctors and the patients on 
the wards and in clinics (section 4.12). 
 
 5.2.3 Conducting the interviews 
 
A trial interview was conducted at an earlier stage with a neurology 
consultant for training purposes. At the beginning of each interview the 
prescribers were ensured confidentiality and anonymity of the information 
provided as explained in the information sheet handed earlier. The 
prescribers signed consent forms before starting the interviews (Appendix 
4). The prescribers were asked permission for audio taping. The 
prescribers were the ones to decide whether to run the interviews in 
English or Arabic language, or a combination of both. As these were semi-
structured interviews the interview topic guide was followed but there was 
always room during the interviews to discuss emerging issues of interest 
and relevant topics brought up by the prescribers (Bowling, 2009b, Smith, 
2002a). 
 
5.3  Handling and analysis of data 
 
Interviews were transcribed verbatim and those which were conducted 
in Arabic were translated by the researcher into the English language. A 
pharmacist from Sudan was asked to choose one interview and then 
validate the transcribing and the translation of the interview chosen. The 
software N-vivo version 9 was used to aid analysis of the interviews. A 











Interviews were conducted with nine prescribers from AlShaab hospital 
and three prescribers from Ahmed-Gasim hospital, making a total of 
twelve prescribers, between May and July 2011. Interviews took between  
20-50min. Permission for audio-taping was asked from the interviewees, 
three of the prescribers preferred not to and hence, the interviews were 
hand-written during the interviews. Two prescribers agreed to be 
interviewed in outpatient clinics and the surrounding environment did not 
allow for good audio taping so the transcribed information depended 
largely on hand-written notes taken during the interviews.  Two interviews 
were conducted mainly in the English language and another two mainly in 
the Arabic language. The rest of the interviews were conducted partly in 
English and Arabic language. The characteristics of the prescribers who 
took part in the interviews are shown in Table 5.1. 
 




Years of practice in    
cardiology 
KAG* F 1 
IAS* M 1 
LAG F 10 
BAS M 19 
AAS M 5 
KAS M 27 
MAS F 12 
NAS M 11 
QAS F < 1year 
ZAS M 24 
SAS M 12 
GAG M < 1year 
         
* AG refers to Ahmed –Gasim hospital whereas AS refers to Alshaab hospital 
 
Although the concept of frame-work analysis is to present a summary of 
the results identified from the interviewees’ quotes rather than presenting 




from the prescribers related to these themes are going to be presented. 
The interviews together with the identified themes and quotes were 
reviewed with the research supervisors. One of the supervisors also 
reviewed part of the analysis technique as it was the researcher’s first 
experience in using N- vivo software.  
 
The quotes were chosen based on statements that could be understood 
easily and make sense if presented separately. The prescribers’ code 
(from Table 5.1) as well as the line number from the transcribed interviews 
in N-vivo will be used as a reference for each quote, for example LAG, l33. 
Some of the quotes were related to more than one theme and this is an 
illustration of how the issues studied were linked to each other (Carlsen 
and Norheim, 2005).  
 
The three main themes identified based on the research objectives 
were: 
 
 Influences on prescribing 
 The use of prescribing guidelines  
 The role of the hospital clinical pharmacist 
 
Following the frame-work analysis approach, a summary of the above 
themes were charted based on each individual respondent’s comments 
(see Appendix 5). 
 
5.4.1 Influences on prescribing 
 
In the interviews the prescribers were asked to identify the factors that 
influence the choice of drugs for their patients. The aim in particular was to 
identify other factors besides the clinical condition that affect prescribing. 
Although the assumption was that all prescribers will identify the patient 
clinical condition as the main criteria before considering any treatment, few 





“Clinical factors, diagnosis of the patient, and the best treatment to help 
this patient […].” (KAG, l22) 
 
The main non-clinical factors identified as affecting prescribing were 
cost and availability. Almost all prescribers considered the cost of the drug 
as a major issue in prescribing especially considering that heart disease 
patients take their medications for life. The cost was also linked with the 
availability of medical insurance. 
 
“Yes, I have to ask the patient first if he can afford [the drug] then I’ll 
prescribe the best one [….] in F..Hospital (private hospital) patients have 
insurance so I can prescribe all the medications.” (IAS, l95) 
 
 “Price of the drug, most of heart disease patients take medications for 
life so the cost is a very important factor.” (BAS, l28) 
“Price, affordability, cost effectiveness are major issues here.” (AAS, 
l14) 
Prescribers considered that availability as well as cost affected their 
drug choice. 
 
“Availability and cost, I am sure if you asked all the doctors they will say 
the same thing.” (NAS, l10) 
“[…] Availability is not reliable in Sudan […].” (BAS, l29) 
“For example I have a patient diagnosed with ‘SVT’, according to any 
guidelines adenosine is the first choice, I do not have adenosine in Sudan 
so what am I going to do?” (KAG, l199) 
When prescribers were asked about their source of information for 
availability of the drug, many of them depended on the patients to inform 
them if the drugs were available in the pharmacies or not. 
 “From the patients themselves, the patients tell us if the drugs are 




The cost of the drug was not a factor of concern for some prescribers 
who saw patients in private clinics. 
 
“Usually patients are different in private [clinics] from hospitals. They 
usually can afford, so I can prescribe to them […] for example the most 
potent even if it was expensive. I can prescribe without a problem.”(QAS, 
l132) 
 
Other doctors thought that the perception that patients who come to 
private clinics will be in a better financial state is not always right. 
 
“Not really, people who come to private clinics cannot afford […] we are 
actually taking money from poor people.” (SAS, l60) 
 
Generic versus brand name prescribing 
The choice of prescribing drugs from certain generic companies versus 
prescribing known expensive companies’ brands of the same drugs was 
very much linked with cost and the patient’s ability to pay for the more 
expensive brand of the drug.   
 
“Mainly for the cost, I tell the patient there is a drug that comes in two 
prices, for example, ‘Lescol’ is more expensive than ‘Atorva’ and I ask the 
patient which one he can afford, usually the patient will be a bit worried 
and will ask if the cheaper drug is ‘not good enough’ and I say no it is good 
but may be less side effects with the expensive drug [laugh].” (NAS, l12) 
 
Some of the doctors interviewed thought that the generics were not as 
effective as the original brand.  Others considered that even within the 
generics there were differences depending on the manufacturing 
company. Some of the doctors felt that prescribing drugs from certain 
generic companies will put their patient’s life at risk. In spite of this, doctors 
had to use these companies for many patients as they were more 




 “You cannot tell obviously, but we feel, yes, some brands are not 
working as effectively, obviously this is a personal perception [...], my 
perception is that some generic brands are not good. Sometimes the 
patient when they changed the brand, things went out of control so you get 
a feeling that the brand was not good.”(AAS, l26). 
 
“Evidence concerning generics is lacking […] I’ll prescribe the drug with 
the known trade name otherwise I’ll go with the cheap drug […] but you  
have to make sure the patient can afford [it] otherwise he’ll go and tear 
apart the prescription.” (SAS, l26). 
 
Many of the prescribers referred to the drug clopidogrel, an antiplatelet 
drug prescribed for many heart disease patients as an example of a drug 
that had to be prescribed by its brand name ‘Plavix’ as it was considered a 
risk to prescribe clopidogrel manufactured by generic companies. 
 
“For example ‘Plavix’ (clopidogrel) and we have ‘Clovex’ (clopidogrel), 
we know that ‘Plavix’ is better and it is confirmed by studies, we know that 
this brand is better than the other one.” (IAS, l91) 
 
“I prescribe ‘Plavix’ in name because we had a very bad experience 
with the other one […], we have stent patients coming back with acute 
thrombosis.” (SAS, l73) 
 
 One prescriber described that he liked his patients to stick to the same 
brand of drug. He considered that this minimized the chances of confusion 
happening, as many patients recognized their tablets by their shape, 
colour and form rather than by the tablet name. 
 
“I like my patients to stick to the same brand they started with, because 
these patients get used to the tablet which is yellow, the tablet which looks 





confused, you could not imagine how this confusion causes mix up of   
patients’ treatment.”(ZAS, l250) 
 
As treatment in cardiology usually requires follow up to ensure 
effectiveness and safety of therapy, prescribers were asked about the 
ease of follow up of patients after discharge. This was considered by some 
prescribers as a problem and can affect the prescribing of certain 
medications. 
 
“Yes there is a great problem with follow up. Patients do not stick to the 
follow up time for many reasons, many are coming from far away” (KAG, 
l132) 
 
“ […] In Sudan we do not have follow up.” (BAS, l81). 
 
“For example, use of warfarin, I cannot prescribe it as an anticoagulant 
for somebody who lives in ‘Um ……’ [a remote place in Sudan] […],   
he/she is going to bleed [...] there is no follow up in certain areas even 
within Khartoum.” (NAS, l29) 
 
 Referring patients to clinics outside Khartoum for follow up was not 
preferred by some prescribers as they cannot ensure the effectiveness of 
these health centres outside Khartoum. 
 
“Usually people with cardiac disease we like to follow them up in 
cardiac centres in Khartoum even if they were from outside Khartoum 
because it is difficult to find things available [in some hospitals outside 
Khartoum], even to find physicians available.”(KAG, l141). 
 
“Patients had disasters from cough induced by ACEI drugs [...]. Cough 







Some prescribers linked the prescribing of certain drugs that require 
monitoring with the patient’s education or the family understanding of the 
possible risks accompanying certain drugs. 
 
“In Sudan there is also the factor of patient education” (BAS, l81) 
 
“I have a young patient with pulmonary hypertension, ideally I should 
give her warfarin, but the family are illiterate and they are living in a far 
eastern part of Sudan, we cannot risk giving her warfarin.” (LAG, l51) 
 
Other factors which were identified by few doctors during the interviews 
as affecting the prescribers’ choice of drugs are shown below in Table 5.2. 
 
Table 5.2 Other factors affecting prescribing 
 
FACTORS AFFECTING     
PRESCRIBING 
QUOTES 
Evidence “No the first is the evidence” (SAS, l38) 
Patient choice “Sometimes patients have preferences 
to certain trade names” (GAG, l42) 
Drug related factors “ To look if there is any drug 
interactions” (QAS, l47) 
 
Company representative “I f they[drug company representatives] 
come frequently, you remember their drug 
and they need to convince you” (BAS, l31) 
                  Easiness of drug name “Sometimes I  prescribe ‘Clovex’ 
[instead of other brands] because it is easy 
to write and easy to remember’(IAS, l197) 
‘ 
 
5.4.2 Use of prescribing guidelines 
 
Most of the prescribers agreed on the importance of following 




to be made based on evidence from research. In addition, having 
guidelines  was considered to assist junior doctors in prescribing in spite of 
the fact that in certain cases it may not be possible to follow guidelines.    
“No I think evidence has shown that guidelines based treatment 
improves survival, improves the outcomes so sticking to guidelines is 
actually important […] you as a consultant cannot deal with every patient 
so once they [the doctors in training] know the guidelines, you have some 
sort of treatment plan that can be applied to all patients except when there 
is something outstandingly [different from the norm].” (AAS, l165) 
 “Appropriate prescribing is the guidelines, if you can stick to the 
guidelines this is better.” (KAS, l62) 
Interestingly, one of the doctors although very much in support of the 
use of evidence from guidelines to assist prescribing, thought that the lack 
of evidence does not automatically disqualify the use of a certain 
treatment. The doctors have thus to understand the evidence so that they 
could make a judgement about using a certain treatment or a dose which 
has not got evidence for or against its use. 
“Lack of evidence does not mean lack of benefit.” (AAS, l155) 
“You need to be careful, the higher doses may have not been tested, 
you have to be able to read the evidence…sometimes there is no 
evidence against or for…” (AAS, l159) 
The doctors were then asked about  following  international guidelines 
in practice in Sudan.  The majority considered it possible to use 
international guidelines for prescribing in cardiology but they have to adapt 
these guidelines to the environment in Sudan. 
“Yes I can apply most of the international guidelines in Sudan […] 





“Guidelines with a grain of salt, guidelines have to be adapted to local 
environment, and that’s what experience is.” (AAS, 145) 
An example where there is a need to use the guidelines in a modified 
way is when the recommended treatments are not available in Sudan. 
 “I cannot prescribe the new drug Li…. which is not found in Sudan. We 
stick to guidelines but with a modified picture.”(SAS, l130) 
 
“For example I have a patient diagnosed with ‘SVT’, according to any 
guidelines adenosine is the first choice, I do not have adenosine in Sudan 
so what am I going to do?” (KAG, l199) 
As guidelines recommendations usually involve follow up of treatment, 
this may not always be practical in Sudan. 
 
“Guidelines sometimes recommend for example renal function tests 
every two weeks or three weeks, this is very costly [for the patient] we 
cannot be dogmatic.” (SAS, l148) 
 
“For example, use of warfarin, I cannot prescribe it as an anticoagulant 
for somebody who lives in ‘Um ……’ (a remote place in Sudan) […]   
he/she is going to bleed [...] there is no follow up in certain areas even 
within Khartoum.” (NAS, l29) 
 
For some doctors it was considered not mandatory to follow 
international guidelines recommendations step by step. 
 
“As long as I am within the room of the guidelines, there is no problem, 
but never stick to it word by word.” (SAS, l211) 
 
“Some research from India showed that we do not need to do regular 
liver function tests as promoted by some international guidelines after 
prescribing statins [...], personally I am interested in practicing cardiology 




Other doctors considered that overall, international guidelines are not 
suitable to be applied on Sudan. 
 
“They do not cover our situation in Sudan.” (NAS, l29) 
“We should not be bringing foreign guidelines and say we want to 
implement them.” (ZAS, l439) 
 
One of the prescribers was against following any guidelines in practice 
in Khartoum hospitals. He considered that guidelines are meant for health 
systems with standard services. While some hospitals in Khartoum can 
perform certain investigational tests others cannot because of limited 
resources, so it is difficult to unify treatment. 
“These things that we call guidelines, there are rules […], if the 
conditions are not available you cannot implement it, if we still  do not trust 
the blood film for malaria, proper urine analysis, proper reading of body 
temperature[…] just imagine the way we are working. Of course if things 
were organised, everything available, guidelines can work but this is not 
there and I don’t think in the coming fifty years it will […] this all needs 
money.” (ZAS, l390) 
 
When prescribers were asked about prioritizing guidelines 
recommendation over personal experience or the other way round, they 
had different opinions.  
“Guidelines, absolutely, I tell them [junior doctors] ’Do and Do not’ in 
guidelines, after that comes my experience which they [junior doctors] see 
it by themselves. But I follow guidelines unless there is something else 
that makes me not to follow it.” (SAS, l182) 
 







 “You need to take both [guidelines and experience] obviously […] I  
never do something out of experience which has not got evidence, if I do 
that I do that in rare situations, as a clinician in areas where there is no 
evidence you are allowed to use that [experience] but if the evidence is 
clearly against or with a drug I don’t pay attention to my experience, but 
generally I do not find problems with both.” (AAS, l146) 
 
Some prescribers also linked experience with therapeutic traditions 
which was considered to precede guidelines. 
“All my colleagues use ‘Amiodarone’, I use ‘Digitalis’ of course old 
school […] I have long experience with digitalis, 32 years, I know its 
benefits, do you get me?” (ZAS, l409) 
“[For prescribing] I use what is known and common and according to 
my experience”( MAS,l22) 
For some doctors experience was not necessarily personal experience 
but it was also of importance to consider the senior colleagues experience. 
‘Experience is more important than guidelines, especially if the 
experience is from a trustworthy person because studies were built on 
restricted conditions.” (BAS, l53) 
“We ask the seniors for their experience.” (KAG, l122) 
“I personally will take the boss [senior consultant] opinion in this 
stage.”(QAS, l203) 
 
As one of the doctors mentioned earlier that the use of international 
guidelines is due to the lack of national guidelines, prescribers were asked 
about the availability of national guidelines in cardiology. Some of the 
doctors confirmed that there are Sudanese guidelines for hypertension. 
Others considered that there may be some national guidelines but they 
could not verify if they were actually implemented in practice.  




 “There are but not updated […] guidelines. In most of the doctors 
meetings they do talk about the need to have Sudanese guidelines.” 
(NAS, l35) 
Other prescribers were sceptical about the attempts made by some 
doctors to make national guidelines. 
“How to write a guideline is a big issue, you cannot leave it for two or 
five persons to do it, they need to have the background, to look into RCTs, 
otherwise it will be copying.” (KAS, l68) 
“ […] the national guidelines for me they are not working.” (BAS, l64) 
As well as discussing the key influences on prescribing such as 
guidelines, respondents were also asked about clinical pharmacists in the 
hospital as an influence on prescribing and their role in patient 
management. 
 
5.4.3 Role of the hospital pharmacist 
Prescribers who were supportive of a role for the pharmacists in the 
hospital thought that this role should be of clinical nature.  
“Most of the pharmacists in the hospital should be clinical 
pharmacists….they should be part of the team managing the patient […].” 
(IAS, l206) 
 
“Well they should be available, come to us, tell us […] prescribe this 
instead of this” for me I think that they are not fully getting what they 
deserve.” (QAS, l222) 
 
Other prescribers considered that the contribution required from the 







“I like to benefit from the pharmacists especially with regard to drug 
interactions.” (MAS, l53) 
 
“I found them very useful; first thing they know side effects of the drugs 
and interactions.” (KAG, l172) 
 
Although there were clinical pharmacists appointed in both hospitals, 
there was a more positive experience from some doctors in Ahmed-Gasim 
hospital than in Alshaab hospital with the role of clinical pharmacists in 
their hospitals as shown in Table 5.3. 
Table 5.3 Responses of senior prescribers about pharmacists’ role 
AHMED-GASIM HOSPITAL ALSHAAB HOSPITAL 
“I found them very useful, first thing they 
know side effects of the drugs and they 
know interactions” (KAG, l172) 
“I know they say that there are clinical pharmacists 
but I did not see them” (BAS, l134) 
“We are trying with the clinical pharmacist 
to make our guidelines here [in hospital] 
derived from the American guidelines” 
(LAG, l45) 
“We do not have[ clinical pharmacists] here in the 
hospital” (AAS, l261) 
 
“Yes for example we have a patient  now 
on Vancomycin and we asked the clinical 
pharmacist  to check the dose” (GAG, l63) 
“No there is no contact we do not see them and 
they do not see us (NAS, l48) 
“Here we really work as a team with the 
pharmacist. I am really happy with the 
work that N [clinical pharmacist] is doing. 
We ask her about many drug related 
issues” (LAG, l101) 
“No, zero pharmacist role, I do not want to lie to 
you” (SAS, l262) 
 
 
Although most of the prescribers were in favour of a contribution from 
the pharmacists in patient care, a large number of doctors were still not in 
contact with the clinical pharmacists. 
 






“I did not see any [pharmacists] personally nobody approached me.” 
(QAS, l95) 
Some prescribers considered that it is the pharmacists’ responsibility to 
convince the doctors that they could have positive contribution to patient 
care. 
“But the pharmacist himself, if he did something to convince the doctor 
that he/she is useful.” (ZAS, l519) 
The same doctor had views that pharmacists lack confidence in 
themselves and the knowledge they have. 
 
“They think that they are less than the doctors and cannot be involved 
with them […] on the contrary the information they have we can make use 
of it.” (ZAS, l505) 
 
In Alshaab hospital a medicine information office was found which was 
used by some pharmacists as their main office. When prescribers were 
asked if they used the medicine information service before, some were not 
aware of its existence while others thought that it was no longer working. 
 
“Not at all and I do not think any of the doctors have ever dealt with it.” 
(IAS, l 271) 
 
“We used to visit them regularly […] now this service has stopped.” 
(ZAS, l465) 
 
“I did not see it, are they working?” (AAS, l279) 
Some prescribers have attributed the lack of contribution from hospital 
pharmacists in patient management to a perceived deficiency in the 






“The basic teaching of pharmacy in this country lacks important clinical 
subjects […] that is why they are not contributing.” (BAS, l127) 
One of the prescribers thought that there may be a relationship between 
the lack of contribution of hospital pharmacists and the absence of 
national clinical guidelines. Although it was an interesting statement 
considering the research objectives, the researcher missed the opportunity 
to discuss this assumption further.  
 
“The absence of guidelines also affects the contribution of pharmacists.” 
(NAS, l53) 
In a different discussion about a future role for the pharmacists in 
Sudan to prescribe, this was not yet favoured by a number of doctors with 
whom this issue was brought up. Some considered it to be a risk as it 
would be more difficult to identify the individual who prescribed. Some 
doctors were more accepting for prescribing if it was for minor ailments. 
 
“It is difficult in Sudan, how can you trace prescribers” (SAS, l287) 
 
“It can be for simple things like analgesics.” (QAS, l271) 
 
After examining prescribers’ views in relation to the factors affecting 
current prescribing and the role of the hospital pharmacist, doctors were 
asked at the end of the interviews about their thoughts regarding what is 
missing from their hospitals in order to achieve appropriate prescribing. 
 
“In Sudan one of the problems is that we do not have records, patients 
come to the hospitals and we do not know which drugs they were taking.” 
(BAS, l100) 
“There are a lot of medication missing […] what I’d like to see is that all 





“To get drugs supplied free of charge.” (NAS, l56) 
 
One of the prescribers was ambitious to see guidelines made based on 
studies on Sudanese patients. 
 
“We need to do our studies because responses of our own patients may 

















  The prescribers’ views explained a number of issues that were 
observed on the wards and clinics with regard to choice of medication; 
follow up of cardiology guidelines and the pharmacist-doctor relationship in 
the hospital.  The main findings of this stage of the study will be 
summarized below in addition to discussion of these findings. Further 
discussion of the results will also be continued in the final chapter of this 
report in relation with the results from the other methods used in this 
study. 
 
Summary of the results: 
 
 Cost and availability of drugs were the main factors influencing prescribing 
in the cardiac hospitals 
 
 Most of the doctors were positive about following guidelines in prescribing  
 
 International guidelines were used in prescribing  but limitations existed to 
their use 
 
 Some national guidelines were available but were not used in practice 
 
 Few doctors were depending on experience more than guidelines as they  
perceived that it is not possible to follow guidelines in practice in Sudan 
 
 Prescribers were positive about a clinical role for the hospital pharmacists 






Influences on prescribing 
The costs of drug treatment for the patient were considered to be the 
main factor affecting drug choice in government hospitals. Although some 
prescribers perceived the cost to be less of an influence when patients 
were seen in private clinics, this may not always be true in Sudan. Patients 
may go to private clinics/hospitals even though they are struggling with 
their finances because their expectation is that private healthcare will 
provide them with a better service compared to that in government 
hospitals. 
 
Unlike  prescribers in cardiology in the UK for example, whom their 
decision to prescribe was influenced by the costs of treatment to the 
healthcare system (Greenfield et al., 2005), the prescribers in Sudan 
seemed to be mainly concerned about the cost implications of healthcare  
to the patient.  It is the perception of the researcher that the majority of the 
Sudanese people consider the government as scarcely spending on the 
healthcare system and is not meeting any of the demands for better health  
care in government hospitals. Thus the burden of the healthcare costs 
usually lies on the patient and the family. Even in government hospitals 
and as was observed during this study, the patients were expected to pay 
for many of the services provided including drugs, which although much  
cheaper than private hospitals, it was still considered hardly affordable for 
many. 
 
The issue of drug cost was linked with the availability of medical 
insurance in the country. Since the participant hospitals are government 
hospitals, the majority of the patients seen in these hospitals are 
financially disadvantaged.  Some of these patients may have enrolled in 
the government medical insurance scheme but many are not (section 
2.9.2). During the time spent in Sudan for data collection, it was noticed 
that the government was using the media to encourage people to enrol in 
its medical insurance scheme. The problem, as perceived by the 





idea of the government medical insurance solving the problem of the costs 
of healthcare for financially vulnerable citizens, is far from being positive. 
The people in Sudan tend to expect inefficiency and bureaucracy in 
services linked with the government. The problem of financing health 
services in many countries in sub-Saharan Africa is known to be critical 
and requires joint work, between the government, the community and the 
private sector (Korte et al., 1992).  
 
Prescribers were concerned that in their attempts to prescribe drugs 
from cheaper companies to some patients they were compromising on the 
effectiveness of the treatment.  This concern was shared by other 
prescribers in cardiology in other parts of the world  whereby in spite of the 
evidence available of bioequivalent clinical effectiveness, many doctors as 
well as patients doubted the claim that generic and ‘branded’ 
cardiovascular drugs are similar in effectiveness (Kesselheim et al., 2008).  
A common example mentioned by the prescribers in this study was the 
drug clopidogrel, brand name ‘Plavix’, used as an antiplatelet for most 
heart disease patients. ‘Plavix’ was very expensive and not available 
under the national insurance scheme in Sudan. This issue of generic 
clopidogrel as discussed by several prescribers led to a search into the 
literature for relevant information.  A number of studies were found 
comparing the effects of different trade names of generic clopidogrel 
versus the brand drug ‘Plavix’ in patients with ischaemic heart disease or 
stent implantation (Ashraf et al., 2005, Park et al., 2012, Tsoumani et al., 
2012).  Although these generics may be different from the ones imported 
to Sudan, similar effectiveness was described between certain generics 
and the brand drug. However, the studies affirmed the need for larger 
studies to document similar bioequivalence. 
 
The availability of drugs in Sudan was considered by prescribers to be 
irregular and thus affected the choice of drugs. Drug companies commonly 
experience difficulties of supply and therefore, it is common in Sudan to 





unstable economy in the country as the majority of drugs are imported. 
The supply problems of drugs in many countries in Africa is known to have  
a negative impact on health care but technical and logistical issues in 
addition to financial limitations are argued to contribute to the problem 
(Jahre, 2012). Prescribers also explained that it was usually the patient 
and not pharmacy staff who notified them about supply problems. This 
may well be due to lack of exposure of doctors to the pharmacists in the 
hospital. This issue will be further studied and discussed in the following 
chapters.  
 
Many prescribers also agreed that the follow-up of patients can be a 
problem in Sudan. Many of the patients were coming from different parts 
of the country to these specialized centres in Khartoum and it is difficult to 
make sure that they would come back for follow up. Relying on health care 
centres outside Khartoum was considered by some prescribers as not an  
option because of a perceived lack of efficiency in these centres. The link 
between hospitals and primary care centres is known to be almost none  
existing in Sudan. Prescribers had to depend on the patient and the 
patient’s family to understand the importance of follow up. In Sudan the 
patient’s family are usually involved in the treatment process. During 
preliminary observation it was found that the patient personal care 
including administration of oral drugs was to a great extent transferred to 
family members once the patient was on the ward and not in a critical 
condition. 
 
The factors identified by prescribers as affecting their prescribing 
decisions were similar to those found in other studies carried in many 
parts of the world including Europe and the United States (Ljungberg et 
al., 2007, Nutescu et al., 2005, Schumock et al., 2004, Theodorou et al., 
2009, Greenfield et al., 2005). These included, in addition to the cost 
implication of treatment, the influence of senior colleagues  on prescribing, 
information from the drug company representatives, the pharmacist, the 





However, in many of these other studies, there was less emphasis on cost 
and availability when compared to clinical effectiveness and the patient‘s 
indications. This is likely to do with the type of healthcare system available 
in these countries and how patients pay for their treatment. For example, 
in the United Kingdom (UK), where some of the above studies were 
conducted, the National Health Service (NHS) is known to provide almost 
free healthcare to all patients resident in UK with no medication charges 
for patients admitted to hospitals. The effect of these factors on 
prescribing will be investigated among a larger group of doctors in the 
cardiology hospitals in chapter 6.  
 
Use of guidelines in prescribing 
During preliminary observation on the wards of Alshaab and Ahmed 
Gasim hospitals, it was noticed that the drugs prescribed were related to 
the recommendations of some of the international guidelines in cardiology. 
Most of the prescribers interviewed considered that they use clinical 
guidelines when prescribing for their patients. For some prescribers 
following guidelines was the way to appropriate prescribing. This is similar 
to what some has considered to be the goal of appropriate prescribing and 
that is to narrow the gap between scientific evidence and clinical practice 
(Brook et al., 1986, Buetow et al., 1997). This goal is one of the main 
advocated reasons for implementing clinical guidelines (Feder et al., 1999, 
Hewitt-Taylor, 2006, Woolf et al., 1999). 
 
   The prescribers mostly depended on foreign clinical guidelines, 
American, European or British for the treatment recommendations. 
However, there were limitations to the use of these guidelines linked with 
the other factors that affected prescribing which were mentioned earlier for 
example cost, availability and possibility of follow up. 
 
 It has been argued that for guidelines to be followed they need to 
consider the patient perspective as well as the environment of the 
healthcare in which they are applied (Hajjaj et al., 2010, Keeley, 2003, 




prescribers in Sudan who are currently using international guidelines 
presumably written with other types of patients and healthcare systems in  
mind, it is to be expected that these guidelines may not be appropriate for 
patients in Sudan.  Prescribers were thus referring to the international 
guidelines of their choice but only choosing from the guidelines what can 
be applied considering the healthcare system of the country and the type 
of patients they treat.  This sometimes involves disregarding 
recommendations for regular monitoring following prescribing certain 
drugs as considered not practical in Sudan. Considering the resources 
required and the high cost involved in making completely new guidelines 
(Feder et al., 1999),  adapting international ready-made guidelines to local 
settings can be considered as a practical approach to treatment in Sudan. 
However, this adaptation although may incur benefits beside the 
limitations, can also be argued as a  manipulation of the international 
guidelines to suit the system in Sudan and this may compromise the  
benefits and safety expected from guidelines recommendations. As 
argued by Fried and Krabshuis (2008), the idea of having a ‘cascade’ of 
guidelines in which certain recommendations of the guidelines are 
followed and others are disregarded, can endanger the whole idea behind 
EBM.   
 
During this study a copy of the Sudanese Hypertension Guidelines was 
found available online ((SSH)), 2012).  The guidelines were published by 
the Sudanese Hypertension Society and the Federal Ministry of Health 
Directorate for Non-Communicable diseases. Some doctors confirmed the 
availability of national guidelines in hypertension in Sudan, others heard  
about them but they had not actually seen them. It is unfortunate that 
although an effort was made to make some national cardiology guidelines, 
they were not actually used in practice. This could have been a starting 
step for doctors and healthcare professionals to start using national 
guidelines and to test their suitability for practice in Sudan. On the other 
hand, some of the senior prescribers doubted the suitability of the national 
guidelines based on the limited capabilities and training of those involved 




guideline making committees were previously raised by other authors 
(Feder et al., 1999). There should be a known process within healthcare  
authorities to develop guidelines. The criteria for making the guidelines 
should be well defined and the persons involved should have the required 
skills and experience that produce a guideline with the best evidence 
available that can be implemented. 
   
Overall, the use of guidelines in prescribing was considered by the 
prescribers as a positive aspect in treatment.  A few prescribers 
considered that national or international guidelines cannot be applied in 
Sudan. The prescribers questioned the readiness of the healthcare system 
in Sudan for the uniformity of treatment promoted by guidelines. This was 
due to what they thought was a wide variation in services between the 
different hospitals as a result of limited funding in some hospitals and lack 
of medical devices and trained staff. However, the argued risk of not 
having a uniform approach to treatment is that unjustified variation in 
prescribing may occur and patients can miss the perceived benefits of 
guidelines recommendations (Ljungberg et al., 2007,Wolf et al.,1999).   
 
Prescribers were divided between whether following guidelines is the 
primary influence on treatment decisions, whether clinical experience 
comes first or as some suggested, experience was rooted in guidelines 
recommendations and thus a link exists between the two. Although clinical  
experience based on the number of years of practice is expected to lead 
to accumulation of knowledge and skills and hence have a positive effect 
on patient care; this may not always be the case. Some evidence 
suggested that doctors with longer years of practice demonstrated a 
decrease in quality of healthcare compared to those with fewer years of 
practice (Choudhry et al., 2005). Part of the reason for that was argued to 
be that older generations of doctors are either resistant to change their 
traditional practice or are less likely not to keep up with the up to date 
recommendations for treatment.  In addition, the education and training of 





certain approach in treatment that prioritize personal experience over 
following new recommendations for treatment.      
 
In a study by Scwartz et al (1989) some prescribers considered that 
when they disregarded guidelines was because their experience in the  
use of certain drugs had come from real life situations in contrast to the 
evidence from clinical trials which was sometimes set in academic 
institutions.  In addition, prescribers in some situations had to submit to 
patient demands and prescribe ‘non-scientifically’ (Schwartz et al., 1989).  
Other reasons argued for prescribers not to follow guidelines are because 
of a deficiency ,or a perceived deficiency, in the guidelines, a lack of trust 
in the guidelines or a perception that the guidelines take away the 
prescribers’ autonomy (Cabana et al., 1999).  This is similar to the views of 
few of the senior doctors in Sudan with decades in clinical practice who 
preferred to rely on personal experience more than recommendations by 
guidelines. For these prescribers, the international guidelines were not 
considered fit for their patients or the healthcare system in Sudan, and on  
the other hand they did not trust the available national guidelines.  One of 
the suggested ways to enhance the use of guidelines is to present them in 
advance to those who will be using them to discover beforehand any 
possible concerns for their implementation that can be addressed (Scott et 
al., 2004).   
 
Interestingly as part of the aim of this study is to look into the influence 
of guidelines on the role of clinical pharmacists in the hospitals, one of the 
doctors identified the absence of guidelines  as hindering the contribution 
of pharmacists in the hospitals. However, as this matter was not pursued 
further with the prescriber, it is difficult to interpret the reasons behind his 
comments. As the notes for this particular interview were hand written, this 
may have distracted the researcher from following the argument and thus 
pursuing the above claim further.  
 
Although there are limited studies on the positive or negative effects of 




guidelines will have similar effects on pharmacists as that on prescribers. 
There are argued benefits as well as disadvantages to prescribers from 
having clinical guidelines such as enhancing professionalism and saving  
prescribers’ time to develop further skills or deskilling prescribers and 
make then loose their autonomy (Berg, 1997, Berg, 2000, Woolf et al.,  
1999). The perceived influence of availability and use of guidelines on 
clinical pharmacy practice in Sudan will be further discussed in chapters 7 
and 8 after examining the views of clinical pharmacists.   
 
Role of the hospital clinical pharmacist 
There were varying responses between the two hospitals with regard to 
any existing contribution to patient management from clinical pharmacists. 
The prescribers of Ahmed-Gasim hospital (AGH) had more positive 
responses than the majority of the consultants in Alshaab hospital (AH).  
This difference in opinions can be the result of two factors, first, there was 
one pharmacist in AH appointed for the cardiology department which has  
more than 60 prescribers. In AGH, there was one pharmacist in cardiology 
in a unit of 20 prescribers.  This made the exposure of physicians to the 
clinical pharmacist much more likely  in AGH. Exposure of the physicians 
to clinical pharmacists in hospitals was shown to have a positive effect on 
their perceptions towards pharmacists’ contribution to patient care 
(Ritchey and Raney, 1981).  In addition, the clinical pharmacist who was 
appointed to the cardiology unit in AGH had been in her current post for 
four years in contrast with the pharmacist in AH who was a clinical 
pharmacist for only one year. Description of the clinical pharmacists in the 
two cardiology hospitals is provided in chapter 7. 
  
The positive view of the prescribers towards the role of the  pharmacists 
working in hospitals was discussed in a previous study in Sudan in 2004 
(Awad, 2007). The study showed that most of  prescribers were not in 
contact with  pharmacists in the hospital as in the case of Alshaab 
hospital, but had positive expectations that pharmacists’ could have a 
positive contribution in hospitals . Furthermore, the findings of this study 




were more positive towards certain roles such as, identifying side effects 
and drug interactions and more resistant to advanced roles such as 
pharmacist prescribing. These findings will be further explored in the next  
chapter when the views of a larger population of prescribers were 
obtained. 
 
It was expected that with the recent introduction of the clinical pharmacy 
role in hospitals, the effect of pharmacists would be more noticeable. 
However, it seems that pharmacists are still not presenting themselves 
enough on hospital wards and clinics. Furthermore, although some 
pharmacists were providing a medicine information service in AH, the 
service seemed not to be advertised enough for the prescribers to be 
aware of its existence. The reason for that could not be determined but 
one can argue that part of the problem is due to lack of resources and   
possibly non-continuity of the service. During preliminary observation it 
was noticed that the pharmacists were not available in the medicine  
information office at all times.  Medicine information can be a great 
opportunity for pharmacists to present themselves by providing written as 
well as face to face information that can be of great use to all healthcare  
professionals. 
 
Although the majority of prescribers interviewed did not object to have 
clinical pharmacists contributing to patient care, a few doubted if 
pharmacists are ready yet to do so.  Different reasons were considered by 
the prescribers as causing the limited contribution of pharmacists in the  
hospitals. These included deficiencies in the undergraduate pharmacy 
course in providing the relevant background, and pharmacists themselves 
not being confident enough to show their knowledge especially when they 
are dealing with doctors. To examine and discuss these perceptions about 
the pharmacists, the views of more prescribers as well as pharmacists 







5.6 Limitations and strengths of the interviews 
 
As it was the first experience for the researcher in conducting 
interviews, there may have been  many times where opportunities for 
probes and prompts were missed which could have added more to the  
information gathered. The researcher’s ability in conducting interviews was  
at a very early stage and this may have had an effect on the prescribers’ 
responses or the information that could have been obtained. However, 
improvement in the interviewer’s skills was felt as more interviews were 
conducted. On the other hand, the fact that the researcher is a pharmacist 
may have created bias in the prescribers’ responses.  
 
Another limitation is that as it was not possible to interview all senior 
prescribers in the two hospitals, it is not known if those who were not 
interviewed had different opinions to add to the issues examined. In  
addition, it cannot be confirmed that saturation was reached. It is argued 
that in many qualitative studies it is problematic to confirm the stage of 
saturation (Brod et al., 2009, Guest et al., 2006).  Some authors 
suggested that in a relatively homogenous group the vast majority of the  
concepts to be identified (92%) can be reached after twelve interviews 
(Guest et al., 2006).   This can relate to this study as the majority of the 
data obtained from the interviews became repetitive as approaching the  
final interviews.  
 
 Furthermore, some of the interviews were not recorded due to either 
the prescriber request or the interview was carried out in a noisy clinic. 
The data provided from these interviews may not be as rich as the 
recorded interviews.   
 
Finally, some of the interviews were translated from Arabic  to  English. 
The results were then presented in a way that would make sense to a 
reader in the English language rather than word by word translation, 
hence, the verbatim transcription may have been compromised. This is 




between languages is not always possible (Al-Amer et al., 2014, Im et al., 
2015). However, understanding the culture behind the language used 
when translating as in the case with this study, is considered to be an 















































CHAPTER 6  SURVEY ON INFLUENCES ON PRESCRIBING IN 








    
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
     
 
  
















 6.1 Introduction 
 
This chapter discusses the next phase of this study which is the survey 
that was conducted among the prescribers in the two participating 
hospitals. After the interviews, a questionnaire was developed to further 
explore the research objectives among a larger population of prescribers 
within the cardiac hospitals. These objectives include the factors affecting 
prescribing, the use of guidelines in prescribing and the role of the clinical 
pharmacists in the hospitals. This chapter presents the method involved, 
the results obtained, discussion of some of the findings and the limitations 
of this phase of the study. Further discussion of the key findings of this 




A cross-sectional survey was used to collect data for this stage of the 
study. A questionnaire was developed which followed a five-point Likert 
scale type of design (section 4.8.3.1). 
 
6.2.1 Sampling of participants 
 
The population for the survey was all the doctors working in the two 
hospitals, Alshaab and Ahmed Gasim hospitals, at the time of conducting 
the survey. However, it was difficult to get an exact number of the total 
doctors available in the hospital. From previous visits to these hospitals 
before the start of data collection in December 2010, the total number of 
doctors who were expected to be prescribing in cardiology in the two 
hospitals was around 80 prescribers (section 4.10.2). Before delivering the 
questionnaires another attempt was made to get information about the 







In Alshaab hospital a large number of the doctors were not actually 
based in the hospital but due to their training program they were only in 
the hospital for a limited period of time. The hospital management could 
only provide the number of doctors who were actually based in the 
hospital. There were six cardiology units in the hospital. The number of 
doctors varied between the different units but was in the range of eight to 
eleven doctors per unit. Each unit was approached and a member of the 
team was asked about the number of the doctors in the unit. The 
estimated total number of doctors in cardiology was around 60 doctors in 
Alshaab hospital which was the same number identified from earlier visits. 
In Ahmed-Gasim hospital, which is a much smaller hospital than Alshaab 
hospital, there were four cardiology units in the hospital; each unit had five 
doctors. There were two other doctors identified as rotational doctors 
making the total number of doctors in the hospital to be 22. Thus the total 
targeted population of prescribers in the two hospitals was 82 doctors. 
 
6.2.2 Developing the questionnaire 
 
The questionnaire was developed based on the objectives of the 
research, the prescribers’ views identified from the interviews as well as 
the relevant literature (Table 6.1). Part of the survey questions were 
adapted, and later modified for the purpose of this study, from previous 
surveys in the literature on relevant topics (Theodorou et al., 2009, Awad, 
2007, Nutescu et al., 2005, Schumock et al., 2004). Other questions 
particularly in relation to the use of guidelines in prescribing in Sudan were 
purposively constructed to investigate some of the research objectives. 
The questionnaire comprised of four main areas of inquiry in addition to 
the personal information of the participants. These areas were sources of 
information, factors affecting prescribing, use of guidelines and the role of 
the clinical pharmacist in hospitals. The personal information of the 










Table 6.1 Sources of areas of inquiry in the questionnaire 
 
AREAS OF INQUIRY SOURCES OF AREAS OF INQUIRY 
 
Sources of information Interviews, literature (Theodorou et al, 2009, Oshikoya et al, 
2011), Interviews 
 
Factors affecting prescribing Literature (Theodorou et al, 2009, Greenfield et al, 2005, 
Schumock et al, 2004, Nutescu et al, 2005, Ljungberg et al, 
2007), interviews,  objectives of the study 
 
Use of guidelines in prescribing Objectives of the study, interviews, literature (Theodorou et 
al, 2009) 
 
Role of the hospital pharmacist Literature (Awad et al, 2007 Smith et al, 2001), interviews,  
objectives of the study 
 
 
6.2.3 Piloting the questionnaire 
 
The questionnaire was piloted among a number of Sudanese doctors. 
The pilot study was used to ensure that the questionnaire makes sense to 
the doctors in Khartoum with regard to the English language used and 
relevance of the issues encompassed to ensure content and construct 
validity. There were two pilots arranged for this study; a preliminary pilot in 
UK during the first stages of preparation of the questionnaire and a second 
pilot in Sudan before the final copy of the questionnaire was developed. 
The preliminary pilot was conducted with four Sudanese doctors working 
in the UK with previous work experience in Khartoum hospitals. None of 
the prescribers in this pilot were currently practicing cardiology.  A first 
version of the questionnaire was mailed to four prescribers in UK who 
were known to the researcher and they were asked to comment on the 




The questionnaires were returned by post to the researcher. One 
prescriber apologized for not participating as he was not familiar with 
cardiology issues.  The other three prescribers provided useful comments  
regarding the easiness or difficulty in understanding the questions. The 
prescribers also thought that the questionnaire made sense to them but 
they could not predict the same response with the prescribers working in 
Sudan. These questions which were found by the prescribers as difficult to 
understand were amended in an effort to make them clearer. A new 
version of the questionnaire was then prepared to be used for the second 
pilot. 
 
Three months after the preliminary pilot, and in May (2012), the 
questionnaire was piloted in Sudan amongst prescribers in cardiology in 
one of the teaching hospitals in Khartoum (Soba hospital) affiliated to the 
University of Khartoum. The hospital has a small cardiology unit 
comprising of five doctors and it is known for providing training for 
pharmacists undertaking the postgraduate course in clinical pharmacy 
provided by the University of Khartoum (section 2.12.2). Prescribers were 
hand delivered a full copy of the questionnaire including the covering letter 
in addition to a specific letter for the pilot to comment on content, structure 
and suitable language. Four cardiology prescribers out of the five identified 
in Soba hospital participated in the pilot study. The questionnaires were 
collected after ten days. The prescribers commented on the questions that 
they found not straightforward to understand. Amendments were made to 
these questions with regard to the language used when preparing the final 
version of the questionnaire (Appendix 6). With regard to the construct of 
the questionnaire, two prescribers questioned the suitability of the 
questions regarding the role of the clinical pharmacists as they were 
considered to be rarely available. This was expected as the role is 







6.2.4 Administering and collecting the questionnaire 
 
There were very limited options in how the questionnaires were going to 
be delivered and collected in these hospitals. No pigeon-holes were 
identified in the hospital and people rarely depend on the post to get things 
delivered within Khartoum. For these reasons, all questionnaires were 
hand delivered to the prescribers. For a few of the senior prescribers who 
were not available most of the time, the questionnaires were left in their 
offices or given to their secretaries.  
 
The prescribers were targeted by their units. In Alshaab hospital a 
member of each unit was approached, usually the senior consultant, if 
available, who was informed about the research and asked about the best 
way to distribute a questionnaire to the group. Some units had tutorials 
running weekly. Others did not have tutorials, especially during the month 
of Ramadan (fasting month) which was when the questionnaires were 
distributed. Distribution of the questionnaires had to be started in 
Ramadan due to the time allocated for data collection for this phase of the 
study in Sudan. Cardiology units which did not have tutorials were then 
targeted in the outpatient clinics, accident and emergency ward (A&E), 
coronary care unit and the echo-cardiology laboratory.  The same unit was 
visited twice, in A&E and the ward to make sure that the majority of the 
team members were approached. In Ahmed–Gasim hospital 
questionnaires were more easily distributed as it is a smaller hospitals with 
a smaller number of prescribers, . Prescribers in the cardiology units were 
targeted in two areas, outpatient clinics where the junior prescribers were 
likely to be and the echo-cardiology laboratory for the senior prescribers. 
 
Seventy-two questionnaires were distributed in both hospitals. This 
number represents the prescribers who were available in the units during 
the time of the questionnaire distribution, in addition to some of the 
senior prescribers who were not found in person but were left with a 





identify their preferred way for questionnaire collection. The majority 
agreed on a date for collection, some preferred to leave the 
questionnaire in a designated place in the hospital, for example, in the 
management office or with the unit secretary and the rest preferred to 
complete the questionnaire immediately and hand it back to the 
researcher. Most of the time, the questionnaires were not ready on the  
agreed date of collection. A reminder for the prescribers who did not 
hand in the questionnaires was given and another date was set.   
 
The distribution and collection of the questionnaire took six weeks 
between June-July of 2012. Each individual cardiology unit was reminded 
verbally once about the questionnaire completion after one week of 
distribution. The first response was the highest response although the 
reminder was also of benefit in getting more participation. The following 
recommendations were followed in order to increase the response rate 
(see section 4.8.3.1). 
 
 Participants were informed about the study in advance through their 
consultant or a member of the team 
 Presentation of the questionnaires was on green paper for the 
questionnaire and white paper for the covering letter to make it easily 
recognizable 
 The questionnaire had no identification numbers or any personal 
questions for example, date of birth 
 Time and place of contact was carefully chosen to suit the prescribers 
and as much as possible not to interfere with their working schedule 
 There was a personal reminder to the units within a short period of time 
of a week to two weeks 
 On reminder, prescribers who were not sure where they placed the 
questionnaire were given another one 
 
It was not possible to deliver the questionnaires to the whole population 




prescribers were on holidays or were just not available on the designated 
days of questionnaire distribution for different personal or work related 
reasons. A few of the senior prescribers were known to be rarely available 
in the hospital due to other commitments outside the hospital and their 
units were usually run by the next senior doctor available. 
 
6.3 Analysis of the questionnaire 
 
The questionnaire was analysed using the software SPSS version 18. 
Descriptive analysis was conducted and the values reported as 
percentages as well as numbers due to the small number of participants 
which was less than 100. Conbach’s alpha (α) was used to measure the 
internal consistency of the set of questions in the questionnaire examining 
guidelines and the role of the pharmacist (section 4.9.3).  Kendall tau-b 
was used to test for association between some dependant variables and 
the independent variables. The Mann–Whitney test was also used to 
explore any differences in responses between the prescribers based on 




Forty-three prescribers, out of the 72 questionnaires distributed, 
participated in the survey providing a total response rate of about 60%. 
The mean response rate from physicians in public surveys in the 
published literature was found to be  about 54% (David A. Asch, 1997).  
Fifty-two questionnaires were distributed in Alshaab hospital and 20 in 
Ahmed - Gasim hospital (Table 6.2). Thirty questionnaires were collected 
from Alshaab hospital and 13 from Ahmed Gasim providing a response 
rate of 58% and 65% respectively.  Forty-one questionnaires were fully 
completed with no missing values.  All 43 questionnaires were entered for 







Table 6.2  Summary of prescribers’ response results  













60 52 30 58 
Ahmed Gasim 
Hospital 
22 20 13 65 




Twenty-nine prescribers out of 72 did not respond to the survey. Some 
of the prescribers had shown their reluctance to participate based on their 
full schedule but were still given a questionnaire in case they could find the 
time. Most of these were the senior consultants. The questionnaire was 
administered to 11 of the senior consultants out of a possible 17 but only 
four consultants responded to the questionnaire.  For the rest of the 
prescribers who did not respond, some accepted the questionnaire and 
agreed on dates for collection but they did not remember to bring the 
questionnaires with them on these dates. Another date was agreed but 
again the questionnaires were not delivered. Two other prescribers 
seemed not keen to participate in the questionnaire and although they 
accepted the questionnaire, they did not show any willingness to suggest 
any date for collection.  
 
Participants’ characteristics 
The participants were doctors at different levels in their medical career 
with experience in cardiology ranging from one year to 23 years (Median = 
5). Because cardiology is considered as a sub speciality, the most junior 
doctors available were the medical officers; these had at least two to three 
years of post-graduate medical practice. Doctors with increasing seniority 





training to be consultant cardiologists and the top senior cardiology  
consultants.  A description of the participants’ characteristics is shown in 
Table 6.3. An illustration of these characteristics is also shown in Figures  
6.1 and 6.2. Two of the respondents did not provide any information about 
their background. Most of the respondents (49% (20)) were registrars.  
These had varying years of medical practice ranging from three to eleven 
years and most of them (73% (30)) had no work experience outside 
Sudan. The majority of the respondents (71% (29)) were male doctors. 
None of the female prescribers had experience outside Sudan. Although  
male doctors were the dominant gender in this study,  a report in 2012 has 
shown that there is almost an equilibrium between females and males 
working in healthcare in Sudan (Government of Sudan, 2012). Although 
the report includes all healthcare workers, the increase in female health 
workers was partly attributed to the increase in the number of females 
joining medical schools in Sudan. 
 




FREQUENCY (%) OF 
PRESCRIBERS 
NUMBER OF PRESCRIBERS 
Gender   
Male 71 29 
Female 29 12 
Job Title   
Medical Officer 32 13 
Registrar 49 20 
Physician 5 2 
Cardiology Fellows* 5 2 
Consultant Cardiologist 10 4 
Work experience   
Experience outside Sudan 27 11 
No experience outside Sudan 73 30 
 












Fig 6.1 Job description of survey respondents (N=41) 
                    
 
 
























6.4.1 Sources of information 
 
In the first part of the survey prescribers were asked about the sources 
of information that assisted them in prescribing. The majority of the 
prescribers (97%, (42)) were in agreement that clinical guidelines were 
used as a source of information to direct their prescribing.  In addition 69% 
(29) of prescribers identified the hospital pharmacist as a source of 
information (Table 6.4). 
 





















51(22) 35(15) 5(2) 5(2) 5(2) 
Journals 
 
17(7) 39(16) 17(7) 22(9) 5(2) 
Drug company  
Representative 
 




2(1) 41(17) 22(9) 29(12) 4(2) 
Internet 
 
21(9) 50(21) 17(7) 9(4) 2(1) 
Conferences 
 












53(23) 44(19) - - 2(1) 
 
             6.4.2 Factors affecting prescribing 
 
Prescribers were asked about their views with regard to different factors 

















65(28) 33(14) - -  2 (1) 
Patient choice 5(2) 
 





37(16) 14(6) 28(12) 7(3) 
Drug related 
effects 














9(4) 51(22) 28(12) 7(3) 5(2) 













37(16) 30(13) 7(3) 5(2) 
Name of drug 
company 
9 (4) 44(19) 23(10) 14(6) 9(4) 
Drug cost 56(24) 
 
39(17) 2(1) - 2(1) 
Guidelines 65(28) 
 





14(6) 44(19) 23(10) 12(5) 5(2) 
Personal 
experience 





Most of the prescribers ‘agreed’ or ‘strongly agreed’ that the availability 
of drugs (98% (42)), the use of guidelines (95% (41)), drug cost (95%, 
(41)), drug related effects (95% (41)) and the patient medical condition 
(91% (39)) affected their prescribing. 
 
In a different question when prescribers were asked to identify in order 
of importance the factors that affected their choice of drug, they prioritized 
guidelines, availability of drugs and patient medical conditions over cost 
and drug related effects when selecting which drug to prescribe. 
 
From the previous interviews prescribers identified several issues with 
regard to prescribing drugs produced by certain generic companies.  In the 
survey, prescribers were asked about the effectiveness of generic drugs 
and if the high cost of a drug implies better effectiveness.  Twenty-two 
prescribers (52%) considered that the effectiveness of a generic drug is 
comparable to the ‘brand’ drug, while 13 prescribers (30%) were in 
disagreement with the above statement. With regard to the link between 
the high cost of a drug and its effectiveness, 43% (18) of  the prescribers 
were not in agreement that the high cost of a drug is a measure of the 
drug effectiveness while 13 (31%) of them considered more expensive 
drugs to be effective. 
 
6.4.3 Use of guidelines in prescribing 
 
Prescribers were presented with a set of statements about the use of 
guidelines in prescribing in Sudan, the availability of national guidelines in 
cardiology, the use of international guidelines by prescribers and the 
relationship between depending on guidelines versus experience as 
shown in Table 6.6.  
 
 More than half of the prescribers (57% (24)) indicated that clinical 
guidelines could be implemented in practice in Sudan. Although there was 
a major agreement (86% (36) that guidelines are to be made for targeted 




apply the international guidelines to Sudanese patients. On the other 
hand, while 56% (24) of prescribers were in agreement that following 
clinical guidelines is more important than following personal experience, 
40% (17) considered the opposite to be true and that following personal 
experience comes first.  
 











It is not possible to apply 
treatment guidelines in 
practice in Sudan 
9(4) 48(20) 5(2) 36(15) 2(1) 
It could be possible to 
make  guidelines for 
cardiology  in Sudan 
- 7(3) 14(6) 56(24) 23(10) 
International guidelines for 
cardiology can be followed  
in  Sudan 
- 16(7) 5(2) 60(26) 19(8) 
Clinical guidelines are to 
be made for targeted 
population 
2(1) 7(3) 5(2) 57(24) 29(12) 
Clinical guidelines are 
more important than 
clinical experience 
2(1) 35(15) 7(3) 35(15) 21(9) 
Clinical experience is more 
important than guidelines 
16(7) 35(15) 9(4) 35(15) 5(2) 
Clinical guidelines are  not 
relevant at this stage of my 
practice 
26(11)   56(24) 9(4) 5(2) 2(1) 
Practice in Sudan is not 
based on guidelines 
7(3) 39(17) 12(5) 37(16) 5(2) 
Adherence to guidelines is 
not always desirable 
9(4) 21(9) 12(5) 52(22) 5(2) 
 
 
In a different question about how often they apply guidelines, the 





‘very often’ applying guidelines when prescribing.  However, when the 
prescribers were presented with the statement that the practice in Sudan  
does not follow guidelines, 42 % (18) considered that to be true while 
about 46% (20%) perceived the practice to be following guidelines. When 
prescribers were asked about adhering to guidelines in all circumstances, 
57% (24) of prescribers perceived that following guidelines in all situations 
is not desirable while 30% (13) were in disagreement with the former 
perception. The prescribers’ responses with regard to the use of 
guidelines in practice are illustrated in Fig 6.3.  
 










Prescribers were then asked to identify the guidelines that they were 
following, 13 doctors (32%) did not mention any, while the rest of the 
prescribers described NICE guidelines (37%(15)), published in the UK,   
American (17%(7)) or European guidelines (5%(2)) as their first preferred 
guidelines. Some of the prescribers (23% (9)) considered their practice to 
draw upon a combination of international guidelines.  Few prescribers (5% 
(2)) referred to some medical websites which were considered to provide 
up to date guidelines recommendation, for example, Uptodate website. 
 
In the interviews with senior prescribers, almost half of the prescribers 
indicated that there were national guidelines in Sudan and these were the 
guidelines for hypertension treatment. In the survey, when the doctors 
were asked about the availability of Sudanese guidelines, almost half of 
the participants (51% (22)) were not sure if such guidelines existed while 
35% (15) thought that there were no Sudanese guidelines in cardiology. 
Only 14% (6) of the prescribers knew about the availability of the 
Sudanese Guidelines for Hypertension.  
 
The reliability test (α) for the set of questions about guidelines use (9 
items) was 0.5. No higher values than 0.5 could be obtained by deleting 
any items from the scale. As discussed in section 4.9.3, higher values of 
alpha indicates good consistency between the statements but lower 
values of α were used  sometimes to indicate acceptable consistency 
(Bryman, 2012).   
 
Association between variables and comparison between the 
groups 
The next part of the analysis of the prescribers’ response to guidelines 
use in Sudan is looking into possible relationships between some of the 
demographic background of the respondents and the range of their views 
captured in the questionnaire. Using Kendall tau-b test, some statistically 






position and their views with regard to the use of guidelines (Table 6.7).  
There was a more positive response to some of the statements about 
guidelines use as doctors became more senior in their job title. For the 
statements ‘Experience more important than guidelines’, and ‘Guidelines 
not relevant at this stage of my practice’ the scale were reversed, that is 
the highest scores were given for the ‘strongly disagree’ answer. 
Therefore, a positive value for ‘tau’ indicates that the more senior the 
doctors, the more negative attitude to these statements. Because of the 
number of statements that was tested against the different grades of 
prescribers, Bonferoni adjustment was applied to test the effect of lowering 
the significant ‘p value’ on the results as a measure of adjustment for Type 
1 error (section 4.9.3). 
 
Table 6.7 Correlation between prescribers’ job title and statements about  
guidelines use 
 


























0.296 0.450 0.448 0.396 
  Sig 2- 
tailed  
 
0.034* 0.001** 0.001** 0.005* 
  N 41 41 41 41 
 
* Correlation is significant at the 0.05 level 
 ** Correlation is significant at the 0.01 level (applying Bonferoni’s test) 
 
Using the Mann-Whitney test, some statistically significant differences 
were found between the two groups of prescribers who had, or had no 
experience outside Sudan, male and female prescribers and their views 





scale for negative statements, prescribers with work experience outside 
Sudan were more likely to have a negative response to the statement 
‘Guidelines not relevant at this stage of my practice’ (U = 99, p = 0.028).  
With regard to gender, male doctors were more likely to agree to the 
statement ‘Guidelines more important than experience’ than female 
doctors (U = 98, p= 0.021) and female doctors were more likely to agree 
than male doctors that adherence to written guidelines is not always 
desirable (U= 98, p=0.024). 
 
 





relevant at this 












99.000 Mann- Whitney U 98.000 98.000 
Sig 2-
tailed 
0.028 Sig 2- tailed 0.021 0.024 
Median*** 
response 
Experience        5 
No experience   4 
Median*** 
response 
Female           2 
Male               4 
Female            2 
Male                3 
 
* Grouping variable: Experience           ** Grouping variable: Male or female 
or no experience outside Sudan       *** Median: 5-point Likert scale  
 
6.4.4 Role of the hospital clinical pharmacists 
 
The final part of the questionnaire explored the prescribers’ perceptions 
of the current role of clinical pharmacists in the hospital. Prescribers were 
first asked if they were in contact with pharmacists in the hospitals; the 
majority, 58% (25) of prescribers said that they were ‘rarely’ or ‘never’ in 
contact with pharmacists in the hospital (Fig 6.5). The majority of 
prescribers indicated that the place where they were most likely to meet 






Fig 6.4 Prescribers perceived contact with pharmacist (N= 43) 
 
 
Prescribers were asked about what they thought clinical pharmacists 
were currently doing in their hospitals. Three prescribers did not answer 
the set of questions and commented that they were not aware of any role 
of the clinical pharmacist in their hospitals.  
 
 The pharmacist’s role that the majority of prescribers (76%, (30)) 
expected hospital pharmacists to be doing was dispensing medication. 
However, there was more agreement than disagreement from the 
prescribers with most of the roles identified for hospital pharmacists such 
as pharmacists identifying prescription errors (66% (25)), drug related 

































15(6) 30(12) 7(3) 40(16) 7(3) 
Identify drug 
related problems 






10(4) 26(10) 18(7) 41(16) 5(2) 
Detecting 
prescription errors 








18(7) 26(10) 16(6) 32(12) 8(3) 
Establish patient 
drug history 
8(3) 39(14) 22(8) 19(7) 11(4) 
Inform  prescriber 
about cost 
effective treatment 

















The set of questions about pharmacists’ role appear to have good 
internal consistency with an α value of 0.9.  Therefore, the positiveness of 
the respondents’ views towards the role of the pharmacist was measured 
(Table 6.10). The total item score for the 11 items of the 5-point Likert 
scale was calculated to give an overall scale for the degree of 
positiveness. The mean value for the total scale was 35.9 with a maximum 
score of 52 and a minimum score of 13. 
 










Associations between variables and comparison between the 
groups 
 Using the Mann–Whitney U test, no statistically significant differences 
in responses to the clinical pharmacists’ role was found among the 
different groups of prescribers with or without experience outside Sudan, 
the doctors working in Ahmed-Gasim hospital and Alshaab hospital and 
the gender of the respondents.  
 
Using Kendall tau-test, two significant correlations were found between 
the prescriber’s job title and their responses towards the pharmacists’ role 
of educating patients about their medicines (tau= -0.324, p= 0.023, 
p<0.05) and taking patients’ drug histories (tau=-0.295, p=0.049, p<0.05). 
No correlation was significant at 0.01 level (applying Bonferoni’s test). The 
negative correlation coefficient (tau) implies a negative relationship 
between the positive perception for these roles of the pharmacists and the 
higher the doctor’s job title. Thus the less senior doctors were more likely 
to be receptive to these pharmacists’ roles.  
 VALUE 
Mean 35.8 
Median (Inter quartile-range) 36 
Standard Deviation 9.9 
Maximum score 52 




In a different attempt to investigate differences in responses between 
the groups, the prescribers’ were divided into senior (cardiologists and  
physicians) and junior doctors (registrar and medical officers) based on 
their job titles. Some statistically significant differences were found  
between the two groups with junior doctors more likely to have positive 
responses with regard to pharmacists educating patients about their 
medicines (U = 37.000, p = 0.019), pharmacists identifying drug related 
problems (U= 23.000, p = 0.003) and pharmacists informing prescribers 
about guidelines therapy (U= 39.500, p = 0.035) (Table 6.11). 
 








  *Grouping variable: Senior versus junior doctors 
























37 23 39 
 Sig.(2-tailed) 0.019 0.003 0.035 
Median** Senior   1.5 
Junior     4 
Senior    2 
Junior     4 
Senior  1.5 
Junior    3 
Summary of the results: 
 
 More than half of the prescribers considered that clinical guidelines 
could be implemented in Sudan 
 
 The majority of  prescribers considered that international guidelines 
can be followed in Sudan 
 
 The majority of  prescribers perceived themselves as using 
guidelines when prescribing 
 
 Some statistically significant  differences between the prescribers 
who had, or had no experience outside Sudan and male and 
female prescribers and their views with regard to guidelines’ use 
 
 Senior prescribers were more likely to have positive attitude about 
guidelines use than junior prescribers 
 
 There was a general positive attitude from the prescribers towards 
the roles of the hospital clinical pharmacist 
 
 Junior prescribers were more likely to have positive responses 








This phase of the research explored the prevalence of the views of the 
prescribers in the two hospitals on a range of issues related to the use of 
guidelines and the role of clinical pharmacists. Before asking the 
prescribers about the use of guidelines and the contribution of the clinical 
pharmacist, it was considered of interest to first examine the resources 
used by prescribers to assist in prescribing. Almost all of the prescribers in  
the cardiology hospitals (97% (42)) identified clinical guidelines as one of 
the most used sources of information for prescribing. Since the majority of 
the respondents were junior doctors and not consultants, a large number 
of them (86% (37)) also relied on senior colleagues experience as a 
source of information. Although more than half of the prescribers (69% 
(29) considered hospital pharmacists as a source of information, 58% (25) 
of prescribers reported their contact with hospital pharmacists to be rare or 
not existing. This result may appear conflicting but can be explained as a 
positive perception from prescribers in considering that hospital 
pharmacists are a source of information that can assist with prescribing 
but that contact with this source of information occurred rarely. 
 
Although prescribers may not always consider themselves as affected 
by the information provided by the drug company, (46% (20)) of the 
participant doctors in Sudan considered the drug company medical 
representative, who in Sudan is usually a pharmacist, as a source of 
information. The argument against the companies’ representatives is that 
the information provided is usually biased and they are not considered as  
a preferred source of information for doctors (Oshikoya et al., 2011). 
Prescribers may argue that as long as the prescriber considers the 
potential bias coming from the company representative, it makes no harm 
in using drug companies’ representatives to identify new drugs or make 
use of the company resources for the benefit of the healthcare system 
especially in countries with limited resources like Sudan. However, some 





get affected in their prescribing by information from commercial sources 
(Avorn et al., 1982).  
 
The survey findings also showed some of the factors that affected the 
doctors’ decisions when prescribing drugs for their patients that were 
similar to the results obtained from the interviews in chapter 5.  The major 
factors affecting prescribing decisions were; information from guidelines, 
affordability of the medication to the patient and the availability of the drug 
prescribed in the market. Availability of medication achieved the highest 
response amongst prescribers in affecting their choice of medication. 
Although the majority of the drugs used in cardiology are registered in 
Sudan, some drugs are still not registered. Drugs need to be registered by 
the pharmaceutical authorities in Sudan before they can be imported or 
manufactured locally.  One of the major problems is that the drugs which 
are registered in the country, the majority of which are imported, are many 
times not available in pharmacies because of a shortage of supply. 
Increasing local drug manufacturing may be considered as a possible way 
to improve the situation. However, and although there are a number of 
pharmaceutical industries in Sudan, there are similar obstacles in 
manufacturing including the availability of the raw ingredients which are 
usually imported. 
 
With regard to the use of guidelines in prescribing, most of the 
prescribers considered themselves to be using guidelines when 
prescribing.  A large number of the participants (72% (31) described 
themselves as using guidelines when prescribing but at the same time 
more than half  of the prescribers (57% (24) thought that there were 
situations where adhering to guidelines would not be the best option. 
Although the vast majority of prescribers affirmed that they were using 
guidelines, the prescribers were divided in their opinions in considering 
whether the current practice in hospitals is following guidelines or not. It 
may be that following guidelines is a personal decision taken by doctors in 





to follow. However, they could not see that implementation of guidelines is 
a practice endorsed by their hospitals. 
  
 The prescribers in the survey had many similar opinions to their senior 
prescribers who were previously interviewed (Chapter 5). The majority 
considered that it is possible to apply guidelines in hospitals in Sudan and 
that international guidelines can be used in Sudan. However, there was 
always a small number of doctors who were still sceptical about the 
possibility of applying guidelines in Sudan healthcare system (section 5.5).  
 
Similar to the interviewed senior prescribers, there were more 
prescribers in the survey prioritizing guidelines over experience (56% (24) 
than experience over guidelines (40% (17)).  The more senior the 
prescribers the more positive was their response in prioritizing guidelines 
over experience.  Furthermore, prescribers with work experience outside 
Sudan were more likely to agree to the importance of guidelines to their 
practice. This can be linked to the more senior prescribers as they are the 
ones expected to have had training outside Sudan.  Although some 
studies have shown that junior prescribers use guidelines more than 
senior prescribers (Choudhry et al., 2005, Higgins and Tully, 2005), junior 
prescribers can also use the experience of their senior colleagues as was 
shown in this study where prescribers referred to senior colleagues as a 
factor affecting prescribing.  The argument concerning following guidelines 
versus personal experience especially with regard to the prescriber‘s 
years of clinical practice was previously discussed in section 5.5.  
 
Most prescribers considered that hospital clinical pharmacists were 
doing most of the activities described in the questionnaire.  The role of the 
pharmacist which almost all prescribers agreed on was dispensing 
medication (76% (30)), and for a large number of prescribers, detecting 
prescription errors (66% (25). This is similar to the findings from the 
interviews conducted earlier where prescribers were more positive about 
pharmacists identifying drug interactions and side effects but more 




in Sudan were similar to the perceptions of doctors in other countries were 
clinical pharmacy in hospitals is a new concept, for example in Jordan and 
Kuwait, where prescribers were positive towards pharmacists involvement 
in patient care with more reception to roles like providing education to 
patients about their medications and detecting prescription errors (Matowe 
et al., 2006, Tahaineh et al., 2009).  Similarly in countries such as the 
United States where clinical pharmacy is now very  developed,  there was 
earlier scepticism from prescribers about advanced roles for the 
pharmacist and more support for traditional roles (Nelson et al., 1978b, 
Ritchey and Raney, 1981, Smith et al., 2002). Prescribers were not sure 
what to expect from the pharmacist outside the traditional roles usually 
linked with being in the dispensary. However, the clinical pharmacists in 
these countries managed to overcome such negative attitudes and pushed 
forward the clinical pharmacy practice.   The new clinical pharmacists in 
Sudan are thus faced with a great challenge to show what more they can 
do with regard to their contribution to patient care in hospitals. The 
challenges facing the clinical pharmacists in Sudan will be further 
discussed in the chapters 7 and 8. 
 
Some significant relationships were found between the prescribers’ 
perceptions about the role of clinical pharmacists and the prescribers’ 
current stage in their medical career. The less senior the prescribers, the 
more likely that they were positive about these pharmacists’ roles.  This is 
similar to other findings that showed that  junior doctors were more 
positive towards advanced roles for clinical pharmacists than senior 
doctors (Smith et al., 2002).  
 
There was no major difference in contact between the prescribers and 
the pharmacists between the two hospitals. This is in contrast to the 
interviews conducted with the consultants in the first part of this study  
where the consultants in Ahmed-Gasim hospital were more in contact with 
the clinical pharmacists than in Alshaab hospital. Considering that the 
majority who answered the questionnaire were the junior prescribers, the 




hospitals and hence might have become more aware of the new role of 
the clinical pharmacists than the juniors. It can be hyposethized that the 
prescribers’ comments with regard to the role of the pharmacist were  
prescribers’ general perceptions rather than perception form actual 
experience considering that the majority were rarely in contact with the 
pharmacists. As mentioned earlier in  section 5.5, this lack of contact 
between doctors and pharmacists was also observed in a previous study 
conducted in Khartoum hospitals (Awad, 2007). In contrast to the previous 
study, this study was conducted after the introduction of clinical 
pharmacists into the hospitals, so the expectation was that the situation 
might have changed. However, the number of clinical pharmacists is still 
very low compared to the number of doctors, so, it may be reasonable for 
a larger number of doctors in the hospitals not to have yet encountered 
clinical pharmacists.  
 
6.6 Limitations and strengths of the survey 
 
Although surveys are the most widely used instrument in research to 
obtain information especially from a larger population, it is acknowledged 
that in surveys there will always be the issue of whether the  responses 
given  are the real views of the respondents with regard to the  topic. The 
respondents may be inclined to provide the most desirable answer rather 
than their actual practice (Bowling, 2009b, Bryman, 2012). This was  
minimized in this study by how the questions were worded and how the 
same concept was tapped into using different questions. In spite of this, 
the risk of bias from self-reports cannot be ruled out.  Some reports 
examining physicians‘ attitudes towards prescribing identified the potential 
bias in the physicians’ answers towards desirable answers than the actual 
practice (Avorn et al., 1982). For example, in this study some prescribers 
may have been inclined to give positive attitudes towards guidelines use 






In addition misinterpretations of the questions especially when the 
language used in the questionnaire was not the first language of the 
participants can be a limitation. Although most doctors in Sudan are 
expected to have a reasonable understanding of the English language, the  
possibility that the respondents may not have fully understood all the 
questions cannot be ruled out. 
 
Furthermore, due to the relatively small number of participants in the 
study, some of the statistical tests were not feasible to undertake that is 
either the test was not possible to be carried out (for example, factor 
analysis) or no significant results were obtained  (for example, some 
correlation tests).  
 
Finally, it is difficult to estimate the effect of response or non-response 
bias on the study. Those who have responded may be biased in the  
information that they provided. In addition, those who did not respond may 
have different opinions from those who responded (Crombie, 1996, Smith, 
2002a). As mentioned above, most of the senior consultants did not 
respond to the questionnaire; these seniors may have different views from 
the other prescribers.  However, the majority of these consultants were 
previously interviewed. This was taken into consideration by linking the 
results obtained from the interviews with the results from the survey as 























    
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
        
 
        
 
        
 
   
     
 
   
     
 
   
     
 
   
         
     
 
   
     
 
   
     
 



















After examining the views of the prescribers in the two cardiology 
hospitals with regard to the use of guidelines and clinical pharmacy 
practice, the next part of the research, chapters 7 and 8, is going to 
explore the views of the clinical pharmacists of Sudan. This chapter 
specifically explores the views of the clinical pharmacists working in the 
two cardiology hospitals who took part in a FGD. The chapter presents the 
method used, the results obtained, a discussion of these results and the 
methodological limitations. Further discussion of the results linked with the 




A focus group discussion (FGD) was conducted with the clinical 
pharmacists working in Alshaab and Ahmed-Gasim hospitals in Khartoum. 
 
7.2.1 Sampling of participants 
 
The pharmacists in this FGD were purposively selected to examine the 
new practice of clinical pharmacy in hospitals in Sudan. Therefore, the 
pharmacists chosen were those appointed as clinical pharmacists in the 
two hospitals. Unlike the other pharmacists working in these hospitals, 
these pharmacists obtained a post graduate degree in clinical pharmacy.  
Five clinical pharmacists were identified in both hospitals. Only two 
pharmacists, one in each hospital, were found to be assigned to 
cardiology wards.  Therefore, due to the small number of first appointed 
clinical pharmacists, their points of view were considered to be of great 
value and hence all the five pharmacists were selected as the sample for 








The pharmacists were approached by the researcher during earlier 
visits to the hospitals to discuss the possibility of conducting the FGD. One 
pharmacist was not available as she was on a long leave from the 
hospital. Verbal willingness to participate in the FGD was given by the 
remaining four pharmacists.  The venue was agreed by the pharmacists to 
be in Ahmed-Gasim hospital because of the availability of a separate 
office for the clinical pharmacists. A date was decided by the researcher 
and a phone message was sent to the pharmacists to check their 
availability on that date and their preferred time of the day to have the 
FGD.   
 
7.2.2 Developing the FGD guide 
 
The FGD guide was developed with the aim to explore the role of the 
clinical pharmacists in hospitals in Sudan and the obstacles encountered 
from these pharmacists’ perspective (Appendix 7). The exploratory 
observation carried out at the beginning of the study contributed to the 
development of the FGD guide mainly with regard to the patient-
pharmacist and the doctor-pharmacist relationships (section 4.12).  
 
7.2.3 Conducting the FGD 
 
Before conducting the FGD the researcher attended a focus group 
discussion in the University of Bath for training purposes. In Sudan, the 
pharmacists were given an information sheet about the research a few 
days before the FGD (Appendix 3). On the day of the FGD, the 
participants were ensured about issues of confidentiality and anonymity as 
explained in the information sheet handed earlier and were asked for a 
written consent for their participation in the study (Appendix 4). The 
pharmacists were also asked for permission to audio-tape the discussion. 
The discussion was facilitated by the researcher. An academic pharmacist 






asked to be the co-facilitator for the group discussion (section 4.8.2.2). 
The co-facilitator listed the extent of participation of each member of the 
group using the seating arrangement.  The co-facilitator was also asked to 
intervene if any problems were encountered with or during the running of 
the discussion. 
 
All pharmacists were continuously encouraged to participate in the 
discussion. The less participating pharmacists were prompted using 
phrases like ‘What do you think?’ or ‘Do you have a different experience?  
Although there was a previously prepared topic guide it was difficult not to 
venture into new areas of discussion. The researcher was aware that the 
issues discussed and arising from the FGD should also be of importance 
to the participants (Smith, 2002a). Therefore, the pharmacists were given 
the chance to add questions or discuss certain issues among themselves.    
 
7.3 Handling and Analysis of data 
 
The amount of data from the FGD was regarded as quite considerable 
(about 33 pages). The researcher thus reduced the amount of data that 
was going to be coded. The data which was either directly relevant to the 
topic guide, the research questions or were considered of interest were 
identified and coded (Krueger and Casey, 2000). The coded conversation 
was then grouped under main themes which were either derived from the 
participants during discussion or from the topic guide. The analysis of the 
FGD was supported by the software N_vivo 9. The FGD was analysed by 
presenting a descriptive summary of the data followed by interpretation of 
the data in the discussion according to Krueger (1994) methods of 












Four pharmacists participated in the focus group discussion which took 
place in Ahmed–Gasim hospital in August 2012. Two of these pharmacists 
were appointed in their hospitals as cardiology pharmacists. For the other  
two pharmacists, one was covering neurology wards and the other was 
covering nephrology wards (section 4.10.1). The characteristics of the 
participating pharmacists are shown in Table 7.  
 
Table 7 Characteristics of the pharmacists in the FGD  
 
PARTICIPANT 
 CODE NAME 
SEX HOSPITAL COUNTRY 
WHERE 








M Female Alshaab hospital 
(cardiology unit) 
Sudan 2 




S Female Alshaab hospital 
(neurology unit) 
Sudan 4 






The focus group discussion took about one hour and a half with few 
interruptions as it was carried out in a pharmacy office. Some members of 
the group dominated the discussion more than others. The pharmacists 
took this opportunity to bring their own concerns to share them with other 
colleagues, for example, the problems they were facing at work and how 
to deal with them. The discussion was recorded and then transcribed 
verbatim. The discussion was carried out mainly in the Arabic language so 
after transcribing, it was translated into the English language. The main 




  Clinical pharmacist role 
  Clinical pharmacy course 
  Obstacles encountered  
  Achievements 
 
The participants’ quotes shown below were chosen in a way so that 
they can describe different types of responses obtained from the 
participants with regard to the topics discussed as well as showing some 
of the interaction between the group members that occurred during the 
discussion. Reporting the interaction between the group is considered 
what differentiates interviews from FGDs (Krueger, 1994). Because the 
quotes were translated from the Arabic language, there was a need to 
change some of the wording so that the text can be understandable in the 
English language. The reference for each quote will be the pharmacist 
code from Table 7 as well as the line number from the transcribed focus  
group discussion in N-vivo from which the quote was extracted, for 
example M, l26. 
 
7.4.1 The role of the clinical pharmacist 
 
All the pharmacists involved in the discussion have been working in 
their hospitals before taking their post graduate degree in clinical 
pharmacy. However, they were only appointed as clinical pharmacists 
when they obtained their post graduate degree in clinical pharmacy.  
Before that, they were based in the dispensary or doing other pharmacy-
related office jobs. There was no obligation for them to be on the wards, 
although one of the pharmacists put some personal effort to attend ward 
rounds. After completing their clinical pharmacy qualification, the 
pharmacists became available on the wards and considered themselves to 
be more in contact with other healthcare professionals.  
“A change has occurred to our job. Before, we didn’t have any contact 
with the wards or the doctors. After the clinical [course] we started going to 




with the doctors if they have any questions [...], this is the change that has 
happened.  Before, the whole day was in the pharmacy, you come in the 
morning you go to the pharmacy and then you leave the pharmacy to go 
home, even the people of the hospital had no contact with us.”(M, l26)  
 
“No pharmacists’ interventions [on ward level] before, and it was not 
compulsory, however, we tried to have at least one pharmacist in the ward 
round but we didn’t manage to keep this as the work load in the 
dispensary was too much with the number of staff available. There was 
not anything obligatory that made me or any pharmacist leave my work in 
the dispensary and go to a ward round. It was just a personal effort.”(N, 
l40) 
 
The different roles that these pharmacists undertook after obtaining 
their clinical pharmacy qualification could be summarised under three 
main roles; ward visits, medicine information service and 
training/educational role. 
 
Ward visits by pharmacists 
As part of their clinical role, the pharmacists were doing ward visits and 
attending doctors’ ward rounds. The pharmacists tried to make their visits 
to the wards to coincide with attending the ward round. For the 
pharmacists in Ahmed-Gasim hospital there was a requirement to attend 
one ward round every week. This requirement, as explained later by the 
pharmacists, came from the State Directorate of Pharmacy in the State 
Ministry of Health which Ahmed-Gasim is part of (section 4.10.1).  The 
pharmacists considered that for their interventions to be considered, they 
needed to be made in the presence of doctors during the ward rounds 
otherwise, their effort was not recognized.  
 
“What is required is one ward round per week (M: interrupts “one 
round?”) for every clinical pharmacist so for the two of us two rounds, then 
people can add up but the minimum is one for every pharmacist […] the 




the consultant  with all the team are usually present], the rest of the 
rounds, nothing formal but whenever I find time I go to the wards, I look 
into the notes, if there is any drug problem,  of course the consultant is not 
there but there is a medical officer in the ward or the sisters. The things 
that are to do with the nurses, I tell the nurses and the things that are to do 
with the medics I tell the medics. But I feel it is a lost effort.”(N, l108) 
 
“This is the advantage of the ward round, you listen to the discussion, 
you know why they prescribed what they prescribed […] that is how I know  
what the doctors were thinking about and then I can go and find more […] 
but really attending the round is very important.”(MS, l746) 
 
Medicine information (MI) service 
One of the activities of the clinical pharmacists was the provision of a 
medicine information service. For the pharmacists in Alshaab hospital this 
service was available even before they were qualified as clinical 
pharmacists. The service was run by other pharmacists some of whom 
had post graduate qualifications but not necessarily in clinical pharmacy. 
The pharmacists in the group disputed over whether the medicine 
information service should be provided by any pharmacist or only clinical 
pharmacists. 
 
“I and MS [clinical pharmacist] are covering MI. In all state hospitals the 
clinical pharmacists are covering MI except one state hospital […]. It is 
difficult to split MI from the clinical work so I think only clinical pharmacists  
should cover MI services.”(N, l453) 
 
“One of the tasks of clinical pharmacists is medicine information. We 
are based in the MI office so if somebody comes with a request we will 
deal with it.” (S, l441) 
 
“The doctors who have questions […] they need a pharmacist based in 





Training/educational role of pharmacists 
The clinical pharmacists in the two hospitals were involved in training of  
other pharmacists and undergraduate students who come to the hospitals.   
Currently, the graduate pharmacists of Sudan spend about three weeks in 
hospitals as part of their pre-registration training.  Part of their training 
requires that they do ward visits. In addition, some of the newly 
established schools of pharmacy have introduced clinical pharmacy as 
part of their under graduate syllabus and some of these universities are 
sending their students for short training in hospitals.  
 
    “Undergraduate and graduate pharmacists, we do clinical work with 
both of them on the ward. We discuss with them the patient notes and 
show them what to do and then ask them to come and do a 
presentation.”(S, l376) 
 
The pharmacists also started to be involved in doctors’ training by   
organizing lectures about drug related topics and inviting the doctors to 
attend. 
 
“The things that have changed for us are the weekly lectures that we 
now organize for the doctors working in the hospital. Before even if we had  
to organize drug information topics, it was only for the pharmacists, now 
we are organizing lectures for the doctors.” (M, l49) 
 
7.4.2 Clinical pharmacy course 
 
For the pharmacists to be appointed as clinical pharmacists they had to 
undertake a post graduate course in clinical pharmacy. Three of the 
pharmacists undertook the clinical pharmacy course run by the Faculty of  
Pharmacy, University of Khartoum, which was the first one of its type in 
the country. One of the pharmacists of Ahmed-Gasim hospital is from the 
first group that was graduated from this course. When the pharmacists 
were asked about how they knew what they needed to do in the hospitals 




provided them with the introduction to their new role.  
 
“The change was from the faculty [who run the course]. When we did 
the clinical pharmacy course we knew what we needed to do.”(M, l63) 
 
“[…] from the course introduction and the syllabus, we became aware of 
what our role will be; in addition, the second year of the course was spent 
in Soba hospital which included being part of the rounds and the unit 
meetings.”(N, l73) 
 
“I felt that there is a great difference, before we did not know, but after 
the course our thinking is bigger and broader, you can link things with 
each other.” (MS, l352) 
 
One of the pharmacists considered that personal effort, in addition to 
the course made her aware of what they needed to do differently as 
clinical pharmacists. 
 
“The course was really the link between the pharmacist and the doctor 
and the pharmacist and the patient. Before we used to deal with the  
prescription only without even properly clinically considering what is written 
inside it, even reading the patient file we didn’t know […] we didn’t know  
the abbreviations regarding patient history, so we really benefited, but 
there was also a personal effort.” (S, l368) 
 
The pharmacists considered certain areas in which the clinical 
pharmacy course in Khartoum was lacking.  One of these areas was the 
amount of time allocated to practical work compared to theoretical work.   
The course was a two year course. The second year of the course was 
meant for practical work and this was done in Soba Teaching Hospital 
which is affiliated to the University of Khartoum. One of the pharmacists 
(MS) did his postgraduate clinical course which was a one year course in 
Malaysia and had different experiences from the others with regard to the 




“I think it [the course] was lacking in a way, it should have been more 
practical because most of what we had in lectures [the theory part] we 
already knew. It would have been better if it was more hospital based,  
medical cases discussion; we would have become stronger [in clinical 
work].” (M, l156) 
 
“To some extent it was different, over there in Malaysia most of the time 
was in hospitals […]. (MS, l234) 
 
The pharmacists also shared the view that even the practical training in 
Soba Hospital had its limitations. For example, not having clinical 
pharmacists involved in the practical training was considered to be a 
setback in the course. 
 
“Soba was one year but it lacks a lot of things […] ((M) interrupts “Soba 
lacked in many ways”).” (N, l160, M, l161)) 
 
“The first thing is that we didn’t have a pharmacist with us.”(M, l162)  
 
“We were lost because there was no clinical pharmacist there.”(N, l173) 
 
The pharmacists had to accompany the doctors during their placement 
in the hospital. These doctors differed in their acceptance of the presence  
of the pharmacists and understanding of the requirements of their training. 
  
“You just follow him [doctor], he used to ask me, ‘who are you?’ […], 
‘what do you want to do?’ […] I felt that that I was lost […].” (M, l188)  
 
“At the same time there was a doctor in the unit who said I don’t want to 
see any pharmacist with me […] he said nobody to touch the file, the 
pharmacist wanted to look into some information from the file, the doctor 






“There were consultants who very willingly accepted us and welcomed 
us; some of them were abroad so they know that there is clinical 
pharmacy. ” (S, l179) 
 
The pharmacists of Ahmed-Gasim hospital, identified that after the 
course they had some external support from the Ministry of Health to 
perform their role. The State Directorate of Pharmacy in the State Ministry 
of Health which Ahmed-Gasim hospital is part of, provided support for a 
time through meetings and advice to the clinical pharmacists in the state 
hospitals. The pharmacists of Alshaab hospital lacked this support. 
 
“In addition to the course, after graduation there were monthly meetings 
in the State Ministry of Health about the things that need to be 
accomplished in our clinical work, including presentations, interventions  
and the feedback from doctors […] every month people discuss what they 
did in their hospitals.”(N, l76) 
 
“Obviously this is only in the state ministry, for us in the Federal Ministry 
of Health [Alshaab hospital], there is no authority that asks you what you 
did or what you are doing. You by yourself have to decide. May be things 
will change in the near future.”(M, l81) 
 
During the FGD it was realized that the pharmacists’ main efforts were 
with the doctors and other healthcare professionals.  Although it is 
acknowledged that any intervention provided by the pharmacists will 
automatically have an impact on the patient, the pharmacists did not refer 
to their direct role with the patient. The pharmacists were therefore asked 
if they were in direct contact with patients. 
 
“The main contact is with the doctors but I work shifts in the dispensary, 
there the contact is more with the patient, those outpatients are more in  
need [of pharmacists], the rest who are inpatients, the nurses are taking 





Outside [the ward] the patients are carrying their own medicines’, it is the 
outpatients that need education.”(MS, l480) 
 
The pharmacists were also asked if they can at least have contact with 
the patients when they are newly admitted to the wards.    
 
“There is a problem with seeing new patients which is you don’t know 
when they are admitted, unless you go regularly to the ward, seven days a 
week.”(N, l492) (MS agreed). 
 
During the observation it was noticed that there were no drug charts 
and doctors wrote drug histories on a sheet placed in the patient notes, so 
clinical pharmacists were asked about that and if they were involved in 
taking drug histories. 
 
“I did try once to review the patient medication, if the medical officer had 
taken the right drug history, there is rarely a problem with a drug missed or 
it is not written in the right way.” (N, l532) 
 
“This is strange because in our hospital doctors do not write drug 
histories […].” (M, l535) 
 
The pharmacist was informed by the researcher based on preliminary 
observation that the doctors usually wrote drug histories on the admission 
chart but without it being clearly stated as drug history.  It could easily be 
confused with medications prescribed on admission. 
 
“Drug histories and patient counselling need somebody who has all the 
time just for the ward.” (S, l496) 
 
Some of the pharmacists started to consider providing direct services to 
the patients, some of which required doctors or managers’ approval before 





“I did start to make something for the patient, like a patient medication 
card, I showed it to you [the researcher] but it didn’t come out, those who 
saw it they said it is nice, but at the end nothing happened.”(M, l476) 
 
“Daily there is a warfarin clinic with a medical officer in charge […] I may 
go and sit inside with the doctor and the dietician in most cases. I may 
stay inside the clinic or there are some patients that come to me [in the 
pharmacy office]. I talk to them about the drug, how to take it, I talk about 
the other drugs that they are using, the diet and try to correct some of the 
information they have.” (N, l996) 
 
7.4.3 Obstacles encountered 
 
The pharmacists discussed a number of obstacles facing them in their 
new clinical pharmacy role. The first of these were the doctors’ perceptions 
to their role. Some of the doctors were more receptive than others to the 
pharmacists’ role. 
 
“The other thing is that although it has been four years since we started 
to be part of the ward rounds, the doctors don’t think that I should be part 
of that [ward round], that I should intervene and contribute to the treatment  
plan, as if all what I am doing is purely a voluntary work from my side, that 
is, an extra thing above of what is required form the pharmacist.” (N, l641) 
 
“The doctors think that they know about drugs more than we do, I did 
realize this, they diagnose the disease and prescribe the treatment without 
thinking that the availability of a pharmacist in this process is of use […] 
even the senior consultants.” (S, l651) 
 
 “I remember the first time that we were distributed over the three units 
(me, Neurology, NO, chest and M, cardiology), we went to Dr (T…) a 
neurologist, he did welcome us and said that it is a good idea to have 





Not only doctors were not familiar with the clinical pharmacist’s role but 
also other non-clinical pharmacists including direct managers were not 
providing enough support for the new clinical pharmacists.   
 
“I have got something to say, the senior pharmacists because they are 
not clinically trained do not understand what we are doing, we put a lot of 
effort [to make them understand our role].”(S, l871)  
 
‘We did not find support; senior pharmacists should have taken us off 
other duties and made us only do this clinical work so that we can prove 
something. We found that the pharmacy managers want us to work in the 
dispensary, we found more support from the doctors than the pharmacists 
[…]. The chief pharmacist cannot see that he is making use of us, he 
thinks that we are not doing anything on the wards, he said if you want the 
money incentive [pharmacists usually get some extra payment on top of 
their salaries known as incentives] come and work with your other 
colleagues in the dispensary’. (M, l68) 
 
The pharmacists also considered that the lack of easy access to 
information sources and absence of national protocols as hindering their  
practice. The pharmacists used the words protocols and guidelines 
interchangeably. 
 
 “Sorry you asked about the obstacles, there is another obstacle which 
is the availability of the information. If you need any information about 
something, you want a book, internet; we have to pay from our own 
money’.”(M, l764) 
 
“There are no national protocols/guidelines; this part of the doctor’s 
experience has got a big role in therapy. What they prescribe may not be 
written anywhere and not evidence-based […] if you intervene, the doctor 
may simply say that he/she has tried this before […] so I don’t have 
anything more to say because there isn’t any national protocols that I can 




by pharmacists and doctors], some doctors will tell you that the 
international guidelines belongs to foreign countries, it does not apply to 
us, it is been written by Europeans and Americans, it does not apply to us, 
and there are no national protocols!”(N, l634) 
 
Although the clinical pharmacists were appointed as ‘specialist’ 
pharmacists, different to the other pharmacists in the hospital, they still 
thought that an agreed upon job description for a clinical pharmacist is not 
yet available. 
 
“Also one of the obstacles which may be clear from the beginning, is 
that there is no job known as ‘clinical pharmacist’, no job description […] 
see this job description [on the wall], there was a quality check by the 
Ministry of Health and they told us that every department in the hospital 
should have their job description on the wall, even the medical manager of  
the hospital was surprised when he saw it, he said ’where did you get this 
job description from?’ We laughed and told him we took it from the 
internet because there is nothing yet called a clinical pharmacy job.” (N, 
l782) 
 
Lack of enough clinical pharmacists in the hospitals also made it difficult 
for pharmacists to cover all patients as only one clinical pharmacist was 
appointed to each speciality. 
 
“We have got six units; it is difficult to cover the six.”(M, l697) 
 
“[…] to see all the patients every day this is extremely difficult.”(N, l703) 
 
The pharmacists were concerned that their managers were not aware 
of their need of continuous training and although they gave them the 
chance to do the clinical pharmacy course, this was not enough and 






“We just started knowing how to practice clinical pharmacy, but there is 
no training, there is no two and three [after step number one].”(MS, l827) 
 
“If we continue to stay like this we will not develop. They cannot depend 
on the fact that you did the Master degree; that is it. This is just the 




The pharmacists were given a chance at the end of the discussion to 
come up with any issues which they thought were of interest and if they 
liked them to be discussed. The pharmacist from Alshaab hospital with the 
least years of work experience as a clinical pharmacist put forward a 
question for the other pharmacists in Ahmed-Gasim hospital about what 
they thought they have managed to achieve in the last years.  
 
“I need a research to measure the outcome [laugh]”! “But I can say that 
we are saving the patient/hospital some money because now we can 
provide the information, for example, we tell the patient or nurse that this  
particular drug can stay 72hrs in the fridge for reuse; this is money 
saving.”(MSl1034, 1039) 
 
“There are things, for example, Vancomycin they used to dilute it in any 
solution, the heparin was not properly monitored, we changed that.”(N, 
l1037) 
 
“Nurses want to know about drugs, in the intensive care we did like a 
timetable […], so I think education wise we are doing well but the clinical  
work, we are still [behind] […].  The other thing is that the doctors started 
to acknowledge our presence, although some are not still very approving  
but they know now that we are going to be on the wards and work as 





Another issue which was brought up to the pharmacists of Ahmed-
Gasim hospital was if they were able to convince their managers of the 
benefits of what they were doing. 
 
“Benefits in hospitals and for managers is always considered from a 
financial perspective. For example, the doctor sees 40 patients a day and  
every patient admission ticket costs […] so the doctor whether a 
consultant or a medical officer is the main important person […], there is a 











7.5  Discussion 
 
This part of the study explored the new role of clinical pharmacy 
through a FGD that was conducted with the first appointed clinical 
pharmacists in Alshaab and Ahmed-Gasim hospitals in Khartoum.  The 
FGD explored the views of these pharmacists considering the training they 
had to prepare them for their new role, the changes that have happened in 
their practice since they became clinical pharmacists and the obstacles 
encountered in their new role.  
 
The pharmacists felt that their hospital professional status has changed 
since they became clinical pharmacists.  They have shifted from being the 
pharmacists who stayed the whole day in the dispensary without being  
 
Summary of the results: 
 
 There was a change in the practice of the hospital pharmacists after 
they obtained their clinical pharmacy qualification. 
 
 The post graduate clinical course of the University of Khartoum helped 
the pharmacists in their new role but was considered as lacking in 
some areas 
. 
 Clinical pharmacists were more concerned to attend ward rounds to 
get doctors’ approval  than spend time with the patients  
 







recognized outside the pharmacy to those on the ward who were in more 
contact with other healthcare professionals. The move of pharmacists in 
hospitals from the drug supply role towards clinical roles has been 
considered as an enhancement to the concept of professionalism in 
pharmacy (Hammer, 2000, Schafheutle et al., 2013). The pharmacists in 
the FGD perceived that a shift in their status has occurred even if their 
work is still not often recognized. 
 
 It is perceived by the researcher that the professional identity of 
pharmacists is a topic which has attracted a lot of discussion between 
pharmacists themselves, other healthcare professionals and even 
members of the public.  The pharmacists may not have a single 
professional identity and it may be more suitable for pharmacists to 
describe themselves as having a number of roles (Elvey et al., 2013). For 
example, the pharmacists can be the drug advisors or the drug suppliers 
or both of these roles together. What is important is that these roles have 
a shared goal of ensuring that drugs are safely prescribed and used by 
patients. While the clinical pharmacists in this study considered that they 
needed to move from being part of the routine drug supply in the 
dispensary, it can be argued that it is an advantage to keep that ‘safe 
supply’ role in the dispensary in addition to the new bed-side clinical role.  
One of the pharmacists in the FGD perceived that the patients who come 
to the dispensary may be more in need of the pharmacist’s counselling 
than the inpatients.  From the researcher experience, clinical pharmacists 
working in hospitals in some other countries, for example UK, maintain 
their dispensary roles, even if it is minimal, in addition to their ward roles. 
The idea is that it is desirable for all pharmacists to maintain the 
dispensary skills of effective and safe supply of drugs and that any 
pharmacist clinical or not should be able to work effectively in the 







With regard to other duties of clinical pharmacists, there were different 
views among the participant pharmacists to whether or not the provision of 
medicine information services should only be performed by clinical 
pharmacists. The development of drug information centres in US in the 
early 1960s as a speciality service was considered to have given way to 
the  movement in clinical pharmacy practice that took place in the late 
sixties (McLeod, 1976). Thus medicine information and clinical pharmacy 
have been linked together since earlier time as being speciality services 
for pharmacists. The current practice in many hospitals in countries like 
UK as experienced by the researcher is that medicine information service 
is usually a speciality service run by clinically medicine information trained 
pharmacists. The possible argument is that the medicine information 
pharmacist need to have the clinical knowledge in order to provide patient 
centred medical advice. However, in situations like Sudan were there are 
only few clinical pharmacists, a compromise may be the solution.  Non-
clinical pharmacists can provide medicine information services but under 
the supervision of a clinically trained pharmacist and in the best scenario 
medicine information trained-clinical pharmacist.  
 
The pharmacists acknowledged that the post graduate course they 
undertook in clinical pharmacy provided a good start for their careers as 
clinical pharmacists. However, the clinical pharmacy course for those who 
completed the course in University of Khartoum was considered to be 
lacking in different ways. One of the main drawbacks from the 
pharmacists’ point of view was that they did not find any senior clinical 
pharmacists to support and guide them in their training.  The majority of 
the doctors in the hospitals were not very much aware of the training 
needs of these pharmacists. Broadhead (1985) discussed the importance 
of clinical training of pharmacists in providing not just the clinical 
knowledge required but to prepare pharmacists with all aspects of the 







As the course in Khartoum is the first postgraduate course in Sudan to 
provide specialized training in clinical pharmacy, it was expected that it 
would be difficult to get pharmacists with clinical experience to do the  
training.  In spite of the fact that the participants in the FGD have been 
hospital pharmacists before joining the course, this did not seem to make 
their training much easier.  This was explained by the pharmacists in that 
their previous work was mainly within the dispensary and no commitment 
to any clinical work.  In the early years of clinical pharmacy, those 
pharmacy graduates who were trained in hospitals, even without 
specialised clinical training, were the ones who led the pharmacy practice 
from the pharmacy to the ward (McLeod, 1976). It is presumably the 
expectation by many that these first clinical pharmacy graduates will be 
the ones to lead the way in clinical pharmacy practice in Sudan. 
 
The clinical pharmacists’ effort in seeking doctors’ recognition for their 
services made them more concerned to be on the wards during ward  
rounds than any other time to make their interventions.  This is similar to  
the findings of other studies in which clinical pharmacists perceived that in 
order for their clinical roles to be recognized they needed to be in 
continuous contact and interaction with doctors (Broadhead and 
Facchinetti, 1985, Weiss, 1994). However, this focus on getting doctors’ 
attention made the pharmacists in this study less in contact with the 
patients on the wards. This idea of clinical pharmacists re-directing their 
attention from patients to doctors may be one of the reasons that clinical 
pharmacy during its development was once considered to be a service for 
doctors and not patients (Smith, 2007).  
 
The effort from pharmacists to get doctors’ recognition has raised two 
sides of an argument.  The first one has been that once the prescribers 
are exposed to the pharmacists, for example on the wards, they will 
acknowledge the pharmacists’ contribution (Nelson et al., 1978a, Ritchey 
and Raney, 1981). This has been considered as an advantage as 
prescribers have been the dominant profession in healthcare so  their 




(Ritchey and Raney, 1981).  The other argument has been that there is a 
lack of confidence from the pharmacists’ side that makes them put a huge 
effort in seeking doctors’ approval (Rosenthal, 2010, Hall et al., 2013,  
Hepler and Strand, 1990).  In Sudan, in this study (section 5.5 and 6.5) 
and another previous study (Awad, 2007), doctors’ seemed to be receptive 
and supportive to the involvement of hospital pharmacists in patient care.  
Some of the pharmacists in this FGD felt that some doctors were more 
willing than others to have pharmacists with them on the wards. Some of 
those supportive doctors had working experience outside Sudan and this 
was perceived by one of the pharmacists as the reason for the positive 
attitude. However, in the survey with the prescribers, there was no 
difference in response towards the role of hospital clinical pharmacists 
between those with or without working experience outside Sudan (section 
6.4.4). It can be argued that the lack of support from some prescribers 
may not be due to prescribers not accepting pharmacists’ involvement but 
more of prescribers not aware of what contribution pharmacists can make. 
This may not be surprising as not only in Sudan but in many countries 
recommending, prescribing and monitoring of drugs, even identifying side 
effects of drugs, have always been performed solely by the prescribers 
(Weiss, 1994). 
 
The clinical pharmacists in Sudan are thus on a mission to 
professionally make their impact especially at the beginning of their clinical 
practice which requires joint work with the prescribers to present their  
unique skills in their area of expertise. The recognition of  prescribers’ to 
the positive effect of pharmacist in patient care may very well increase the 
pharmacists’ confidence and lead the way to pharmacists accepting 
responsibility and accountability to patient care. Once this recognition is 
established the pharmacists may not have to put up with the issue of 
prescribers’ approval and their presence will be a routine that is required in 
everyday patient care. 
 
Relating the above to the interviews with the prescribers, doctors who 




clinical pharmacist was involved with them in solving drug-related 
problems (section 5.4). Thus the clinical pharmacist’s effort in seeking 
doctors’ recognition by being there on doctors’ rounds may have proved 
worthy. This recognition even if by a small number of prescribers, can but 
only be considered as a positive step for these pharmacists and may well 
provide them with the drive to continue to improve their clinical services. 
 
When the subject of achievements was brought up by one of the 
pharmacists, it was difficult for the pharmacists to exactly measure what 
they had achieved in the last years. For pharmacists in Ahmed-Gasim 
hospital the changes were more noticeable as it is a smaller hospital and  
the two clinical pharmacists in the hospital have jointly longer experience 
in clinical pharmacy. The only way that these achievements can be 
recognized is for pharmacists to document their interventions and carry 
out research into their practice. Research in the outcomes of clinical 
pharmacy service is known to be needed to obtain the evidence for the 
effectiveness of the service (Cooper, 1993). 
 
The pharmacists had also identified several obstacles which were 
perceived as hindering their practice. These were, the absence of 
opportunities for further training, lack of resources of information, limited 
support from other healthcare professionals, lack of national protocols (or  
guidelines), no job description and not enough clinical pharmacists.  In the 
first meeting of the Sudanese Society of Clinical Pharmacists which was  
attended by the researcher, a number of the society pharmacists 
discussed the obstacles that were facing them in the hospitals and 
hindering their work. These obstacles were more or less similar to what 
was identified in the focus group discussion including; the resistance by 
the prescribers to their role, the lack of information resources particularly 
national guidelines, not enough clinical pharmacists and lack of further 
training for those pharmacists who were already qualified. This can be an 
indication that many of the clinical pharmacists of Sudan are facing similar 





non-availability of guidelines, with be further examined with a larger 
number of clinical pharmacists in chapter 8.  
 
The clinical pharmacists of Sudan may be aware of the need of 
continuously developing their profession, however, they may lack the 
means of how to. The pharmacists will require their managers and 
healthcare system support for further training. However, the pharmacists 
have also to put some personal effort in order to develop and maintain the 
knowledge and skills training required so that they can gradually advance 
hospital clinical pharmacy practice in Sudan. 
 
7.6 Limitations and strengths of the FGD 
 
One of the ways the validity of a focus group is thought to be measured 
is by the extent to which the participants are able to present their views 
and have influence in directing the discussion (Smith, 2002a).  The extent 
to which this was achieved with the pharmacists in this FGD is difficult to 
measure. However, pharmacists were ensured of the confidentiality of the  
information provided during the discussion. The researcher was also 
known to the pharmacists and this was hoped to have a positive effect on 
pharmacists in freely expressing their views. With regard to influencing the 
discussion, the pharmacists were given different opportunities to discuss 
the issues that were of concern to them. The pharmacists in the group  
found the FGD as a useful opportunity to discuss several issues regarding  
their work so that they could know what the other hospital is doing. Some 
of these issues were not considered directly related to the main discussion 
but the pharmacists were given the chance to discuss them. The 
researcher being a previous hospital clinical pharmacist was not able to 
detach from the discussion and also contributed by offering some advice 
regarding certain issues that were brought up by the pharmacists.  
 
The group contained a variety of participants including the dominant  




into trying to fairly engage every participant in sharing their perceptions, 
the dominance of certain speakers was clear from the transcript and also 
from the flow chart diagram of how the conversation was going as drawn  
by the co-facilitator. This may have prevented the shy participants from  
fully presenting their views. As it was the researcher’s first experience in 
conducting a FGD some opportunities may have been missed to obtain 
further information from the participants. 
 
Finally, because of the small number of clinical pharmacists found in  
the two hospitals, it was only possible to conduct one focus group. This 
has led to the need to further examine the views of this small group  
among a larger population of clinical pharmacists in Sudan. Hence, 
a survey was conducted among some of the clinical pharmacists in Sudan 




































CHAPTER 8  ON-LINE SURVEY ON CLINICAL PHARMACY     






    
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
         
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 







This chapter discusses the online survey which was conducted among 
the clinical pharmacists of Sudan. The aim of the survey was to investigate 
the views of the clinical pharmacists with regard to their current role, the 
availability and use of guidelines in clinical practice and other obstacles 
facing clinical pharmacy in Sudan. The chapter presents, the method 
used, the results, a discussion of the results and the methodological 
strengths and limitations. Further discussion of the results will also be 




An online survey was used to collect data for this stage of the study. 
The questionnaire was designed using the University of Bristol Online 
Surveys website (BOS), a free online survey tool available through the 
University of Bath.  
 
8.2.1 Sampling of participants 
 
The population for the survey was the Sudanese pharmacists with a 
post graduate clinical pharmacy qualification. Getting contact details for 
the clinical pharmacists in Sudan was a challenge.  A request was made 
to the Sudanese Society of Clinical Pharmacists (SSCP) to get contact 
details for the clinical pharmacists registered with the society. The SSCP 
was able to provide e-mail addresses as well as some telephone numbers. 
There were 172 e-mail addresses of clinical pharmacists provided by the 
society but only 109 pharmacists had phone numbers as well as email 
addresses. A similar request was also made to the University of Khartoum 
which was the first university in Sudan to start a postgraduate course in 
clinical pharmacy but the university did not keep any contact details. The 
SSCP later informed the researcher, after launching the survey that the list 
of clinical pharmacists provided was not only for the clinical pharmacists 




registered with the Sudanese Medical Council (SMC). This is the body 
responsible for registering pharmacists and more recently, clinical 
pharmacists in Sudan. That meant that only a number of pharmacists who 
are registered as clinical pharmacists with the SMC joined the SSCP. The 
number of pharmacists who were actually registered with the SSCP was 
only 66 clinical pharmacists. All 172 email addresses were included in the 
survey. 
 
8.2.2 Developing the questionnaire 
 
The questionnaire comprised of an introductory section containing 
personal demographic information, followed by three sections covering the 
current role of the clinical pharmacist, the obstacles facing these 
pharmacists and the use of clinical guidelines in practice in Sudan  
(Appendix 8). These sections followed a 5- point Likert-scale design 
ranging from ‘strongly agree’ to ‘strongly disagree’. The sections about the 
clinical pharmacist role and the use of guidelines were previously used in 
the survey conducted with the prescribers (section 6.2.2). These sections 
were slightly modified from the ones previously used to particularly target 
pharmacists rather than prescribers and the new role of clinical 
pharmacists in hospitals. In the second section of the questionnaire, a new 
set of statements were developed based on, the research objectives 
examining the challenges facing clinical pharmacists, drawing upon the 
pharmacists’ views from the FGD and some of the literature about clinical 
pharmacy practice. The pharmacists were also given the opportunity in the 
questionnaire to add their comment on any relevant issues. 
 
8.2.3 Piloting the questionnaire 
 
The questionnaire was piloted in two stages. The first pilot was 
conducted at an early stage of the questionnaire design. Four pharmacists 






these pharmacists previously took part in the focus group discussion so 
their views with regard to the content of the questionnaire were considered 
to be of value. Only two pharmacists replied willing to take part in the pilot. 
One from the previous FGD and the other was a Sudanese pharmacist 
working in UK who was previously involved in some training activities with 
the pharmacists in Sudan. The pharmacists were asked to comment on 
the language used as the questionnaire was in the English language 
which is not the first language of the participants, the construct and 
content, ease of understanding and any other relevant issues with the 
questionnaire that might have been missed.  In the second stage of the 
pilot, a similar check was performed for the final lay out of the 
questionnaire. This time the questionnaire was hand delivered to four 
clinical pharmacists who were active members in the Sudanese Society of 
Clinical Pharmacists (SSCP). The pharmacists’ comments were positive 
about the questionnaire. There were few comments with regard to the 
ease of understanding of some of the questions which were taken into 
consideration and these questions were rewritten. In addition, one of the 
pharmacists in the first pilot tried to verify if it is intentional that some of the 
questions were asking about the same thing. The pharmacist was 
informed that this was intentional for the Likert-scale type of statements.  
 
As this survey was using an online questionnaire, a final pilot for 
technical issues check was carried out by sending the questionnaire to the 
research supervisors in the University of Bath and the University of 
Helsinki before sending the questionnaire link to the participants. 
 
8.2.4 Administering the questionnaire 
 
An invitation e-mail was sent to the pharmacists asking them to 
participate in the online survey with the link to the survey attached. The e-
mail provided details of how to contact the researcher if any of the 






The link to the survey was sent to 172 e-mail addresses through the 
SSCP e-mail in an attempt to get a high response.  This was followed by a 
reminder through telephone messages to 109 pharmacists whose phone 
numbers were available. Two pharmacists phoned back after experiencing 
technical difficulties which prevented them from moving from one page to 
the other. This was immediately investigated and resolved by the 
researcher over the phone. This led to the need to make phone calls to the 
pharmacists in case others experienced such difficulties. Another e-mail 
reminder was sent to the pharmacists via the SSCP with additional 
information about possible technical difficulties.  
 
A decision was made to extend the time for the survey to an extra 
month as the response was low at the beginning but was increasing 
steadily especially  after the phone calls. E-mails were again sent to all  
172 email addresses giving them another chance to respond to the 
survey. This time the e-mails were sent directly from the researcher and 
not through the SSCP so as to account for any undelivered email 
addresses. Apologies were sent to the pharmacists via the e-mails in case 
they felt overwhelmed by e-mails about this research. The e-mails were 
again followed by phone messages to all pharmacists who had registered 
phone numbers. The survey was opened for two months from the 20th of 
April till the 25th of June 2014. 
 
8.3 Analysis of the questionnaire 
 
The BOS website provided some of the descriptive analysis of the 
results. However, to do more statistical tests the data was transferred into 
SPSS statistics package version 20. Descriptive analysis was conducted 
and the values reported as percentages as well as numbers due to the 
small number of participants. Cronbach’s alpha (α) was used to measure 
the internal consistency of the set of questions in the questionnaire.  The 
Mann–Whitney test was used to explore any differences in responses 
between the pharmacists based on gender and clinical hospital 




relation between the gender of the participants and their current work in 




 Twenty-four e-mail addresses out of 172 sent came back as failed-
delivery.  One pharmacist who participated in the final pilot sent a 
message apologizing for not taking part in the survey as she had 
participated in the pilot.  It was difficult to exclude the other pharmacists 
who participated in the pilot based on e-mail addresses. Therefore, it is not 
known if the other pharmacists who participated in the pilot, responded or 
not to the questionnaire. Therefore, based on delivered e-mail addresses 
51 pharmacists out of 148 (34%) participated in the survey with 47 
pharmacists completing all survey questions. The data from all 51 
participants were included for analysis in SPSS. The values for the 




There was participation from clinical pharmacists with a wide range of 
years of practice based on their graduation year from pharmacy school 
with graduates from 1982 to 2010. The majority of the participating 
pharmacists (92% (47)) did their post graduate clinical pharmacy course in 
Sudan between the years 2007 and 2011. The remaining pharmacists 
obtained their clinical pharmacy post graduate degrees from universities in 
India, Malaysia or UK. The participants’ characteristics are summarized in 
Table 8.1. The participants were 71% (36) female and 29% (15) male 
which reflects the gender distribution of practising pharmacists in Sudan. A  
report from the Ministry of Health in Sudan in 2006 estimated that more 
than 70% of the pharmacists working in the government federal hospitals 
were females (Directorate of Pharmacy, 2006). Almost half of the clinical 
pharmacists who participated (49% (25)) were not currently involved in 





of pharmacy practice including community pharmacy, academia, the 
Ministry of Health and for pharmaceutical companies. Some of the 
participants were currently working outside Sudan.  The majority of the 
participants had clinical hospital work experience, while 24% (12) of the 
participants never worked as clinical pharmacists in hospitals in Sudan. 
Using chi-square test, no statistically significant relation was obtained 
between gender of the participants and their current work in clinical 
pharmacy. 
 
Table 8.1 Characteristics of survey participants (pharmacists) (N=51) 
 





Gender   
Male 29 15 
Female 71 36 
Clinical pharmacy course   
In Sudan 92 47 
Outside Sudan 8 4 
Currently working in a hospital in Sudan   
Yes 51 26 
No 49 25 
Previous  clinical hospital experience in Sudan   
Yes  76 38 
No 24 12 
 
 
8.4.1 Role of the clinical pharmacists 
 
In this section of the survey, pharmacists were asked about the different 
roles of clinical pharmacists in hospitals in Sudan. The vast majority of 
pharmacists were in agreement that the different roles presented were 

























































































The top two roles of clinical pharmacists with which almost all participants 
either ‘strongly agree’ or ‘agree’ on were; ‘Pharmacists educating patients 
about their medicines’ and ‘Identifying  drug related problems’.  
Furthermore, most of the participants were in agreement that the clinical 
pharmacists have a role in ensuring that prescribers are providing 
optimum therapy (90 % (44), assisting prescribers in prescribing (83% 
(39), advising prescribers on treatment guidelines (82 % (40) and to be 
involved in the doctors’ choices of medicines (79% (39).  
 
With regard to the clinical pharmacists’ role being mainly to provide 
information to patients, 22 % (11) of the participants found that not to be 
true. Similarly only 18% (9) of participants did not agree that the role of 
clinical pharmacists is to provide drug information mainly to doctors. 
 
The Cronbach alpha for this set of questions (13 items) was 0.9. This 
good consistency led to measure the overall positiveness of the 
participants to the role of clinical pharmacists in hospitals in Sudan.  The 
total item score for the 13 items of the 5-point Likert scale was calculated 
to give an overall scale for the degree of positiveness. The mean value for 
the total scale was 56.8 (Table 8.3).  
 









Comparison between the groups 
To conduct further analyses of the participants’ views, the Mann-




Median (Inter quartile-range) 57 
Standard Deviation 7.6 
Maximum score 65 




views about the clinical pharmacist role based on their current working 
status as hospital-clinical pharmacist, previous clinical experience or  
gender.  Current working status, gender and previous clinical experience 
were not found to significantly affect participants’ views with regard to the 
role of clinical pharmacists.  
 
8.4.2 Barriers to clinical pharmacy practice 
 
In the next part of the survey, pharmacists were asked about their views 
with regard to a number of obstacles considered to be facing the clinical 
pharmacy practice and pharmacists in Sudan. The details of these results 
are shown in Table 8.4.The majority of the pharmacists were in agreement 
with most of the listed obstacles as barriers facing practice (Fig 8.1).   
 
Interestingly 68 % (34) of the pharmacists did not consider that the 
limited support from doctors to be an obstacle for clinical pharmacists. On 
the other hand 59% (27) considered that there was resistance from 
doctors to pharmacists’ involvement in prescribing. In addition, 61% (29) of 
the pharmacists thought of pharmacists more concern with doctors’ 
approval to their role than actually performing their role as a barrier to their 
practice.  
 
The pharmacists were also presented with statements examining 
personal characteristics of pharmacists that might affect their development 
as clinical pharmacists. There was a split between the pharmacists’ views 
with regard to pharmacists themselves being resistant to change.  While 
48% (24) found this not to be true, 40% (20) were in agreement of this 
statement. With regard to the pharmacists’  lack of communication skills as 
an obstacle in practice, 44% (21) of pharmacists were in disagreement 
with this statement while 40% (19) thought that communication skills is a 
true challenge to pharmacists.  A large number of pharmacists 65% (31) 
either ‘agreed’ or ‘’strongly agreed’ that there is a lack of confidence from 




























18(9) 30(15) 12(6) 30(15) 10(5) 
Limited support 
from doctors 
32(16) 36(18) 14(7) 12(6) 6(3) 
Lack of 
confidence 
2(1) 15(7) 19(9) 46(22) 19(9) 
Hospital 
payment 





























4(2) 20(9) 17(8) 35(16) 24(11) 
Lack of CPD 
opportunities 























15 (7) 40(19) 21(10) 11(5) 13(6) 
 




With regard to opportunities for continuous professional development 
(CPD), almost all pharmacists either ‘agree’ (40.4% (19) or ‘strongly agree’ 
(57.4% (27) that the lack of CPD is one of the obstacles facing the clinical 
pharmacy practice in hospitals in Sudan. 
 





The set of statements (16 items) about the obstacles facing 
pharmacists had a low internal consistency with the value of α = 0.3. A 
higher value of 0.4 can be obtained if the statement ‘Limited support form 





discussed in section 4.9.3. Although higher values of α (≥ 0.7) are required 
to show good consistency between the statements, it has also been 
argued that a lower consistency value indicates that items are testing a 
wide range of  issues and that can be of an advantage depending on the 
objectives of the research (Taylor, 2014).  
 
Comparison between the groups 
Using the Mann-Whitney test, a statistically significant difference in 
response was found between participants with regard to whether or not 
they had previous hospital clinical experience and their responses with 
regard to some of the obstacles facing practice (Table 8.5). Pharmacists 
with hospital clinical experience were more likely to agree than those with 
no clinical experience that there are not enough clinical pharmacists in the 
hospitals (U = 136, p= 0.037). In addition, pharmacists with no clinical 
experience were more likely to agree than the other pharmacists that the 
lack of access to patients notes creates a barrier to practice (U = 117, p = 
0.024). Furthermore, with regard gender, males were more likely to agree 
than females that there is a lack of confidence from the pharmacists’ side 
that is creating a barrier to practice (U = 104, p = 0.001).  
 
Table 8.5 Mann-Whitney Test to pharmacists’ views about the barriers to clinical 
pharmacy practice 
 
*Grouping variable: Clinical work experience                     **Grouping variable: Gender 
*** Median: 5 -point Likert scale 
 
Statement * Not enough 
clinical 
pharmacists 
No access to 
patients notes 






Sig.(2-tailed) 0.037 0.024 Sig.(2-tailed) 0.001 
Median*** Experience 4.5 
No experience 4 
Experience 2.5  
No experience 3.5 
Median*** Male 4 
(Minimum 3, Maximum 5) 
Female 4 




8.4.3 Use of clinical guidelines 
 
In the previous section, 80 % (37) of the pharmacists felt that the 
unavailability of national clinical guidelines was an obstacle affecting their 
clinical practice. On the other hand 40 % (19) perceived the use of 
international guidelines by prescribers as an obstacle to their practice. In 
the final section of this survey, the pharmacists were asked about their 
opinions with regard to the use of clinical guidelines for prescribing in 
Sudan (Table 8.6). 
 











It is not possible  to 
implement clinical 
guidelines in practice in 
Sudan 
 
4%(2) 23(11) 8 (4) 50(24) 15(7) 
It is possible to 
implement international 
guidelines  in  practice in 
Sudan 
 
17(8) 52(25) 8(4) 19(9) 4(2) 
 For guidelines to be 
followed  they need to 
consider the socio-




33(16) 53(26) 10(5) 4(2) - 
 Guidelines need to be 
developed based only  
on scientific evidence 
 
29(14) 33(16) 14(7) 21(10) 2(1) 
The current prescribing  
in  hospitals  is  not 
based on guidelines 
 
31(15) 27(13) 27(13) 8(4) 6(3) 
Pharmacists have a duty 
to ensure that doctors’    
are following evidence-
based medicine  when 
prescribing 
 
35(17) 39(19) 12(6) 8(4) 6(3) 
Adherence to written 
guidelines is not always 
desirable in clinical 
practice 






The majority of pharmacists (65% (31) thought that it was possible to 
follow guidelines in clinical practice in Sudan. However, 58% (28) of 
pharmacists perceived that the hospital practice was not following any 
guidelines.  Furthermore, while 69% (33) of participants were in 
agreement that international clinical guidelines could be applied in Sudan,  
86% (42) perceived that guidelines need to suit the socio-economic 
condition of the patients. 
. 
When asked about their role in ensuring evidence-based medicine 
(EBM), more than 70% (36) of the pharmacists perceived that they had a  
duty to ensure that doctors are following EBM when prescribing. On the 
other hand the pharmacists diverged with regard to the use of guidelines 
in all circumstances, while 43% (21) perceived the statement ‘Adhering to 
guidelines is not always desirable’ to be true, 31% (15) were in 
disagreement with the statement. 
 
The reliability test (α) for the above set of statements (7 items) was 
equal to 0.4 with a higher value of 0.5 obtained if the item ‘Guidelines to 
consider the socio- economic state’ is deleted. Lower values of α are said 
to be expected in scales with fewer number of items that is less than 10 
(Pallant, 2005).  
 
Comparison between the groups 
        There was differences in responses about the use of guidelines in 
Sudan between those who were currently working as clinical pharmacists 
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Table 8.8 Difference in pharmacists’ responses on guidelines use (mean and median)  






MEAN MEDIAN  MAXIMUM MINIMUM 
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* 5-point Likert scale 
 
Using the Mann-Whitney test two statistically significant differences in 
responses were found between the participants based on their current 
practice with regard to the statements ‘Possible to implement international 
guidelines in Sudan’ and ‘Not possible to implement guidelines in practice  
in Sudan’ as shown in Table 8.9. The pharmacists who were currently 
working as clinical pharmacist were more likely to agree that it is possible 






those who were not working as clinical pharmacists. Using Mann-Whitney, 
gender had no effect on the views of the participants. 
 
Table 8.9 Mann-Whitney Test for pharmacists’ views about  














* Grouping variable:  current hospital clinical work (Yes/No) 
 
 
8.4.4 Survey participants’ comments 
 
At the end of the questionnaire the pharmacists were given the chance 
to add any further comments with regard to the issues discussed in the 
survey. The pharmacists had a few comments to add with regard to the 
obstacles facing their practice. These comments were grouped into main 
obstacles themes based on their content (Table 8.8). Some of these 
comments were related to the issues addressed in the questionnaire and 







Statement* Possible to implement 
international guidelines 
in Sudan 
Not possible to 
implement guidelines in 
practice in Sudan 
Mann-Whitney -U 190 179 
 Sig.(2-tailed) 0.029 0.016 
Median Yes 4 (Maximum: 5, 
Minimum: 2) 
No  4 (Maximum: 5, 
Minimum: 1) 
Yes 4 (Maximum: 5, 
Minimum: 2) 





Table 8.10 Survey participants’ (pharmacists) comments (N=10) 
 
OBSTACLE PHARMACIST’S COMMENT 
Not enough effort from pharmacists  to 
prove their role in patient care 
“Clinical pharmacist should work hard to prove 
their important role in patient management plan 
because if this not done by us no-one can do it for 
us.” 
Limited resources “ Lack of tools is a big problem facing clinical 
pharmacy” 
Not enough clinically trained pharmacists 
in hospitals 
“Lack of enough clinical pharmacists in hospitals 
because they were scattered between hospitals, 
we need to implement the ideal role of clinical 
pharmacy with the optimum number of clinical 
pharmacists in a specific hospital […]” 
Job description ‘The main problem facing clinical pharmacist in 
hospitals is a lack of job description […] and the 
majority of managers in ministry of health do not 
understand the role of clinical pharmacist.’ 
Implementation of guidelines ‘Guidelines in Sudan are very well implemented in 
three clinical areas, HIV, malaria and 
tuberculosis.’ 
Lack of clinically trained senior 
pharmacists 
“No senior clinical pharmacist available in hospital 
to help the junior pharmacist with no experience.” 
Lack in clinical pharmacy module “The study of clinical pharmacy in Sudan is mainly 
theoretical and there is no good implementation of 
clinical clerkship for student of clinical pharmacy 
in Sudan, moreover, the syllabuses of most 
colleges need to be revised and refined.’ 
Government role in healthcare ‘Sudanese government haven't got the will or 
desire to improve healthcare or the people’s 
health in Sudan, they don't care’ 
 
 











Summary of the results 
 
 The majority of the pharmacists in the survey perceived  that the different roles 
presented for pharmacists were part of the clinical pharmacist’s job in hospitals in 
Sudan 
 
 Pharmacists perceived that a number of obstacles were hindering the clinical 
pharmacy practice in Sudan. Some were related to the pharmacists themselves and 
others to the environment surrounding them. 
 
 Most of the pharmacists considered the unavailability of national guidelines as a 
challenge to their practice. On the other hand,  a large number of pharmacists  felt 
that international guidelines could be implemented in practice in Sudan  
 
 Pharmacists who were currently working as clinical pharmacist were more likely to 
agree that it is possible to implement guidelines including international guidelines in 










Clinical pharmacy in hospitals is a relatively new area of practice in 
Sudan.  The majority of pharmacists when presented with different duties 
related to clinical pharmacy practice expected the clinical pharmacists in 
Sudan to be performing most of these duties.  
 
There were roles which achieved an overall agreement by pharmacists 
as part of the clinical pharmacist’s job. These were the education of 
patients about their medicines (96% (48)) and identifying drug related 
problems (100% (49)). There was also almost overall acceptance from 
pharmacists in that their role in hospitals involved participation with 
prescribers in providing optimum therapy. The latter can be considered to 
be a positive move from the clinical pharmacists of Sudan towards 
accepting their responsibility in ensuring that patients get the maximum 
benefits from their medication. 
 
With regard to the use of guidelines in prescribing, the participants 
seemed to be positive about the implementation of evidence–based 
medicine in prescribing. The majority of pharmacists (65% (31)) perceived 
that clinical guidelines can be used in practice in Sudan and pharmacists 
have a duty to make sure that guidelines are followed. However, a high 
number of pharmacists (58% (28)) could not consider the practice in 
hospitals as adopting guidelines.  On the other hand, the majority of 
participants considered the lack of national guidelines as a barrier facing 
their practice. This issue of guidelines availability was also brought forward 
by the pharmacists in the FGD conducted earlier (chapter 7). This shows 
that although the pharmacists in Sudan seemed to be willing to embrace 
prescribing based on guidelines, more than half of the pharmacists felt that 
the current practice in hospitals is not based on guidelines. The 
pharmacists also considered that in the absence of the national guidelines 
and potentially the lack of access to information, their role in ensuring 
prescribing based on evidence is very much hindered. In a study in 




pharmacists as making them less capable of ensuring evidence-based 
prescribing (Abu Farha, 2014). 
 
 While the majority of the participant pharmacists (86% (42)) perceived 
that for guidelines to be implemented they need to consider the socio-
economic state of the patients, (69% (33)) of the pharmacists were not 
against implementation of international guidelines in practice in Sudan. 
This may be contradicting perceptions considering also that pharmacists 
thought that the unavailability of national guidelines is a challenge to their 
practice. However, a possible explanation of these perceptions is that in 
the absence of national guidelines, it is possible for the clinical practice in 
Sudan to embrace international guidelines. This is similar to what most of 
the prescribers in Khartoum cardiology units perceived in that in the 
absence of national guidelines, international guidelines can be used with 
certain adaptations so as to suit the patients of Sudan (section 5.5). One 
of the pharmacists also commented that in certain diseases such as 
malaria, HIV and tuberculosis, guidelines are very well followed in Sudan. 
The reason for this may be because these guidelines even if they are not 
national guidelines, are very much made considering the patients residing 
in more deprived countries who are most affected by these diseases. 
Interestingly, the clinical pharmacists who were currently working in 
hospitals were more positive in their views about the possibility of 
implementing guidelines in hospitals in Sudan than those clinical 
pharmacists who were not working in hospitals. 
 
 
With regard to the obstacles facing pharmacists, these can be divided 
into two groups. The first group is about pharmacists themselves being the 
barrier to role change.  The pharmacists in this study seemed to be almost 
divided with about half of the participants perceiving the personal 
characteristics such as a lack of communication skills and the attitude 
towards changing the professional role as challenges to their practice. 





considering pharmacists’ lack of confidence as affecting clinical practice. 
However, most of the pharmacists felt that they faced the difficulty of 
applying what they learnt as clinical pharmacists to practice. The argument 
that pharmacists’ attitudes have prevented them for making role changes 
was previously discussed (Al Hamarneh et al., 2011, Hall et al., 2013, 
Rosenthal, 2010). The claim was that the key constraint to advancement 
of clinical pharmacy practice is due to more than just external factors such 
as resistance from the doctors and the healthcare organizations or lack of 
enough pharmacists. The main obstacle was seen to be the pharmacy 
culture which is resistant or very slow in shifting from the ‘comfortable 
zone’ of drug focused practice to the ‘unknowns’ of the patient centred 
practice. However, it can be argued that since the pharmacists in many 
parts of the world have made the move from the comfortable zone of the 
dispensary to the unknown world of the medical wards, they have already 
overcome this suggested restricting ‘pharmacy culture’. With regard to 
other personal characteristics, the pharmacists in this study accepted that 
some of the constraints to their advance in practice, were related to factors 
such as lack of confidence. It can be expected with clinical pharmacy 
being a new area of practice in Sudan such lack of confidence may occur. 
However, the assumption is that with more time and as more skills are 
acquired, pharmacists will be able to overcome these personal barriers 
that are restricting their development. 
 
The second group of obstacles included challenges such as not having 
senior clinical pharmacists as role models or having prescribers resistant 
to pharmacist involvement. Many of these obstacles were also faced by 
pharmacists in the FGD (chapter 7). The need for support from prescribers 
and the acceptance of prescribers to the pharmacists’ role was discussed 
earlier (section 7.5). Interestingly 68% (34) of the pharmacists in this 
survey did not perceive the lack of support from doctors to be an obstacle 
to their clinical pharmacy practice. Whether this means that the doctors 






is not known. However, more than half of the participants (59% (27) 
considered that doctors’ resistance to pharmacists getting involved in  
prescribing as a challenge to clinical pharmacy practice. This again 
resonates with previous findings in this study (section 5.5), and other 
studies that the prescribers may be less comfortable with advanced roles 
of the clinical pharmacists such as recommending prescription drugs 
(Awad, 2007, Matowe et al., 2006, Smith et al., 2002, Tahaineh et al., 
2009, Zaidan et al., 2011).  
 
The pharmacists also considered the lack of a job description for clinical 
pharmacy as a major obstacle to their practice. When presented with the 
different roles for clinical pharmacists in the hospital, the majority of the 
pharmacists seemed to identify these roles as part of the clinical 
pharmacist job. As a new role one can understand the uncertainty these 
pharmacists are facing in deciding to what extent this new ‘clinical’ identity 
will allow them to intervene in patient management. Having certain 
standards for clinical pharmacy practice in Sudan that will consider the 
healthcare system in Sudan and the resources available is expected to be 
of benefit to the practice and the pharmacists. Some of the pharmacy 
governing bodies, for example the American College of Clinical Pharmacy  
has put standards for clinical pharmacy practice ((ACCP), 2014). These 
standards describe the duties of clinical pharmacists not only for  
pharmacists’ benefit but also for other healthcare professionals to know 
what to expect from clinical pharmacists.   
 
Although a smaller number of pharmacists (24%(11)) identified  the lack 
of access to patients’ notes as an obstacle to practice, this can be 
considered as a major challenge for clinical pharmacists in hospitals in 
Sudan as this is the first step  in being able to provide patient care. This 
can be either due to resistance from other healthcare professionals to 
pharmacists using or writing on the medical notes or hospital policies that 
do not recognize the need for pharmacists to have access to patient notes. 
This issue was identified by some clinical pharmacists in their first SSCP  




The number of clinical pharmacists in hospitals that were identified in 
this study was found to be small compared to the larger number of non-
clinical pharmacists who also work in the hospitals. Although it is expected  
that there would be fewer clinical pharmacists in Sudan than non-clinical 
pharmacists, the survey found that half of the participants who were 
clinical pharmacists were not actually working in hospitals. The actual 
cause of this is unknown but some explanations can be suggested. For 
example, the rate of pay in hospitals as identified by some pharmacists as 
a barrier to clinical practice may be one of the reasons for pharmacists 
with post graduate clinical pharmacy not to choose to work in hospitals. 
Furthermore, there may not be enough ‘clinical pharmacist’ jobs compared 
to non-clinical in the hospitals as the managers may not be still supporting 
the need for more clinical pharmacists as explained by the pharmacists in 
the FGD (section 7.4). It may also be a personal decision from the 
pharmacists that although they acquired the clinical post-graduate degree, 
they do not necessarily link that with hospital work. 
 
The pharmacists in the survey as well as in the FGD identified that CPD 
is a challenge facing them. Pharmacists seem to be aware that obtaining 
their clinical pharmacy speciality is just a start in their clinical career. 
Despite limited resources or lack of support from senior healthcare 
professionals, pharmacists may need to take the initiative themselves and 
find suitable methods to undertake CPD. It is hoped that now with the 
effort put by the Sudanese Society of Clinical Pharmacists to organize 
training sessions in different areas of clinical care (section 2.12.2); this 
may be a starting step for the pharmacists for professional development. 
However, the society need to consider that  pharmacists not only require 
to get more clinical knowledge but also need to develop certain skills and 
competencies such as communication skills and the means of transferring 








The pharmacists in their open text comments at the end of the 
questionnaire considered different difficulties facing the current practice.  
Most of these issues were also identified from the FGD and the 
prescribers’ responses to the questionnaire, for example, the unavailability 
of senior trained staff, the lack of enough clinically- trained pharmacists 
and the absence of a defined description of the clinical pharmacist’s job. 
These comments emphasized that the questionnaire touched on many of 
the difficulties that were encountered by clinical pharmacists in Sudan. 
 
8.6 Limitations and strengths of the survey 
 
The response rate to the questionnaire was difficult to determine.  The  
 response rate could be based on the e-mail addresses, the pharmacists 
with e-mail addresses and phone numbers or the pharmacists who were 
actually registered with the SSCP. The list of clinical pharmacists 
registered with the Sudan Medical Council which included the pharmacists 
registered with the SSCP contained e-mail addresses as well as some 
phone numbers for the pharmacists.  Therefore, all pharmacists with e-
mail addresses were included in the questionnaire and the response rate 
for this survey was based on the delivered e-mail addresses. 
 
A technical difficulty was encountered by some of the pharmacists in 
this study. Once the researcher was informed,  e-mails  were   sent as well 
as phone calls made to explain to the pharmacists about possible 
technical difficulties and how to resolve them if encountered or to contact 
the researcher.  None of the pharmacists contacted by phone had 
experienced any difficulties but the majority who were called had not yet at 
the time of the phone call made an attempt to reply to the questionnaire so 
the phone calls also served as a reminder. Although the technical error 
was later corrected on the online survey and the time for the survey was 







Another limitation as with all self-reports is that it is not possible to 
confirm that the actual responses reflected the true behaviour of the 
participants. Although measures such as anonymity and confidentiality  
were used to minimize effects like social-desirability bias, the risk of such 
bias cannot be ruled out. 
 
Similar to the previous survey limitations (sections 6.6), there were 
limitations in the statistical analysis. Due to the relatively small number of 
participants, it was not possible to perform certain statistical tests or no 
significant relations or differences between the groups were obtained 
when a test was carried out.  
 
The use of online survey can have its limitations including technical 
difficulties, availability and quality of the internet service and the ease of 
using the internet for some participants. However, the main contact 
available for the majority of clinical pharmacists was their e-mail address 
which implied that the pharmacists were using electronic mail. In addition, 
using the online option for the survey proved to be of value as some of the 
respondents were currently working outside Sudan.  
 
Finally, the findings were based on the results obtained from the 
pharmacists who responded to the questionnaire. The small sample of 
participants creates a potential response bias. It is not known if those who 
did not respond would have a different perspective of the issues explored 
in the survey.  However, the responses obtained were still considered to 
be of value as they shed light on a new area of practice in Sudan. The 
study has  managed to capture the views of clinical pharmacists with 
regard to  the challenges they are facing in their new practice that is hoped 










CHAPTER 9  FINAL DISCUSSION AND CONCLUSION 
     
 
   
 
 
    
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
         
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
     
 
   
         
         
         
         
         








9.1 Introduction  
 
This final chapter presents a discussion of the key findings of this study. 
The chapter also presents the strengths and limitations of this study, the 
conclusion and the contribution of this study to knowledge. Finally, the 
researcher presents a personal reflection on how her preconceived 
notions about this study were transformed during the research process 
and the way forward from the findings obtained. 
 
The main aim behind this study was to explore if guidelines were used 
by prescribers in Sudan, if guidelines can be implemented in practice and 
if international guidelines are suitable to be used in Sudan. The other part 
of the study aimed was to investigate the influence of clinical guidelines on 
the practice of clinical pharmacists in Sudan and further explore the 
pharmacists’ new clinical role with the challenges facing them.  To achieve 
the above aim, the study explored the perceptions and views of some of 
the prescribers in cardiology and clinical pharmacists in Sudan. The 
research is thus exploratory in nature. Exploratory studies are considered 
to be different from explanatory and evaluation studies in that they have 
no intentions of describing causes, evaluating conducts or generalizing 
results (Sue and Ritter, 2012). The study have achieved its aim by 
identifying the  prescribers and pharmacists’ perceptions with regard to the 
issues presented above as will be discussed in the following section.  
 
9.2 Summary of the key findings and discussion 
 
 The use of guidelines in clinical practice has been regarded as a means 
of providing healthcare of high quality by providing unified scientific-based  
approach to treatment (Berg, 1997, Hewitt-Taylor, 2006, Keeley, 2003, 
Woolf et al.,1999). With regard to the possibility of implementing 
guidelines in clinical practice in Sudan, the majority of the doctors who 
participated in this study thought that it is possible to apply guidelines in 




guidelines when prescribing for their patients.  Using international 
guidelines was considered as a suitable option in the absence of national 
guidelines. Doctors who were using international guidelines were trying to 
adapt the foreign guidelines to the healthcare situation in Sudan. Difficulty 
in implementing foreign guidelines is expected when they are applied to 
different populations (Hajjaj et al., 2010, Keeley, 2003). The main 
limitations for the doctors in following the international guidelines in Sudan 
were thought to be, the availability of the drug, the high cost of the drug 
and follow up of the patient’s treatment after discharge. Thus the doctors 
were choosing from the international guidelines what can be applied in 
Sudan and for their type of patients. This may be a logical approach in 
trying to implement evidence based treatment promoted by these 
international guidelines in settings with limited resources. However, this 
approach can affect the benefits expected from guidelines which can only 
occur when guidelines are taken as a whole set of recommendation 
whereby each part of the evidence is linked to the other. Some has 
cautioned that not following the sequence of treatment as presented in the 
guidelines can lead to the treatment provided not to be based on evidence 
(Fried and Krabshuis, 2008) . 
 
  The solution in implementing clinical guidelines in healthcare settings  
like  Sudan  can be seen in having national guidelines to suit the patients 
and the healthcare system of the country.  The concept of guidelines  
adapted for settings where there are particular social conditions and 
limited resources issues, is recognised and has been promoted in order 
that the perceived benefits from guidelines are not missed by patients in 
different parts of the world (Lindback et al., 2014, WHO, 2005b).  
However, the challenge for countries with limited resources is that it is 
considered a costly process to make guidelines from scratch (Feder et al., 
1999). During this research it was found that there are national guidelines 
in hypertension in Sudan ((SSH)), 2012). Unfortunately, many of the 
doctors involved in this study were not aware of the existence of such 
guidelines.  Different elements may have led to these guidelines not being 




when interviewed, few doctors were sceptical about the ability of a number 
of healthcare professionals in writing suitable clinical guidelines. Some 
also criticized the national guidelines as being a duplication of other 
international guidelines and therefore, not fit for practice in Sudan.  
 
It was difficult to determine if the guidelines made in Sudan were 
suitable for Sudanese patients as it seemed that they were not used by 
the majority of prescribers. Considering the resources required in 
constructing guidelines from the beginning, the national guidelines in 
hypertension in Sudan were adapted from British, European and World 
Health Organization guidelines ((SSH)), 2012). Recently, the Pan-African 
Society of Cardiology  emphasized the need for making guidelines based 
on studies on African patients in order to achieve the best management of 
diseases like hypertension (Dzudie et al., 2015).  However, in the absence 
of such local studies, and with the limited resources available, national 
guidelines in countries like Sudan will presumably continue to be adapted 
from international guidelines. In such case, these adapted guidelines  
should consider the resources of the healthcare system and the type of 
patients involved in order for them to be applicable in practice. 
Furthermore, the authors of such guidelines may need to be chosen 
according to certain criteria to be inclusive of not only medics but a variety 
of expertise and even patients’ representatives in order to ensure 
applicability of the guidelines and also add credibility to it.  Some studies 
have suggested that the risk of bias from non-inclusive guidelines 
developing committees may be a great limitation for the use of guidelines 
(Shaneyfelt and Centor, 2009, Woolf et al.,1999). A number of doctors in 
this study shared a similar view in that the individuals involved in making 
the guidelines should have certain characteristics in order to produce 
guidelines that can be implemented in practice.       
 
Although the recommendations of international organizations such as 






the healthcare settings in which they are applied (WHO, 2005b), some 
have also argued that to be able to use guidelines, certain specifications 
need to be  available in the health care system (Feder et al., 1999). This 
later argument was shared by some of the prescribers in Sudan who 
considered that it was not possible to implement any guidelines in practice 
in Sudan as hospitals even within Khartoum, the capital, were not able to 
provide comparable services. For those prescribers who could not depend 
on guidelines, prioritizing personal experience when prescribing was the 
solution. The debate about following experience versus guidelines was 
previously raised in a number of studies (Armstrong, 2002, Nutescu et al., 
2005). The suggested way forward is that prescribers do not need to 
choose between either following experience or following guidelines. 
Prescribers can depend on the guidelines to direct them to rational 
approach to treatment but they can use their experience and judgement to 
make their final decision.  
    
Considering all the above challenges in using guidelines especially in 
healthcare settings with limited resources, there does not seem to be a 
one solution to overcome all the difficulties.  Considering Buteow et al 
(1997) definition of appropriate prescribing which is prescribing that 
‘maximizes net individual health gains within society available resources’, 
it can be suggested that a possible solution to the use of international 
guidelines in countries like Sudan is to provide evidence from research to 
support doctors in that their manipulation of foreign guidelines to suit 
certain settings provide more benefit than harm to patient care. However 
considering the status quo, the practical approach will be to consider the 
benefits from treatment recommended by guidelines but accept that 
guidelines are there to guide and not rules to be followed blindly. As 
Sacket (1996) has defined EBM which is the base for clinical guidelines, 
as ‘using the best evidence to make the final clinical decision’, the final 
decision on prescribing will lie with the prescriber who should consider the 
suitability of applying the recommendations of the guidelines to the 





Although the lack of national guidelines did not seem to greatly affect 
the practice of the participating doctors, it was perceived by many clinical 
pharmacists and a few doctors as limiting the contribution of the 
pharmacists in the hospitals. The use of unified guidelines that all 
healthcare professionals can follow in their practice can be an advantage 
to healthcare professionals and also streamline the approach to patient 
management (Woolf et al, 1999). Most of the pharmacists considered that 
clinical practice in Sudan was not following any particular guidelines and 
that was seen as an obstacle in their clinical practice. However, the 
pharmacists may not have considered that even if guidelines were used in 
practice, they as pharmacists may face challenges in applying these 
guidelines. Other health care professionals, for example nurses, have 
perceived different barriers in implementing guidelines in clinical care 
settings including the ability to interpret the guidelines themselves 
(McCaughan et al., 2002).  
 
Similar to what some studies claimed to be a positive effect of 
guidelines on prescribers (Berg, 2000), it may be that the use of guidelines 
can enhance Sudanese pharmacists’ professional status by giving  them 
the knowledge, skill and power to make their interventions. On the other 
hand, it may also be a professional characteristic of pharmacist that make 
them perform better in the presence of certainty and standardized 
information which is provided by guidelines recommendations.  As other 
authors have argued, this certainty contradicts the element of 
professionalism which is considered by many to rely on the element of 
indeterminacy (Hall, 2013, Traynor, 2009). This indeterminacy as 
explained by Hall (2013) is an element of professionalism that makes 
professionals contrary to the lay person, able to process information and 
perform activities which cannot be directly derived from written text. 
Interestingly, this professional indeterminacy that guidelines limit, is one of  
the argued reasons that make some prescribers resist the use of 
guidelines (Armstrong, 2002,Traynor, 2009).  On the positive side, 





guidelines are providing evidence based medicine, pharmacists were 
found to enhance adherence to guidelines medications in healthcare 
resulting in improved patient outcomes (Horning et al., 2007).  
 
The existence of a specific pharmacy culture that makes pharmacists 
resistant  to make a change to a more patient-centred role has been 
argued  by some authors (Al Hamarneh et al., 2011, Al Hamarneh et al., 
2012, Hall et al., 2013, Rosenthal, 2010). Certain trends in pharmacists’ 
personalities and attitudes have been claimed to be a barrier in 
pharmacists making the move to acquire new roles in patient care. 
Pharmacists are seen as having a fear of venturing into new areas and 
thus they are resistant to be directly accountable and sharing responsibility 
for patient care. The pharmacists in this study were divided in considering 
whether or not it is pharmacists’ personal characteristics that are standing 
in the way of change to clinical role. 
 
The majority of prescribers in this study were receptive towards a 
clinical role for hospital pharmacists. In addition, the majority of the 
participant pharmacists did not perceive that the lack of support from 
doctors to be a challenge for their clinical practice. Some of the 
pharmacists considered some doctors to be very supportive while others 
were not.    The pharmacists felt that the lack of senior clinical pharmacists 
in hospitals who can support the new clinical pharmacists and act as 
leaders as one of the major challenges facing practice.  Being a new area 
of practice in Sudan, the current clinical pharmacists need to consider 
themselves as the leaders to the new practice, especially as a large 
number of those who did the clinical pharmacy course had a previous 
hospital work experience. The leaders of clinical pharmacy practice in 
many parts around the world were the pharmacists who were working in  
hospitals but made the move from being pharmacy based to being 







Clinical pharmacists in Sudan were found to have undertaken a post 
graduate training in clinical pharmacy to be able to practice as clinical 
pharmacists in hospitals. This means that there are currently two tiers of  
pharmacists in Sudan, clinical and non-clinical pharmacists. Both were 
found to be working in the hospitals in Sudan but only clinical pharmacists 
were expected to have ward duties.  The concern regarding two tiers of 
pharmacists was previously raised in that it allows different levels of 
services to be provided by pharmacists (Provost, 1972).  This can create 
confusion among the public and healthcare professionals about what 
service to expect from pharmacists which is not in favour of the profession. 
However, many of the available undergraduate pharmacy courses were 
perceived as not providing the required clinical training. Even the post 
graduate course which was undertaken by the majority of the pharmacists 
in this study and was the first of its kind in Sudan, was not satisfying to all 
pharmacists. Although many new schools of pharmacy have started to 
include clinical pharmacy training in their curriculum, some academics in 
Sudan seem to be resistant to the complete shift to clinical based training 
(Mohamed, 2011). The argument is that this may undermine the 
importance of teaching other subjects traditionally taught in pharmacy 
schools which are considered as a core in giving pharmacists the required 
scientific base.   
 
Many of the participating pharmacists identified the need for a less 
theoretical and more clinical approach to pharmacists’ training. The later 
has been discussed in previous studies where the emphasis on a change 
in pharmacy teaching was perceived to be the main element in creating 
competent pharmacists (Hammer, 2000, McLeod, 1976, Hepler and 
Strand, 1990, Schafheutle et al., 2013). This is not only about acquiring 
the clinical knowledge required for practice, but also to understand and  
learn elements of the professional identity that is expected from   
pharmacists. This professional identity includes the professional ethical  
parameters of the profession, the responsibility of the job, the professional 





Broadhead and Facchinetti, 1985). The pharmacists in this study identified 
the lack of some of the above professional elements, for example, the  
interprofessional communication skills and the exact responsibility of the 
job as obstacles in their clinical practice. 
 
It is argued that pharmacists alone could not advance without the 
support of the healthcare institutions in which they are practicing (Hepler 
and Strand, 1990, Phillips et al., 1987). This is similar to what some 
pharmacists in this study explained in that the lack of support from the 
healthcare authorities and hospital managers is a challenge facing them in 
developing their practice.  This support whether in the form of training or 
availability of resources was considered by some pharmacists to be a 
requirement in order to progress in clinical practice.  The Federal Ministry 
of Health in Sudan supported the call for improvement of hospital 
pharmaceutical services to meet future challenges (Directorate of 
Pharmacy, 2006). Currently clinical pharmacists in Sudan are recognized 
as specialist pharmacists in contrast to non-clinical pharmacists. Some 
effort as explained by a number of pharmacists was also put by Khartoum 
State Ministry of Health in arranging a number of meetings to support the 
clinical pharmacists working in some of the state hospitals. However, still 
many clinical pharmacists have not been encouraged to work in hospitals, 
like half of the pharmacists who participated in this study. As pharmacy is 
only one issue out of many concerns facing the healthcare system, it may 
be a while before the health authorities will have the resources to put into 
clinical pharmacy practice in Sudan.  
 
Finally, the changes that happened in pharmacy practice through the 
years from compounding, to dispensing to clinical duties has provided a 
challenge for the pharmacy profession to change the role specification so 
as to maintain its place as a recognized profession. Considering the 
changes that are either advocated for pharmacy practice or those which 






by other authors that there is a need to identify the exact role of the 
pharmacist of today (Elvey et al., 2013).  The assumption is that unless 
the exact role of the pharmacist is clearly known, pharmacists will struggle 
to get the recognition for their new clinical identity. In this study, the effort 
exerted by some pharmacists in getting prescribers’ recognition seemed to 
be at the expense of the effort that needed to be spent by the patient’s 
bedside.  However, the assumption that there is a one model or one role 
for clinical pharmacy practice that fits all may be far from realistic. 
Although many pharmacy bodies in different countries especially those 
with advanced clinical pharmacy practice may have set descriptions and 
standards for clinical practice, these may not fit with the practice in Sudan. 
This is similar to the challenges that prescribers have encountered in 
trying to implement international guidelines in clinical practice in Sudan.  
There is no doubt that there is a need for certain standards for practice. 
However, with the obstacles encountered in practice, clinical pharmacists 
of Sudan together with pharmacy regulating bodies in Sudan need to set 
the standards and the job specification for practice that suits the patient 

















Summary of the main findings: 
 
 Prescribers in Sudan were largely dependent on foreign guidelines 
for prescribing. 
 
 A number of challenges were facing prescribers in applying foreign 
guidelines in Sudan 
 
 A number of prescribers considered that it is not possible to 
implement guidelines in practice in Sudan   
 
 The clinical pharmacists were challenged by the non-existence of 
unified guidelines in hospital practice in Sudan 
 
 Other obstacles were identified as facing the new practice of clinical 
pharmacy ranging from difficulty in translating clinical knowledge 
into practice, lack of certain personal skills to the environment they 






9.3 Strengths and limitations of the study 
 
Different steps were taken in this study to enhance validity and reliability 
of the quantitative and qualitative methods used and hence add 
trustworthiness to the results obtained. In addition, to ensure the concept  
of rigour, detailed explanation of the steps used in this research, care for 
details and also honest approach during the whole research process was 
maintained. As it may not be possible to generalize the findings of this 
study, a degree of transferability of these findings can be expected to be 
applicable in similar settings to where the research was conducted.  
 
Quantitative methods 
Face, content and construct validity were used to enhance the validity 
of the quantitative part of this study. Reliability test for internal consistency 
between the set of statements used in the questionnaires was performed 
using values of Cronbach’s alpha. 
 
Qualitative methods 
Although reliability  measure is debatable in  qualitative research 
(Bowling, 2009a), certain measures were used to increase transparency 
and credibility of the qualitative data obtained. The background and the 
experience of the researcher were stated as these may have an influence 
in the collection, analysis or interpretation of data. To enhance 
transparency, the themes and codes obtained from the analysed data 
were checked by the supervisors in the University of Bath. In addition, an 
independent pharmacist was asked to check the transcribing and 
translation of an interview of his choice.  
 
Although there were different methodological limitations with each 
method, an effort was made to minimize these limitations whenever 
possible as explained in sections 5.6, 6.6, 7.6 and 8.6. 
 
Finally, this was the first time for the researcher to use any of the 




step of this work was training and learning experience for the researcher. 
Therefore, with greater experience, it is possible that any of these 
methods could have resulted in different findings. 
          
9.4 Conclusion 
 
The findings of this research identified that prescribers in Sudan were 
largely dependent on foreign guidelines for prescribing.  The prescribers 
were facing a number of challenges in trying to adapt the 
recommendations of the foreign guidelines to the situation of the patient 
and the healthcare system in the country. This was considered as the only 
practical approach in the absence of national guidelines. However, 
research is required to determine whether this adaptation of foreign 
guidelines, which is most of the time done individually, will lead to the most 
possible appropriate prescribing that can be achieved in limited–resources 
healthcare settings. The pharmacists on the other hand, although not 
against the use of foreign guidelines in clinical practice in Sudan, were 
challenged by the non-existence of unified guidelines to treatment that is 
agreed upon by both pharmacists and doctors. Again studies are required 
to understand the influence of having guidelines in practice on the 
professional performance of pharmacists.  
 
The clinical pharmacists in Sudan were facing many challenges in their 
new practice. Although some of these challenges were created by the 
surrounding environment of healthcare in Sudan, these new pharmacists 
need to share the responsibility in trying to overcome these obstacles and 
pave the way for clinical pharmacy practice in Sudan.  
 
9.5 Contribution to knowledge 
 
What is known about this topic is that clinical guidelines need to be 
suitable for the patients and the healthcare system they are supposed to 
be applied in. On the other hand, it is also known that creating guidelines 




healthcare bodies especially in developing countries. However, a solution 
to such a dilemma appears not to have been yet reached.  With regard to 
pharmacists, it was shown that pharmacists in the presence of guidelines 
play a positive role in ensuring adherence to medications guidelines. 
However, the influence of the availability or non-availability of clinical 
guidelines on the practice of clinical pharmacy was rarely studied. 
 
This study is considered to be a contribution to research in healthcare in 
Sudan by looking into areas which have not been studied before. This 
study may also help to emphasize the importance of examining healthcare 
from the views of different professions to increase the interprofessional 
link as team work should be the aim for better health care.  
 
The use of online questionnaires in this study was of interest to many 
pharmacy researchers in Sudan who contacted the researcher to know 
more about the process. This was an innovative approach and may 
contribute to how researchers in Sudan can now think of making use of 
the World Wide Web to start adopting new methods in conducting 
research.  
 
In addition, qualitative methods such as interviews and focus group 
discussions were rarely used in pharmacy research in Sudan. This 
research can thus add to show the benefits of these methods in pharmacy 
practice research.   
 
The findings of this study, although limited to certain healthcare settings 
in Sudan and involved a limited number of participants, is expected to be 
of value to healthcare policies in Sudan and furthermore for other 












At the beginning of this research and based on the researcher’s 
previous experience, the idea was to find out if doctors in Sudan are 
following the prescribing guidelines for heart disease that are used by 
doctors in countries like the UK so that the patients in Sudan would not 
miss the benefits of the drugs recommended by these guideline. The other 
thought based on the knowledge that there are now clinical pharmacists in 
hospitals in Sudan, was that how these pharmacists are managing to 
provide interventions assuming that there were no guidelines in practice in 
Sudan.  
 
After starting the research and spending time in the hospitals in 
Khartoum this idea started to change gradually and the question became 
more about how possible it is to apply international guidelines in Sudan 
considering the current healthcare situation in Sudan and the socio-
economic factors of the patients in Sudan. My thoughts became that 
guidelines are not just about prescribing  drugs but linked with these drugs 
there are other factors such as follow ups and monitoring which are 
necessary to get the maximum benefits from these drugs. The feasibility of 
that in Sudan may be questionable. 
 
 Also my initial idea was that as pharmacists we need guidelines in 
practice to make our interventions in patient care so that patients can get 
the maximum benefit from their treatment.  But during the research and as 
talking to pharmacists I started thinking if  guidelines  as a set of 
recognized recommendations for drug use, provide us pharmacists with 
the confidence we need (or lack) to communicate with prescribers. It may 
be also be that we as pharmacists are set to ‘function better’ professionally 
if we depend on what can be perceived as a ‘solid’ form of information that 







9.7 The way forward 
 
Attempts have already been made to apply some of the findings of this 
study.  Several ideas for future work in hospitals in Sudan were identified 
and were presented by the researcher to the pharmacists in a meeting of 
the Sudanese Society for Clinical Pharmacists (SSCP) to which the 
researcher was invited. These suggestions can be summarized as follows: 
 
 As there is a wide agreement especially from pharmacists on the need 
for national guidelines, more effort should be made to have national 
guidelines, probably adopted from international guidelines that are 
acceptable to all healthcare professionals involved, with pharmacists 
contributing to the development of these guidelines that will take into 
account the healthcare system in Sudan. One of the interviewed  doctors 
in Ahmed-Gasim hospital mentioned that there is a plan to make local  
cardiology guidelines with the help of the clinical pharmacist to be used 
in the hospital. 
 
 To have a source of information for the use of drugs in Sudan that is 
agreed by all healthcare professionals as their main provider for 
information. The British National Formulary (BNF) was found to be used 
by some prescribers and pharmacists but the current versions were not 
always available. During data collection in Sudan, the researcher 
became aware that there were plans from the Ministry of Health to restart 
printing the Sudanese National Formulary (SNF) which was previously 
available but its issuing has stopped for a number of years. The SSCP 
can work with the Ministry of Health to push forward the production of the 
SNF. 
 
 To have the non-clinical pharmacists working in the dispensary to be 







 Now that it is almost ten years since the start of the clinical pharmacy 
course in Sudan, clinical pharmacists with experience could be involved 
in training of other pharmacists in the post graduate clinical course.  
 
 To have separate drug charts for prescribing as no drug charts were 
used in the hospitals.  Upon request, a version of a drug chart used in 
one of the hospitals in UK was given to the pharmacists in Alshaab 
hospital. 
 
 The clinical pharmacists need to be more involved with patients on ward 
level and especially in doing medication reconciliation and managing the 
patients’ medications as currently only the doctors are taking drug 
histories and the nurses are managing the medications on the ward.  
 
 Clinical pharmacists to get an exchange of experience with other clinical 
pharmacists abroad or having clinical pharmacists from abroad to 
provide training in Sudan. An attempt was made by the researcher to 
arrange placement for the clinical pharmacists in Ahmed-Gasim hospital 
by contacting one of the Sudanese pharmacists working in hospital in 
UK.  In addition during this study the researcher gave a lecture to the 
clinical pharmacists in Sudan about clinical pharmacy practice in 
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Appendix 2 Interview guide 
 







 Participants’ characteristics 
 Current position 
 Practicing years 
 Previous work experience 
 
 
2- Influences on prescribing 
 
 Factors influencing prescribing 
 Parameters that guide the prescribing of pharmacological interventions 
 Availability and use of guidelines 




3- Role of clinical pharmacists 
 
 Pharmacists as part of the healthcare team in hospitals 
 Doctor-pharmacist interaction 
 Pharmacist input on prescribing 
 
 















Appendix 3 Information to healthcare professionals 
 
Part1: 




You are being asked to take part in a study about the factors affecting prescribers’ 
choice of drugs in the management of heart disease and the role of hospital pharmacists 
in the disease management in Khartoum hospitals. This study aims to ensure that heart 
disease patients are not missing the benefits of the pharmacological interventions that 
can decrease mortality and morbidity. 
 
Cardiovascular disease (CVD) once thought to be confined to industrialized nations has 
emerged as a major health threat in developing countries. Management of the disease in 
these countries is said to be limited because of other competing health issues.  Published 
studies have shown that CVD is one of the specialities very much influenced by clinical 
prescribing guidelines however there are major arguments about the advantages and 
disadvantages of the use of guidelines in prescribing.  
Another question which the study wants to look into is the role of the hospital 
pharmacist in the cardiac wards in Khartoum hospitals and if they can contribute to 
effective prescribing. Studies have shown that the impact of the pharmacists in hospitals 
reduce morbidity and mortality, improve prescribing of medicines and reduce 
medication errors. Pharmacist impact can be greater if they can provide input at the time 
of prescribing and this is achieved most of the time in hospitals when pharmacists are 
present as a full member of the patient health care team. 
 
You have been chosen because you are either a cardiology prescriber or a ward 
pharmacist covering cardiology wards in one of the hospitals in which the research is 
taking place. We would like to hear your views, opinion and experience about the 
research questions. 
 
Part 1 of this information letter tells you the purpose of this study and what will happen 
to you if you take part. Part 2 gives you more detailed information about the conduct of 
the study. Please take time to read this information carefully and talk to others about 
this if you wish. If you would like more information or if there is anything that is not 
clear, then please contact the researcher Hwaida Elsadig (Contact details below). 
 














No. It is up to you to decide whether or not you want to do this research. If you do take 
part you can keep this information sheet and you will be asked to sign a consent form. If 
you decide to take part you can still change your mind later, without giving a reason.  
 
 
What will happen during the study? 
 
If you agree to take part in the study, you will be asked to do an interview with the 
researcher. You will be contacted by the Research Officer, who will explain things to 
you in further detail. A suitable time and place will be arranged for the interview to 
occur. This can be at a place of your choosing. You will also be asked to sign a consent 
form. The interview will follow a flexible approach during which the researcher will 
have questions to ask regarding the research questions. We expect the interview to last 
between 45 and 60 minutes.  
The interview will be recorded and you will be asked your consent for this to happen. 
When the tape is being written up, you will not be able to be identified in any way from 
the recording. The first part of the study will take between 4 to 6 months to complete so 




We expect to interview you at your place of work at a mutually agreeable time.  
 
What are the possible disadvantages and risks of taking part? 
 
Taking part in the study is very unlikely to put you at any risk. In the unlikely event that 
the interview brings up difficult issues for you, the researcher will deal with these 
sensitively. You may ask to stop the interview at any time.  
 
What are the possible advantages of taking part? 
 
We do not expect that there will be direct personal advantage to you in taking part. 
However the information you give us will help us to understand and describe different 
issues regarding the pharmacological management of heart disease in Khartoum 
hospitals.  
 
What if something goes wrong? 
 
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. However, if you wish to complain or have any 
concerns about any aspect of the way you have been approached or treated during the 
course of this study, you can contact the local supervisor in  
Al-Shaab hospital or the lead supervisors in Bath University (contact details below). 
 
Will my taking part in the study be kept confidential? 
 
Yes. We will follow ethical and legal practice and all information about the participants 
will be handled in confidence. All information coming from any of the interviews will  
not have any name on it and will not be shared with anyone else who is not part of the 





3-5 years and then destroyed. You can see the written report of your participation at any 
time.  
 
What will happen to the results of the research study? 
 
We may have some of what you say printed in a journal, report or thesis. If this happens 
your name and details will always be removed, so that nobody will know whose words 
they are. If you are interested to know more about the results, you should contact the 
researcher or supervisors for further information. 
 
Who is organising and funding this research? 
 
The study is supported by a grant from the University of Bath in UK. 
   
Who has reviewed this study? 
 
This study has been reviewed by the National Health Research Ethics Committee of the 
Federal Ministry of Health in Sudan. 
 
Who do I contact for further information? 
 




Researcher: Hwaida Elsadig  
                   Tel no (Sudan): 906111128 
                   Email: h.m.elsadig@bath.ac.uk 
 
 
Lead supervisors: Prof.Marjorie Weiss: m.weiss@bath.ac.uk 
                          Dr.Jenny Scott: j.a.scott@bath.ac.uk 
                          Dr. Raisa .Laaksonen: raisa.laaksonen@helsinki.fi 
 
Local supervisor: Mr. Ahmed Al-Sayed: asaelsayed@hotmail.com 
 
      
What do I do now? 
 
If you would like to take part, you can complete the reply slip, leave it in your office 
and the researcher will come and collect it in the next few days or you can directly 
contact the researcher (See contact details). 
 














Place of work: 
 
 
Preferred method of contact (circle one):  
 





What is the best time of day to contact you? 
 
 






















HEALTH CARE PROFESSIONAL CONSENT FORM 
 
 
Please initial the box 
 
1. I confirm that I have read and understood the  
information provided to me about the above study    
 
2. I understand that my participation is voluntary 
     and that I am free to withdraw at any time 
 





_________________           ______________           _________________ 






_________________           ______________           _________________ 










1 for participant; 1 for researcher 
 
Researcher: Hwaida Elsadig               
Department of Pharmacy & 
Pharmacology 




Appendix 5 Frame-work analysis 
Frame-work analysis of interviews 
 Influences on prescribing 
 
Consultants 
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B/G: Price can 
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treatment 
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NAS(11yrs) M The 
disease 
  Cost 
B/G: prefer 
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ity is an 
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B/G: Believe in 
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administration 





























 Use of prescribing guidelines 
 
Consultants and years of 
experience in cardiology 
Use of guidelines for 
prescribing 
Availability of national 
guidelines 







KAG (1yr) F Treatment according to 
guidelines 
National guidelines for 
hypertension 
They are not made for 
people in Sudan; some of 
the drugs recommended 
are not available 
Experience limited so try to 
stick to guidelines; senior 
doctors depends on 
experience 
American guidelines 
IAS (1yr) M Guidelines to be followed Not available Can be applied in most of 
the situations; 
Was not in a situation 
where guidelines were not 
applicable 
Guidelines always first NICE ((BHF)) 
guidelines 
LAG (10yrs) F Guidelines cannot always 
be followed 
National guidelines for 
hypertension available but 
not adopted 
Attempts in the hospital to 
make guidelines based on 
international guidelines 
Older generations of 
prescribers prefer to stick 
to experience 
American guidelines 
BAS (19yrs) M Not applicable in all cases Guidelines for hypertension 
(ACS and heart failure in 
progress) 
Not applicable in all cases Experience more 
important. Experiments are 
conducted on restricted 
situations 
American and Saudi 
guidelines 
AAS (5yrs) M Improve survival, and 




for management are 
available based on 
guidelines) 
Cost and availability of 
drugs hinder following 
guidelines. 
Guidelines adapted to 
personal settings(cardiac 
care limited resource 
setting) 
Experience is based on 
evidence from guidelines, 
both work together well; 
guidelines are not rigid 
allowing room for 
experience so both work 
well together 
American and 
European (there is a 
difference) 
KAS (27yrs with gaps) M For the patient benefit, 
Appropriate prescribing is 
guidelines 
National guidelines were 
not made appropriately 
No major problems with 
following international 
guidelines(most of them are 




MAS (12yrs in cardiology, 





Not much into guidelines, 
use what is known and 




 Do not use any specific 
foreign guidelines 
Prescribe based on 








Consultants and years of 



























QAS(starting fellowship) F Not much experience Can be of advantage to 
unify treatment 
 Always consider  my 
seniors’ opinions 
 
ZAS(24yrs) M Difficult to unify treatment 
in Sudan(resources vary) 
Not available, attempts till 
now were not successful 
Not suitable for Sudan Therapeutic traditions 
precede over guidelines 
 
SAS(14yrs) M Guidelines are important 
factor for prescribing  
Guidelines for hypertension 
(some protocols under 
review by the ministry of 
health) 
Can be used with 






European and then 
American 
GAG(first  
year in cardiology 
fellowship) M 
Important, most of the time 
cannot be applied 
Some are available but 
people don ’t  know about 
them 
Can be used with some 
modification 
Guidelines and experience 
of the seniors 
American guidelines 
NAS (11 yrs) M Important Not available Can be used with 
adaptation to the situation in 
Sudan 
























Role of hospital pharmacist 
 
Consultants and years (yrs) of 
experience in cardiology 
Contact with pharmacists Current role Expected role Type of experience 
KAG (1yr) F One pharmacist available on the 
ward 
Informing doctors of side effects 
and interactions/MI service 
Can recommend medication if 
doctors forget to prescribe 
Found the pharmacist to be 
useful 
IAS (1yr) M Only in contact with medical 
representatives (usually 
pharmacists) 
No pharmacist on the 
ward/never used MI service 
Should be clinical, part of the 
team, participate in patient 
management 
No experience 
LAG (10yrs) F In contact with one pharmacist 
in the hospital 
Drug related issues information, 
formulary, part of the group to 
make hospital guidelines 
 Happy with what the pharmacist 
is doing 
BAS (19yrs) M One pharmacist on rounds (use 
to have pharmacist on ward 5yrs 
ago) 
Just starting Can be useful for S/E and 
interactions 
Team work is required 
AAS (5yrs) M Have a new clinical pharmacist 
on the ward round 
Not aware of any current 
contribution/never used hospital 
MI 
Interactions Never used them (don’t like 
pharmacists who are medical 
reps.) 
KAS (27yrs with gaps) M  Being on the wards is not part 
of their job in Sudan 
Did not come across clinical 
pharmacists in the hospital 
Drug  monitoring and help in 
providing proper team work 
In contact with medical reps, 
information is not reliable as 
basic teaching of pharmacy is 
lacking 
MAS (12 yrs in cardiology 
(not cardiologist) F 
Aware of one pharmacist, the 
chief pharmacist 
No pharmacists on the ward  The chief pharmacist for drug 
supply problems 
NAS(11yrs) M Only in contact with company 
reps. pharmacists 
Cannot contribute in the 
absence of guidelines 
  
QAS(starting fellowship) F Not in contact with hospital 
pharmacists 
In the pharmacy(dispensary) Participation, be in contact with 
doctors and available in ward 
rounds 
 
ZAS(24yrs) M Previous contact , no longer 
available, good social relations 
In the pharmacy (dispensary) Can contribute if they have more 
confidence in their abilities 
Previous MI service provided by 
pharmacists, no longer available 
SAS(14yrs) M No clinical pharmacists in the 
hospital (previous contact with 
pharmacists in Ireland) 
Not aware of any contribution Attendance of rounds, advice on 
drugs, but difficult to be 
prescribers 
Not aware of MI in hospital 
GAG (first year in 
 cardiology fellowship) M 
A pharmacist is available on the 
ward 
Assist in reviewing doses (as an 
example) 





Appendix 6 Questionnaire with the prescribers 
 
Respondent Information Leaflet 
 
 
Prescribing in cardiovascular disease and the role of the hospital pharmacist in 





You are asked to take part in a research study. You have been chosen because you are a 
prescriber in cardiology in one of the hospitals in which the research is taking place. 
 
Interviews have been conducted with some of the doctors working in cardiac units in 
Khartoum about their opinions in what influence their prescribing and what they think is 
the role of the hospital pharmacist. The purpose of this questionnaire is to explore the 
prevalence of these opinions in a larger group of prescribers and to identify potentially 
new opinions. 
 
Please take time to read this information and the covering letter that accompanies this 
questionnaire. Some of the questions will require a written answer; if you prefer to do 
that in Arabic language please feel free to do so. If you would like to receive more 
information on this research or if there is anything that is not been explained clearly, 
then please contact the researcher on 0906111128. Alternatively you can contact the 
research lead supervisor, Dr. Jenny Scott on j.a.scott@bath.ac.uk. 
 
This research has been approved by the National Ethics Committee of the Federal 
Ministry of Health in Khartoum. The information gathered will be treated with strict 
confidentiality and will only be used for the purposes of this research. The research is 
for a PHD study so we hope that we can publish some of the findings. No participant 
will be identified at any stage during or after the research. Any information gathered 
will be safely stored with the researcher and disposed of securely within five years of 
this project.  
 
We would like now to express our thanks for your support in advance. If you would like 
to receive a summary of the results of this questionnaire please leave your contact 

















Firstly, we would like to ask you some questions about yourself. Please, tick as 






   Others (please specify): 
                        
 
iii) Please give information about your current position (e.g. medical officer, registrar,     
 
     physician, cardiologist and/or any other titles):  
 
 




    If no, please specify in which country:  
 






ix) If no (to question viii), please specify in which country(s):  
 
 




xi) If yes (to question x), please specify, in which country(s) and for how many years in 
each country: 
                         
                                       














A. The first section is exploring the different sources of information generally used by 
doctors to assist prescribing.  
 
Please consider the following statement, choose your response from the list below and 
then ‘tick’ in the box that applies to you for each option in the list: 
 


















































     
11- Clinical 
Guidelines 
     
 








B. The following section is about the different factors that may influence prescribing in 
heart disease.  
Please consider the following statement with regard to the following ‘list of factors 
which may influence prescribing’ and then ‘tick’ in the box that applies to you: 
 











13-  Availability of the drug 
  
     
14- Patient choice of  medicines 
 
     
15- Patient (or patient carer) is 
educated  enough to know about 
the safe use of  their medicines 
 
     
16- Drug related effects (e.g. 
side effects, contraindications) 
 
     
17- Drug frequency 
 
     
18- Patient medical condition      
19- Information from the drug  
representative 
 
     
20- The likelihood of patients  
coming back  for follow up after 
discharge 
 
     
21- Information from colleagues  
     
     
22- Drug monitoring (e.g. lab 
tests) 
 
     
23- The company making the 
drug 
 
     
24- Drug cost implication on the 
patient 
 
     
25- Guidelines 
 
     
26- Working place  (whether 
 government or private sector) 
 
     




                                  
                            
28- Are there any other factors (not mentioned in the previous list of factors which may 








29- Please select from the list of factors in page 4 (or if there is any other factor that you 
consider not mentioned in the list) the THREE most important factors that influence 
your choice of drug for your patients and write them in order of their importance for 
you: 
 





































What is your opinion about the following statements regarding clinical guidelines? 










30- It is not possible to apply 
treatment guidelines in 
practice in Sudan 
 
     
31- It could be possible to 
make Sudanese guidelines for 
cardiology  that could be  
followed  in Sudan 
 
     
32- International guidelines 
for cardiology can  be 
followed  in  practice in 
Sudan 
 
     
33- For guidelines to be 
followed  they need to be 




     
34- Clinical guidelines are 
more important than clinical 
experience 
 
     
35- Clinical experience is 
more important than clinical 
guidelines 
 
     
36- Clinical guidelines are 
not relevant at this stage of 
my practice 
 
     
37- The current clinical 
practice in my hospital is  not 




     
38- Adherence to written 
guidelines is not always 
desirable  
 













39- How often do you use guidelines when prescribing for heart disease patients? 
Please ‘tick’ in the box that applies to you: 
 
 
Never Rarely Sometimes Often Very  
often 
     
     
 
 
40- Are there any Sudanese guidelines in cardiovascular disease? 
 



























41- If you happen to use guidelines when prescribing; please specify the name(s) of the 








The following statements are about brand and generic drugs. For example, in Sudan, the 
drug paracetamol is available as Panadol, Amidol, Paramol (and others). In general, 
Panadol is considered to be the main brand name while Paramol and Amidol are 






With regard to drugs used in cardiology, please consider the following statements and 
then ‘tick’ in the box that applies to you: 
 
 
42- The effectiveness of generic drugs is comparable to (that is, as good as) the brand 
drug: 
 
































































C. The final part of this questionnaire explores the contribution of hospital pharmacists 
in disease/patient management. 
 
45- How often are you in contact with a hospital pharmacist?  
Please ‘tick’ in the box that applies to you: 
 
Never Rarely Sometimes Often Very often 
     




If you are in contact with hospital pharmacists where do you usually meet the hospital 
pharmacist(s)?  
Please ‘tick’ in the box that applies to you for each option in the list below: 
 
 
 Very often 
 
    Often  Sometimes   Rarely   Never 
46- On the 
wards 
 
     
47- In pharmacy 
(dispensary) 
 
     
48- In pharmacy 
office  
 
     









     
51- Other areas 
in the hospital 
 




52- If you are in contact with hospital pharmacists by any other means (e.g. phone, 












The following statements are about different activities related to the role of hospital  
pharmacists. 
 
Please indicate what you think hospital pharmacists are currently doing in your hospital. 















     
54- Educate patients 
about their medicines 
 
     
55- Identify drug related 
problems 
 
     
56- Assist the prescriber 
in recommending 
medicines to be 
prescribed for the patient  
 




     
58- Inform prescribers 
about availability of 
drugs 
 
     
59- Inform prescribers 
about  guidelines 
therapy 
 
     
60- Establish patient 
drug history 
 
     




     
62-  Providing drug –
related information 
 
     
63- Ensuring prescribers 
are providing optimum 
therapy for patients 
 






64- Are there any other hospital pharmacists’ role(s) (not mentioned above) that you 



































Appendix 7 FGD guide 
 






1- Role of the clinical pharmacist (difference from before) 
 Description of activity 
 Ward pharmacists  
 
2-  Current influence of hospital Pharmacist 
 
3- Clinical pharmacy training 
 
4- Difficulties encountered 
 
5- Pharmacist-doctor interaction 
 Ward rounds 
 Medicine information 
 
6- Pharmacist-patient relationship 




 Years of experience 




 Any further comments  
 
 

















Appendix 8 Questionnaire with clinical pharmacists 
 




You are asked to take part in a research study. You have been chosen because you are 
registered as a clinical pharmacist with the Sudanese Society of Clinical Pharmacy. We 
obtained your contact details by permission from the society. 
The study is part of a PHD project with the universities of Bath, UK and Helsinki, 
Finland. In this part of the study we wish to explore the role of hospital clinical hospital 
pharmacists, hence, we would like to ask you to participate in the attached survey. It 
should take no more than 10 min to complete the survey. 
This research has been approved by the National Ethics Committee of the Federal 
Ministry of Health in Khartoum. The information gathered will be treated with strict 
confidentiality and will only be used for research purposes. No participant will be 
identified during or after the research or in the reports that result. Any information 
gathered will be safely stored with the researcher and destroyed after five years of the 
completion of the project.  
If you would like to receive more information on this research or if there is anything 
that is not been explained clearly, then please contact me (the researcher) or any of the 
research supervisors in the contact details shown below. 
Please respond to this questionnaire before 30th of April 2014. 




Hwaida Elsadig;  Email: h.m.elsadig@bath.ac.uk 




Professor Marjorie Weiss; Email: m.weiss@bath.ac.uk 
Dr. Jenny Scott; Email: j.a.scott@bath.ac.uk 



















Firstly, we would like to ask you some background questions about yourself. Please, 
tick as appropriate and follow other instructions. 
 
i- When (year) did you obtain your degree (qualification) as a clinical pharmacist? 
    ---------------------------------------------------------------------------- 
 
ii- Did you complete your clinical ph  
 
iii- If yes (question iii), please tell us in which university. 
    ----------------------------------------------------------------- 
 
iv- If no (question iii), please tell us in which country. 
    ------------------------------------------------------------- 
 
v- Are you currently working as a clinical pharmacist in a hospital in Sudan?  
  
     
 
vi- If yes (question vi), when (year) did you start working as a clinical pharmacist in a 
hospital? 
    ----------------------------------------------------------------------------------------------- 
 
vii- If no (question3), have you ever worked in a hospital in Sudan as a clinical 
pharmacist?  
 
      
 
vii- If you are currently not working in a hospital in Sudan, can you briefly tell us about 
your current field of practice (e.g. sales, community pharmacy, etc.)? 




                        
In the following part of the questionnaire we would like to ask your opinion as a clinical 
pharmacist about clinical pharmacy practice in hospitals in Sudan. Please follow the 


















A) Clinical pharmacists in Sudan are those pharmacists with post graduate qualification 
in clinical pharmacy. Clinical pharmacists are expected to acquire new roles with regard 
to patient care in hospitals. The following statements are about different activities 
related to the role of clinical pharmacists in hospitals.  To what extent in your opinion 
are these statements related to the role of clinical pharmacists in hospitals in Sudan? 





  Agree Neither 
agree nor 
disagree 
 Disagree Strongly 
Disagree 
1-To provide drug 
related information to 
healthcare professionals 
     
2-To educate patients 
about their medicines 
     
3-To identify drug 
related problems 
     
 4-To assist doctors in 
prescribing drugs 
     
 5-To provide drug 
related information 
mainly to doctors 
     
 6-To inform doctors 
about availability of 
drugs 
     
 7-To inform doctors 
about   therapy 
guidelines 
     
 8- To take drug 
histories of  patients on 
admission 
     
 9-To inform doctors 
about cost-effective 
treatment 
     
10-To provide drug-
related information 
mainly to patients 
     
 11-To participate in 
multi-disciplinary 
clinical care teams 
meetings 
     
12-To ensure prescribers 
are providing optimum 
therapy for patients 
     
13-To be involved in 
doctors' choices of 
medicines to patients 








B) Clinical pharmacy is considered to be a relatively new area of practice in hospitals in 
Sudan. The following statements consider some possible obstacles facing clinical 
pharmacists and clinical pharmacy practice in hospitals in Sudan. What is your opinion 








 Disagree Strongly 
Disagree 
14- Availability of  
information  sources 
(clinical, pharmaceutical) 
limits the extent of 
clinical pharmacy practice 
in hospitals 
     
15-Clinical pharmacists 
are resistant to change 
from their traditional roles 
to  expanded new clinical 
roles 
     
16-There is limited 
support from doctors for 
the new role of clinical 
pharmacists 
     
17- Clinical pharmacists 
are not confident that they 
have the required clinical 
skills to perform their new 
clinical roles in hospitals 
        
18- Hospital payment 
(salaries/incentives) for 
clinical pharmacists has 
no influence on their 
motivation  to provide 
clinical services in 
hospitals 
     
19- Doctors following  
international guidelines 
when prescribing create 
an obstacle for 
pharmacists to intervene 
     
20-The unavailability of 
national guidelines for 
treatment  is an obstacle 


















 Disagree Strongly 
Disagree 
21- Lack of experience of 
applying clinical 
knowledge to practice is a 
barrier for clinical 
pharmacy practice in 
hospitals 
                 
22-Clinical pharmacists  
are more concerned with 
doctors’ approval  to their 
roles than actually 
performing their new 
expanded roles 
                 
23-Doctors are resistant to 
clinical pharmacists’ 
involvement in assisting 
in prescribing 
                 
24-The lack of 
opportunities of  
continuous professional 
training  is a barrier in 
performing the expanded 
roles of clinical 
pharmacists 
                 
25-The lack of enough  
clinically trained senior 
pharmacists is a barrier in 
performing the expanded 
roles of clinical pharmacy 
                 
26-The not well-defined 
description  of the role of 
clinical pharmacists is an 
obstacle against clinical 
pharmacy practice 
                 
27- Pharmacists lack of 
communication skills 
affects their interaction 
with the prescribers 
                 
28- The lack of enough 
clinical pharmacists in 
hospitals  affects the 
development of clinical 
pharmacy 
                 
29- Access to patients’ 
notes is an obstacle in 
clinical pharmacy practice 
in hospitals in Sudan 





C) Clinical guidelines are perceived by many healthcare professionals and healthcare 
organisations as a necessity for providing optimum patient care. These guidelines are 
usually derived from evidence-based medicine made available by clinical trials. The 
following statements are about the application of clinical guidelines in practice in 
Sudan. What is your opinion with regard to the following statements? 










30-It is not possible  to 
implement clinical 
guidelines in practice in 
Sudan 
     
 31-It is possible to 
implement international 
guidelines  in  practice 
in Sudan 
     
 32-For guidelines to be 
followed  they need to 
consider the socio-
economic state of  the 
specific targeted 
population 
     
33- Guidelines need to 
be developed based only  
on scientific evidence 
     
 34- The current 
prescribing  in  hospitals  
is  not based on 
guidelines 
     
35- Pharmacists have a 
duty to ensure that 






     
 
 
36- Adherence to written 
guidelines is not always 
desirable in clinical 
practice 











If you have any further information or comments that you would like to add from your 
experience or practice or about any aspect covered in the questionnaire, please feel free 












Thank you for completing this questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
